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ABSTRACT
THE STUDY OF NITRIC OXIDE SYNTHASE EXPRESSION, 
FUNCTION, AND REGULATION IN THE RENAL VASCULATURE 
DURING POSTNATAL RENAL DEVELOPMENT
Brian Blake Ratliff 
Old Dominion University / Eastern Virginia Medical School, 2006 
Director: Dr. Michael J. Solhaug
The newborn kidney is vulnerable to vasomotor acute renal failure (ARF) from 
adverse perinatal events or complications of prematurity. Nitric oxide (NO) vasodilation 
is vitally protective in this type of ARF, but its relationship with other vasoactive 
factors, such as angiotensin II (All) has not been examined. In the immature kidney, 
nitric oxide synthase (NOS) isoforms, specifically eNOS and nNOS, are 
developmentally regulated, but their specific role and regulation are unknown.
The enhanced vasodilatory role of NO in the immature kidney was hypothesized 
to be attributed to regulatory, expressional, and functional differences in eNOS and 
nNOS isoforms from the adult. The objective of the dissertation was to: (1) determine 
which NOS isoform regulates immature renal hemodynamics by using functional whole 
animal studies utilizing intrarenal infusion of NOS inhibitors; (2) continue 
characterization of NOS expression in immature renal microstructures utilizing LCM 
(glomerular eNOS expression); (3) characterize expression and functional patterns of 
NOS isoforms, renin, and ATI and AT2 receptors in immature preglomerular resistance 
microvessels utilizing novel microdissection techniques; and (4) determine All 
regulation of NOS expression and function in the immature renal vasculature using ATI 
and AT2 receptor inhibitors.
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Isoform specific inhibition demonstrated nNOS is the major NOS isoform 
regulating neonatal, but not adult, renal hemodynamics. nNOS expression, greatest in 
the newborn’s preglomerular resistance microvessels, decreased, while eNOS 
expression increased, with maturation. NOS enzymatic activity was greater in the 
neonate’s preglomerular resistance microvessels, than in the adult’s. ATI and AT2 
receptor inhibition demonstrated All regulation of neonatal NOS expression and 
function via both receptors. Newborn nNOS expression demonstrated enhanced 
sensitivity to AD receptor inhibition.
Dissertation conclusions include: nNOS is the major isoform regulating renal 
hemodynamics in the immature, but not the mature, kidney. Glomerular eNOS 
expression is developmentally regulated with differences between intracortical location 
of glomeruli. NOS enzymatic activity in preglomerular resistance microvessels is 
greater in the newborn, than in the adult, and may be due to upregulated nNOS 
expression. While All regulates eNOS expression and NOS enzymatic activity, via ATI 
and AT2 receptors, in newborn and adult preglomerular resistance microvessels, nNOS 
expression is regulated by All only in the newborn.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Understanding the mechanisms that produce the unique renal functions of the 
neonate following birth are of high physiologic and pathophysiologic relevance for 
clinical management of newborns. A variety of different factors combine to promote a 
renal functional state in the newborn that is different from that of the adult. The 
newborn mammal, including humans, exhibits lower renal blood flow (RBF) higher 
renal vasculature resistance (RVR) lower glomerular filtration rate (GFR) and higher 
reabsorption of sodium as compared to the adult counterpart. The low RBF in 
conjunction with low GFR are produced by a high RVR. The uniqueness of the 
neonate’s renal hemodynamics impacts newborn clinical management, and predisposes 
the immature kidney to develop vasomotor-mediated acute renal failure (ARF) due to a 
variety of perinatal pathologies such as hypoxia, ischemia, shock, and prematurity 
complications.
The neonate’s unique renal condition is sustained by a crucial balance between 
vasoconstrictors, such as All, and the counter-acting vasodilator nitric oxide (NO). 
Angiotensin II (All) is highly activated at birth and maintains the high RVR found in 
the newborn kidney. A balance between these vasoactive factors in the developing 
kidney is the paramount mechanism that modulates renal hemodynamics during the 
postnatal period of development by influencing RVR reduction, with subsequent
increases in RBF and GFR.
This dissertation follows the style o f the American Journal o f Physiology Regulatory Integrative 
Comparative Physiology.
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NO plays a greater role in modulating renal neonatal hemodynamics under 
physiologic and pathophysiologic conditions. Current research suggest NO is the most 
important counter regulator of vasoactive constrictors in the developing kidney. This 
could be due to the developmental expression pattern of the NO-synthesizing enzyme 
nitric oxide synthase (NOS). Previous studies have identified two nitric oxide synthase 
isoforms, both of which are developmentally regulated in the immature kidney, 
endothelial NOS (eNOS or NOS III) and neuronal NOS (nNOS or NOS I) (131,132). 
The enhanced participation of NO in the immature kidney is attributed to the regulated 
difference in expression of nNOS and eNOS in the neonate and during postnatal renal 
maturation as compared to the adult. Previous studies on NOS isoform expression in the 
immature kidney have found that both nNOS and eNOS mRNA and protein levels 
undergo distinct and differing whole kidney and corticomedullary developmental 
regulation (128, 129).
While studies have shown the developmental patterns of the NOS isoforms in 
the whole kidney and cortex/medulla regions, the distribution, expressional abundance, 
and the functional capabilities of each isoform in specific segments of the developing 
renal vasculature have not been reported. The changes in renal hemodynamics that 
occurs during development are modulated primarily in the glomerular resistance 
vessels, including the afferent, interlobular, and efferent arterioles. The maturational 
patterns of NOS isoform expression and NO function in the developing glomerular 
resistance vessels are unknown.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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The role of NOS isoforms and the production of the vasodilator NO appear to be 
essential to keep in balance the enhanced vasoconstriction found in the newborn. In 
order to further understand the importance of the enhanced role of NO in the immature 
kidney, the distribution, expression and function of the NOS isoforms in these specific 
renal arterioles must be examined. Insight into the characteristics mediating the 
neonate’s renal hemodynamic state may be reflected in ARF prevention and treatment.
Several characteristics of nNOS in postnatal renal maturation suggest that this 
isoform may importantly participate in renal hemodynamics after birth. Whole kidney 
nNOS gene and protein expression are greater in the developing piglet kidney than the 
adult throughout postnatal renal maturation. nNOS also demonstrates an interdependent 
morphological relationship with the RAS. nNOS in the postnatal kidney may have 
interaction with the RAS
The mechanisms that regulate NOS expression in the developing renal 
vasculatory system have not yet been identified. Preliminary studies have indicated that 
All stimulates increases in whole kidney nNOS and eNOS expression in the kidney via 
ATI receptors as seen in ATI receptor inhibitory experiments. The stimulation of 
nNOS and eNOS by All via the ATI receptor has been linked to increases in cytosolic 
calcium. However, whole kidney experiment models do not delineate the specific 
regulatory mechanisms that are utilized by discrete renal vascular segments during 
development.
The enhanced vasodilatory role of NO in the immature kidney was hypothesized 
to be attributed to regulatory, expressional, and functional differences in eNOS and 
nNOS isoforms from the adult. The objective of the dissertation was to: (1) determine
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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which NOS isoform regulates immature renal hemodynamics by using functional whole 
animal studies utilizing intrarenal infusion of NOS inhibitors; (2) continue 
characterization of NOS expression in immature renal microstructures utilizing LCM 
(glomerular eNOS expression); (3) characterize expression and functional patterns of 
NOS isoforms, renin, and ATI and AT2 receptors in the immature preglomerular 
resistance vasculature utilizing novel microdissection techniques; and (4) determine All 
regulation of NOS expression and function in the immature renal vasculature using ATI 
and AT2 receptor inhibitors.




NOS IN THE KIDNEY
General description of NO
The vasorelaxative properties of nitric oxide (NO) were first discovered in 1979 
by Gruetter et al. (73). However, it wasn’t until 1987 that Ignarro et al. and Palmer et al. 
identified endothelium-derived relaxing factor (EDRF) as NO, thus realizing 
mammalian cells produce endogenous NO (73). NO is a lipophilic gas with unique 
physiological properties. NO is synthesized from the single amino acid precursor L- 
arginine by the enzyme nitric oxide synthase (NOS) with citrulline as a by-product. The 
NOS enzyme requires a variety of cofactors in order to generate NO from L-arginine 
including NADPH, calmodulin, FAD, FAM, heme and BH4. In the early 1990’s, three 
different nitric oxide isoforms were cloned and characterized for the first time thus 
defining the biological source of nitric oxide in mammals. The three NOS isoforms 
identified are: neuronal NOS (nNOS), inducible NOS, (iNOS), and endothelial NOS 
(eNOS). Alternatively, the isoforms are numerically identified: NOS I or NOS 1 
(nNOS), NOS II or NOS 2 (iNOS), and NOS III or NOS 3 (eNOS). The text here will 
refer to the NOS isoforms as nNOS and eNOS. Once produced, NO, acting in either an 
autocrine or paracrine fashion, can diffuse across cell membranes and interact with 
guanylate cyclase within vascular smooth muscle cells and influence calcium flux,
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contractile protein sensitivity, and inhibit phosphodiesterase activity thus reducing 
cAMP degradation resulting in vasodilation of renal arterioles.
All three NOS isoforms are present in the adult kidney (9,92). Two isoforms, 
nNOS and eNOS, are constitutively expressed and are calcium dependent within the 
immature kidney. iNOS is present only in low basal abundance in both the adult and 
immature kidney (128), not located in the renal resistance arterioles (92), and does not 
play a role in adult physiologic renal hemodynamic function (92). Furthermore, iNOS 
requires a number of activators under pathophysiological conditions that include 
lipopolysaccharide, interferons, and other cytokines (126).
In the adult rat kidney, both eNOS and nNOS are located in renal resistance 
arterioles and demonstrate enzymatic activity in these vessels (92,150). nNOS may also 
alter renal hemodynamics from its location in the adult rat macula densa (9,149).
Newer studies also suggest that NO may mediate adjacent cellular function in the 
macula densa without direct diffusion (111). Other studies have indicated that NO 
derived from nNOS, possibly from perivascular nerves at neuromuscular junctions and / 
or in vascular smooth muscle cells, can effect adult microvessel vasoactivity (76). NO 
derived from eNOS located in the endothelium of microvessels has been proven 
repeatedly to contribute to adult microvascular vasoactivity. However, little is known 
about NO production or the localization and expression of eNOS and nNOS in the 
immature postnatal kidney, particular in the preglomerular resistance vessels. The exact 
role of eNOS and nNOS in the immature kidney’s renal hemodynamics and the role 
each isoform plays in modulating All vasoconstriction is unknown.
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NO/NOS in postnatal renal hemodynamics
The newborn mammal, including humans, exhibits lower RBF, higher RVR, and 
lower GFR than the adult counterpart (95, 151). The postnatal maturation of renal 
hemodynamics involves synchronous decreases in RVR accompanied by increases in 
RBF and GFR to adult capability (5, 51,64). The major factor influencing the 
maturational increase in RBF and GFR is the progressive decrease in RVR (51, 79). 
RVR in the developing kidney is influenced by structural factors, the number of existing 
vascular channels, as well as functional factors, the arteriolar resistance offered by each 
channel (6, 30). Several studies confirm that in the developing kidney, the functional 
maintenance of vascular tone, principally through a balance of vasoactive factors, is the 
paramount mechanism of the modulation of renal hemodynamics (5, 71, 126). The 
maturational changes in RBF and RVR must proceed normally to achieve adult 
capability for GFR (3,151) and sodium homeostasis (130).
The primary vasoactive substance that causes the newborn’s elevated RVR is 
the RAS. All components of the RAS are highly expressed in the developing kidney. 
Many studies have indicated that an intact and functional RAS are required for normal 
kidney development. The highly activated Ail is the major vasoconstricting factor that 
maintains the high RVR, whereas NO is the most important vasodilator counteracting 
All, and other vasoconstrictors, such as endothelin (14, 52,120). Fetal angiotensin 
levels are twice that found in the maternal plasma and circulating levels of AD remain 
high during the newborn period and decrease with age (36). All elicits its effect on the 
porcine vasculature through two subtypes of receptors, the ATI and AT2 receptors. It is 
believed the ATI receptor elicits vasoconstrictor and hypertrophic effects on the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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vasculature while the AT2 receptor mediates vasodilation and possibly proliferation.
The intrarenal infusion of a non-peptide-specific ATI receptor antagonist produces 
greater increases in renal blood flow in newborn piglets than in adults, a finding that 
further suggests All is a more important renal vasoconstrictor in the developing piglet 
than in the adult pig (132). However, the full functions of the two All receptors have yet 
to be fully identified in the immature piglet kidney.
Understanding the mechanisms that produce the unique neonatal renal 
functional state has physiologic and pathophysiologic relevance for the clinical 
management of the newborn. The newborn's unique renal hemodynamic state impacts 
neonatal clinical management, and predisposes the immature kidney to develop 
vasomotor-mediated ARF, caused by a variety of perinatal pathologies. Neonatal renal 
hemodynamics (3, 64,151), contribute to the newborn’s altered pharmacokinetics of 
renally excreted medications, and avid tubular sodium reabsorption, which blunts the 
expected natriuresis of an acute saline load (130). The newborn's renal condition also 
importantly participates in renal pathophysiologic conditions, such as ARF due to 
relatively common occurring adverse perinatal events, including hypoxia, shock, and 
complications of prematurity (6).
Gaining an understanding of the role of NO and the factors regulating NO 
function in the immature kidney may provide insights into creating therapies directed at 
the prevention or treatment of ARF. The maturation of renal hemodynamics is pivotal to 
the achievement of fully integrated renal-cardiovascular homeostasis. Investigating the 
role of NO in this maturational process may reveal causes of disrupted renal-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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cardiovascular function in the adult leading to pathologic conditions such as 
hypertension.
NOS in the adult kidney
NO plays a major role in the maintenance of RBF and GFR in a number 
of adult animal models in a variety of experimental conditions (42, 83). Both 
systemic and intrarenal administration of competitive NOS inhibitors, such as L- 
NAME (123), leads to decreases in RBF and, depending on the method, 
reduction in GFR (12,42,48).
In the adult kidney, nNOS localizes predominantly to the macula densa, Fig. 1, 
with additional expression in the resistance arterioles, Bowman's capsule, thick 
ascending limb and collecting duct (7, 8, 81,92, 138). nNOS mRNA has been identified 
in microdissected renal vascular segments including the afferent arteriole (92). NO 
produced from nNOS participates in regulating the glomerular microcirculation (9, 32, 







Fig. 1. NOS localization in the adult kidney.
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participates in TGF regulation of preglomerular (afferent arteriole) vascular tone (63,
67,147, 148). The exact mechanism of macula densa nNOS regulation of afferent 
arteriolar tone is not known. Rather than directly diffusing into the afferent arteriole,
NO from nNOS, acting within the macula densa, stimulates a cGMP-dependent 
signaling pathway producing vasodilation (111).
Both eNOS mRNA and protein are found in the adult afferent and efferent 
arterioles (81), (Fig. 1). The direct study of eNOS-derived NO on the glomerular 
microcirculation is difficult, because of the lack of an eNOS-specific inhibitor. Most 
studies suggest that the local effect of eNOS may be to function as an autoregulatory 
factor on the afferent arteriole (15,42, 83). eNOS-derived NO, produced locally in the 
glomerular microcirculation, modulates RBF and counter acts the effects of All (42).
NOS in the postnatal developing kidney.
Several reports identify NO as a vital participant in postnatal developing renal 
hemodynamics, functioning as a critical vasodilator under physiologic and 
pathophysiologic conditions (11,105, 124, 126). The immature renal vasculature is 
highly responsive to intrarenal NO stimulation with acetylcholine and NO inhibition 
with L-NAME (126). Utilizing L-NAME in a variety of animal models including 
anesthetized piglets (119,124, 125), conscious lambs (121), and isolated perfused rabbit 
kidneys (125), support an enhanced functional role for NO in the immature kidney, 
critically maintaining RBF and GFR under physiologic conditions. Intrarenal infusion 
of the NOS inhibitor, L-NAME, in both whole animal (piglets) (131) and isolated 
perfused kidneys (rabbits) (124), produces greater renal hemodynamic responses in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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immature kidney than in the adult. Fig. 2 demonstrates the intrarenal infusion of L- 
NAME in immature piglets and adults (131). At 3 pg/kg/min, L-NAME produces 
greater responses in RBF and RVR in the piglet than in the adult. Non-specific NOS 
inhibition results in increased preglomerular resistance at the afferent arteriole, 
reduction in glomerular ultrafiltration coefficient, and variable effect on the 
postglomerular efferent arteriole (42, 83). Intrarenal perfusion of the NOS inhibitor L- 
NAME caused greater changes in RVR, RBF and GFR in the newborn piglet than in the 
adult (121,127,131). Pre-perfusion with an ATI receptor inhibitor prior to L-NAME 
renal perfusion blunted the effects of L-NAME in the newborn kidney, but not in the 
adult (42). These studies indicated that not only was All a more important 
vasoconstrictor in the newborn kidney, but also that NO is a more important regulator 
of renal function in the newborn through modulation of the RAS (42). The enhanced 
role of NO in the neonate kidney is further supported by the distinct developmental 
patterns in the postnatal maturing porcine kidney.
NO is also a critical vasodilator during neonatal pathophysiologic conditions, 
particularly in conditions of perinatal hypoxemia, which is associated with respiratory 
or cardiovascular stress. These conditions induce an intense renal vasoconstriction, 
mediated by All, resulting in vasomotor ARF (6). In newborn rabbits, the renal 
hemodynamic responses to L-NAME are significantly greater during hypoxemia (11). 
NO protects the immature kidney from the deleterious effects of adverse perinatal 
events. The loss of NO protection renders the newborn kidney vulnerable to increased
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Fig. 2. Percent change in renal hemodynamics with L-NAME, 
3^g/kg/min (preliminary studies). N=8. *P < O.OS, adult vs. piglet
constriction by highly activated vasoconstricting factors such as AH, and possibly 
endothelin (139). The immature kidney, therefore, requires an intact NO system to 
prevent vasomotor ARF.
Increased NO vasoactivity in the developing kidney may be due to a difference 
in localization and expression of NOS compared to the adult. The recently published 
postnatal pattern of steady state quantification by RNase protection assay (RPA) of 
whole kidney nNOS mRNA is shown in Fig. 3 (used with permission from APS) (128). 
Every age studied up to 21 days, has significantly greater nNOS mRNA than the adult. 
The newborn kidney demonstrates the greatest nNOS mRNA gene expression. With 
increasing age, nNOS mRNA gene expression progressively declines. The lowest level 
occurs in the adult. Whole kidney nNOS protein content by Western Blot, not shown, 
(128) parallels the mRNA pattern almost identically. In Fig. 4 (used with permission 
from APS), cortical and medullary nNOS protein content also demonstrates distinct 
developmental patterns during postnatal renal maturation.
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Fig. 3. The mRNA expression of whole kidney nNOS. *P < 0.05, newborn and 7 days old vs. adult. 
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Fig. 4. Corticomedullary nNOS expression in the kidney. Statistical significance not 
acheivable. Am J  Physiol Regul Integr Comp Physiol 278: R1453-R1459. 2000.
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Medullary nNOS protein content is proportionately greater than cortical at all 
ages studied; newborn, 14 day old piglets, and adults. Medullary nNOS, greatest in the 
newborn, decreases with age in a pattern that parallels whole kidney nNOS to the 
lowest level in the adult. Cortical nNOS remains at the same level from newborn to 14 
days of age, respectively, then declines to the adult level.
The expression of eNOS during renal maturation has also been recently 
published (129). Experiments measured whole kidney mRNA gene expression by RT- 
PCR and protein content by western blot, and corticomedullary protein content by 
Western Blot. Additionally, whole kidney eNOS mRNA expression from the same 
kidney sample for nNOS and eNOS was determined. The latter experiments were 
designed to validate the expression patterns obtained from kidney samples that came 
from separate animals. As shown in Fig. 5 (used with permission from APS), the pattern 
of whole kidney eNOS mRNA expression differs from nNOS (Fig. 3). In the 
developing kidney eNOS is higher in the newborn kidney and dramatically decreases to 
the lowest level at day 7. Then, the expression level of eNOS significantly increases, 
and is maintained at this level throughout the maturation until adulthood. Whole kidney 
eNOS protein content, not shown, (119), has a similar pattern to that of mRNA 
expression. The high eNOS protein content in the newborn decreases to the lowest level 
at day 7, then increases by day 14 and remains at this level until adulthood.
eNOS protein, Fig. 6  (used with permission from APS), also demonstrates a 
pattern that differs form nNOS. Cortical eNOS protein was highest in the newborn. 
Cortical eNOS protein was greater than medullary in newborn and 7 day piglets. The 
adult has relatively equivalent cortico-medullary eNOS protein expression.
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Fig. 5. The mRNA expression o f whole kidney eNOS. *P < 0.05. 7 days old vs. 
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Fig. 6. Corticomedullary eNOS protein expression in the kidney. *P < 0.05, newborn 
vs. all ages. &P < 0.05, 7 days vs. all ages. #P < 0.05, adult vs. all ages. Am J  Physio! 
Regul Integr Comp Physiol 280: R1269-R1275. 2001.
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The postnatal whole kidney nNOS and eNOS experiments are the first to 
demonstrate the postnatal renal expression of NOS isoforms throughout the 
maturational spectrum to adulthood. When compared, both the nNOS and eNOS 
isoforms undergo distinctively different developmental expression patterns, as seen in 
Fig. 7 (used with permission from APS). The nNOS and eNOS pattern support the 
hypothesis that developmental changes in NOS contribute to the differences in renal 
function between the immature and the adult. Both isoforms undergo developmental 
regulation. However, both isoforms have contrasting whole kidney and cortico- 
medullary patterns. These differing developmental patterns suggest nNOS and eNOS 
may also have differing functional contributions during postnatal renal maturation.
Now that whole kidney NOS mRNA expression and protein translation has been 
identified in the postnatal kidney, the next step in determining the role of NO/NOS in 
the neonate’s renal hemodynamics is to identify the specific localization and expression
i
♦  NOS 3 
♦NOS 1
•  N O S 3
Newborn 7 day Adult
Fig. 7. nNOS and eNOS mRNA expression in same kidney. UP < 0.05, 7 day vs. newborn 
and adult, *P < 0.05, newborn and 7 day vs. adult Am J  Physiol Regul Integr Comp Physiol 
280: R1269-R1275, 2001.
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of NOS isoforms in specific renal segments. nNOS is identified in the earliest stages of 
nephron morphogenesis, marking the location of the site of the macula densa 
throughout nephron formation. As the nephron becomes fully differentiated, but still 
maturing, nNOS increases in abundance, particularly in the thick ascending limb, and 
macula densa. With further maturation, as the nephron migrates centrally out of the 
superficial cortex closer to the juxtamedullary region, this tubular distribution recedes to 
the macula densa. In the adult, nNOS is mainly confined to the macula densa (85, 128).
The novel technique Laser Capture Microdissection (LCMD) was used by 
Solhaug et al. to acquire macula densas from porcine kidneys at ages newborn, 21 day 
and adult Macula densas were analyzed for nNOS mRNA by RT-PCR (85).
The nNOS mRNA expression in LCMD macula densas is illustrated in Fig. 8 ., which 
graphs the results of the quantification of LCMD macula densas for the three age 
groups. Using cyclophilin as an internal control, nNOS mRNA is greatest in the 
newborn compared to the two other age groups. Macula densa nNOS mRNA, lower in
*  #
Newborn  21 Day Adult
Fig. 8. Quantification o f nNOS mRNA in LCMD macula densas (unpublished). N=8. 
*P < 0.05, newborn and 21 day vs adult, #P < 0.05, newborn vs. 21 day.
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the 2 1  day-old piglet than in the newborn, appears to decrease with advancing age in the 
developing kidney. The quantity of this isoform in the macula densa at 21 days of age, 
when nephrogenesis is complete, is greater than in the adult. The lowest level of macula 
densa nNOS mRNA is seen in the adult
In summary, both eNOS and nNOS undeigo significant regulation after birth in 
the immature kidney. Studies show distinct, but differing patterns in whole kidney, 
cortico-medullary, as well as selected components of the renal microstructure including 
the macula densa. These studies support the hypothesis that the enhanced role for NO in 
the immature kidney is due to quantifiable differences in the NOS isoforms from the 
adult kidney. However, the developmental pattern of NOS isoforms in distinct renal 
segments, such as the renal resistance vasculature and glomeruli, are not known.
NOS IN THE RESISTANCE ARTERIOLES 
NOS in the adult renal resistance arterioles
In the adult, acute systemic and intrarenal NOS inhibition increased vascular 
resistance in both the afferent and efferent arterioles (5). Nonspecific NOS inhibition 
results in increased preglomerular resistance at the afferent arteriole, decrease in 
glomerular ultrafiltration coefficient, and variable effects on the postglomerular efferent 
arteriole (42, 83). Results of such studies indicate the importance of NOS derived NO in 
maintaining normal adult renal hemodynamics. It is important to ask what isoform is the 
source of the critical NO that modulates adult vascular renal hemodynamics. Many 
studies have focused on eNOS as the major source of NO in the adult vasculature, while
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NO derived from macula densa nNOS may effect vasoreactivity as well. However, 
localization and function of nNOS in the vasculature may also play a role in adult renal 
vasoreactivity.
In the adult kidney, increases in renal blood flow are associated with a decrease 
in resistance of all glomerular vessels, the interlobular, afferent, and efferent arterioles 
(4). The relationship between the lowered vasculature resistances of the renal resistance 
arterioles, characteristic of the adult kidney, and nNOS derived vasodilator NO is not 
fully understood. While the vast majority of studies have localized nNOS 
indiscriminately to either the cortex or the medulla, more specific 
immunohistochemistry and in situ hybridization experiments have localized nNOS to 
specific renal vasculature. Overall, contradictive results have arisen from studies that 
have further localized nNOS to segments of the renal vasculature. Some studies agree 
that nNOS is intrarenally distributed to the endothelium of afferent arterioles, efferent 
arterioles, the glomerular parietal epithelium, and the renal pelvic and perivascular 
nerves (81, 83, 126). In one serious of experiments on a variety of species including rat, 
mouse, guinea pig, rabbit, pig, and human kidneys, Bachmann et al. found glomerular 
arterioles showed stronger labeling of nNOS in the efferent than in the afferent 
endothelium, while at the capillary level, only the glomerular tuft showed NOS-positive 
endothelia (7). A subpopulation of renal nerves containing nNOS was found in 
perivascular connective tissue and near pelvic epithelium (7). Other studies have led to 
variable results indicating both the presence and absence of nNOS in the interlobular 
artery, afferent arterioles, and in the medullary vasa recta (3). The vast majority of 
studies agree nNOS is predominately localized to the macula densa, with further studies
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implicating macula densa derived NO diffuses to the afferent arteriole where it 
participates in TGF regulation of preglomerular vascular tone (63,67,147, 148).
eNOS derived NO, produced locally in the glomerular microcirculation, 
modulates RBF and counter acts the effects of AH (42). Both eNOS mRNA and protein 
have been found in the endothelium of the glomerulus, arcuate artery, interlobular 
artery, afferent arteriole, glomerular capillaries, efferent arteriole, vasa recta bundles, 
and intrarenal arteries (81, 83, 126,141). In one serious of experiments on a variety of 
species including rat, mouse, guinea pig, rabbit, pig, and human kidneys, Bachmann et 
al. found glomerular arterioles showed stronger labeling of eNOS in the efferent than in 
the afferent endothelium, while at the capillary level, only the glomerular tuft showed 
NOS-positive endothelia (7). The majority of functional eNOS in quiescent endothelial 
cells resides in caveola, the result of dual acylation. The NO produced by eNOS in 
endothelial cells of the resistance arterioles diffuses to adjacent smooth muscle cells and 
stimulates a cGMP-dependent signaling pathway producing vasodilation. Studies have 
demonstrated the importance of eNOS derived NO in counter balancing the effects of 
vasoconstrictors, such as All, in the adult kidney. Deficiencies in the ability of eNOS to 
counter-act vasoconstrictors predispose individuals to pathophysiological conditions 
such as hypertension.
Studies by Patzak et al. (105) using adult mice demonstrated the functional role 
of NOS in the adult renal resistance arterioles. Perfused afferent arterioles exhibited a 
vasoconstrictive response to the nonselective NOS inhibitor L-NAME (105). The nNOS 
specific inhibitor L-SMTC was found to induce afferent arteriolar constriction in studies 
done with rats (131). However, the L-SMTC studies used whole nephron preparations
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instead of dissected afferent arterioles to assess the effects of nNOS inhibition on 
arteriole diameter. Thus, inhibited NO production could be a result of macula densa 
nNOS inhibition instead of nNOS localized to the resistance arterioles. Overall, the data 
concerning functional roles of nNOS and eNOS in the resistance arterioles of the adult 
is very limited. The majority of studies to date have looked at the effects of NOS 
inhibition on whole kidney models. Thus, the functional contributions of nNOS and 
eNOS in the resistance arterioles and the subsequent effect on adult renal 
hemodynamics remains unclear.
NOS in the developing renal resistance arterioles
Initial increases in renal blood flow with maturation mainly results from the 
progressive reduction in RVR (51). The site of high renal vascular resistance in the 
newborn animal has been localized primarily to the preglomerular resistance 
vasculature, the interlobular artery and afferent arterioles (133). The decrease in renal 
vascular resistance with age may be modulated by developmental changes in the 
intrinsic properties of the renal resistance vasculature. However, very little is known 
about the myogenic and internal vasoactive capabilities of these vessels, or any 
developmental differences in resistance vessel responsiveness to vasoactive factors. 
Ultimately, the characteristics of postnatal renal hemodynamics is considered to be a 
balance between neurohormonal vasoactive factors. Both the vasoconstrictors and the 
vasodilators producing this immature renal condition have increased effects, intrarenal 
levels, or differing sites of action compared to the adult. Several studies have confirmed 
that in the developing kidney, the functional maintenance of vascular tone, principally
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through a balance of vasoactive factors, is the paramount mechanism of the modulation 
of renal hemodynamics (5, 71, 126). The maturational changes in RBF and RVR must 
proceed normally to achieve adult capability for GFR (3,13) and sodium homeostasis 
(130). The distribution and expressional patterns of NOS isoforms in the resistance 
arterioles of the neonate may play a role in kidney maturation, the decrease in RVR, and 
subsequent increases in RBF and GFR to adult efficiencies.
nNOS undergoes developmental expression patterns in whole kidney models. 
However, it is unknown if any such developmentally regulated nNOS pattern exists in 
the neonate’s renal resistance vasculature. The expressional and distributional pattern, if 
any, to date has not been looked at in the resistance arterioles of the developing kidney. 
Fischer et al. (37) and latter localization experiments in piglets provided insight that 
vascular nNOS distribution and expression in the developing kidney may differ from 
that of the adult. However, the results of Fischer et al. (37) indicate the absence of 
nNOS in the resistance arterioles of the developing kidney, contradictive to other 
similar studies (126). Thus, such results mean either nNOS is not expressed in the 
resistance arterioles of the developing kidney of certain species, or that the sensitivity of 
experimental techniques used thus far may not allow for the identification of minute 
amounts nNOS mRNA in the resistance arterioles.
The enhanced expression of eNOS in the early stages of the developing kidney 
suggests eNOS may contribute to angiogenesis and/or critically participate in the renal 
hemodynamics of the immature kidney. Studies thus far have not obtained the entire 
picture regarding eNOS in the immature kidney. To date, studies have used only in situ 
hybridization and immunohistochemistry to identify eNOS localization in only a few
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animal species. In the endothelial cells of the peritubular capillary, eNOS decreases in 
expression after birth. The endothelial cells of the arcuate arteiy strongly express eNOS 
from gestation throughout maturation into adult stages (53). After birth, eNOS 
expression in the vasa recta gradually increased in the renal medulla (53). Complete 
analysis of expression and distributional patterns of eNOS in the developing kidney, 
particularly in the renal resistance arterioles, has yet to be examined.
Information concerning function of NOS in the immature renal resistance 
arterioles has been confined to whole kidney studies. In whole kidney immature pig 
models, inhibition of NOS with either the nonselective L-NAME or the nNOS specific 
L-SMTC resulted in an increase in RVR and decreases in RBF and GFR (131). Whole 
kidney models fail to delineate the function of NOS isoforms in distinct renal resistance 
arterioles. Identification of specific functional contributions of NOS isoforms in the 
resistance arterioles would allow better understanding of the developing differences 
found in the immature kidney as compared to the mature kidney. Functional differences 
of NOS in the developing kidney may contribute to the maturation of neonatal renal 
hemodynamics to the level of adult proficiency. The function of NOS in the resistance 
arterioles of the neonate may play a role in the decrease of RVR, and subsequent 
increases in RBF and GFR, that occurs during development NO appears to be required 
in the renal vasculature for normal physiological function during development, but the 
functional role of NO in the newborn renal vasculature remains incompletely studied. 
Understanding the function of NOS in the resistance arterioles during development may 
translate into improved prevention and treatment of neonatal ARF.
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INTERACTION BETWEEN NOS AND All IN THE KIDNEY 
A ll stimulation of NOS in adult renal resistance arterioles.
Thorup et al. was able to determine that All stimulates NO release in isolated 
renal resistance arteries in experiments utilizing the measurement of NO production in 
isolated rat renal resistance arterioles (135). All stimulation of NO was significantly 
attenuated by ATI receptor blockade, thus suggesting the endothelium-dependent 
modulation of All-induced vasoconstriction in renal resistance arteries is mediated, at 
least in part, by ATI receptor-dependent NO release (135). In a separate set of 
experiments, Thorup’s findings were confirmed when it was determined that All 
induced stimulation of NO release in isolated renal resistance arterioles is attenuated by 
simultaneous ATI receptor blockade (136). The extent of NO production regulation by 
All through the ATI receptor in the resistance arterioles was expanded to the 
interlobular arterioles in latter experiments (57). All produces vasoconstriction by a 
direct action on smooth muscle cells via ATI receptors, as demonstrated in Figs. 15 and 
17. These receptors are also present in the endothelium, but their function is poorly 
understood. Furthermore, All has been found to increase intracellular free calcium in 
endothelial cells, which mediates vasoconstriction and possibly a counter vasodilatory 
affect. All stimulated NO release from macrovascular endothelium may modulate the 
direct vasoconstrictor effect of All on smooth muscle cells (109). To date, few 
experiments have attempted to identify the relationship between All stimulation of NOS 
via the ATI receptor in the resistance arterioles of adult models. There are presently no
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studies that address the developmental pattern of All stimulation of NOS via the ATI 
receptor in the resistance arterioles of the developing kidney.
Vasoactive factors, such as All, may play a role in the postnatal regulation of the 
renal NOS isoforms. In the postnatal developing kidney, the renin angiotensin system is 
highly activated at birth (45). Plasma All exhibits a postnatal renal pattern that is 
similar to that of nNOS, greatest in the newborn, then decreasing with age (45, 107). 
Systemic and renal All decreases with age in the postnatal period (45), including in 
maturing piglets (101, 132). Co-localization studies suggest an interactive relationship 
between nNOS containing cells and renin producing cells in the developing rat kidney 
(37). Ail is considered to be the principle vasoconstrictor maintaining the high RVR, 
which sustains the low RBF and GFR, in the newborn and during maturation (119,
132). Previous studies have shown that All is a more active vasoconstrictor in the 
immature piglet kidney. Acute intrarenal infusion of an ATI antagonist altered renal 
hemodynamics in the immature kidney, but not in the adult, significantly increasing 
RBF in the piglet (132). The possibility that All may be an important factor regulating 
NOS expression and function during postnatal maturation is supported by the following 
observations: All may regulate NOS in the adult kidney, All is highly activated at birth 
and undergoes postnatal changes similar to NOS, the vasoactive counter-modulating 
interrelationship between All and NOS is more important in the immature kidney.
The abundance of All receptors could impact NOS regulation during renal 
maturation. The AT receptor sub-types, ATI and AT2, undergo postnatal changes in 
abundance. Previous studies have indicated the ATI receptor, relatively low in the 
fetus, rises rapidly at birth, and remains relatively unchanged in abundance during
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postnatal maturation (75,140,152). The AT2 receptor is more abundant in the fetus, 
drops rapidly after birth to very low levels that are maintained during postnatal 
maturation (152,153). Thus, if the AT2 receptor participates in postnatal NOS 
regulation, it is in the immediate period after birth.
Of the two AT receptors, ATI is more likely to mediate All regulation of NOS.
It is the predominant receptor shortly after birth, and remains so during maturation. 
Studies have demonstrated that All vasoconstriction, mediated by the ATI receptor, is 
more pronounced in the immature kidney (132). Based on these observations, our lab 
conducted a series of experiments to explore the regulation of NOS isoforms by All 
focusing on the ATI receptor in the postnatal maturing kidney. Acute ATI intrarenal 
infusion pretreatment produced greater attenuation of the renal hemodynamic responses 
to L-NAME in the piglet compared to the adult. After pretreatment with acute intrarenal 
ATI receptor inhibitor infusion, the percent changes in RBF and RVR responses to 
intrarenal L-NAME were attenuated to a greater degree in the immature kidney than in 
the adult. A similar functional interaction between NO and AH is seen in the isolated 
perfused kidney of the newborn rabbit (124). In the studies conducted by our lab, ATI 
receptor inhibition (AT IX) significantly attenuated the renal hemodynamic responses to 
L-NAME in the immature kidney as compared to the adult. These findings in earlier 
studies utilizing acute intrarenal administration of an ATI receptor antagonist confirm 
that, in the immature kidney, NO plays an enhanced vasodilator role, and demonstrate 
that ATI inhibition modulates the responses to NOS inhibition to a greater degree in the 
neonate than in the adult.
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Our lab was also able to determine whole kidney nNOS and eNOS mRNA gene 
expression following the unilateral intrarenal arterial infusion of an ATI receptor 
antagonist, candesartan, at a dose that did not alter systemic blood pressure.
Fig. 9 displays the effect of acute AT1X on the mRNA gene expression of the two NOS 
isoforms. Both nNOS and eNOS mRNA exhibit developmental patterns very close to 
those previously described (128, 129). In the newborn, acute AT IX profoundly 
decreased both nNOS and eNOS mRNA expression. Acute AT IX did not alter eNOS 
mRNA in the 7 day piglet or the adult. The 7 day old piglet kidney experienced 
decreased nNOS mRNA with acute AT1X. Interestingly, acute AT1X did not alter 
eNOS protein as measured by Western Blot (data not shown). However, nNOS protein 
expression was altered by acute ATI receptor antagonist infusion. As seen in Fig. 10, 
acute AT IX decreased nNOS protein in the newborn, and possibly the 7 day old, but 
not the adult. These studies demonstrated that both nNOS and eNOS are upregulated by
nNOS □ Control ■ATX-infused eNOS
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Fig. 9. Effect o f acute ATI receptor inhibition on nNOS and eNOS mRNA gene expression by 
RT-PCR (preliminary studies). N=3. Statistical significance not acheivable.
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All via the ATI receptor in the immature kidney, most pronounced in the immediate 
newborn period. nNOS mRNA and protein are regulated in parallel in the newborn 
kidney, thus changes in this isoform would have a greater impact on NOS function. 
Although eNOS mRNA in the immature kidney was profoundly decreased, eNOS 
protein was not changed. This may be due to the length of time acute AT1X was 
administered, since chronic AT IX significantly alters eNOS protein expression. This 
discordant regulation of eNOS mRNA and protein is consistent with the findings of 
Hennington et al., who showed acute All infusion in adult rats changed eNOS mRNA 
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Fig. 10. Effect o f  acute ATI receptor inhibition on nNOS protein by western blot 
(preliminary studies). N=3. POS = positive control, pig cerebellum, NEG = negative control, 
fetal bovine serum. Statistical significance not acheivable.
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MECHANISMS OF All REGULATION OF NOS VIA CALCIUM 
MOBILIZATION
Role of Calcium in Vascular Smooth Muscle Contraction and Relaxation.
Contraction of vascular smooth muscle (VSM) can be initiated by mechanical, 
electrical, and chemical stimuli. Passive stretching of VSM can cause contraction that 
originates from the smooth muscle itself and is therefore termed a myogenic response. 
Electrical depolarization of the VSM cell membrane will also elicit contraction, most 
likely by opening voltage dependent calcium channels (L-type and T-type calcium 
channels) and causing an increase in the intracellular concentration of calcium. Finally, 
a number of chemical stimuli such as norepinephrine, All, vasopressin, endothelin-1, 
and thromboxane A2 can elicit contraction. Each of these substances bind to specific 
receptors on the VSM cell (or to receptors on the endothelium adjacent to the VSM), 
which leads to contraction of the VSM. The mechanism of contraction can involve 
different signal transduction pathways all of which converge to increase intracellular 
calcium (77).
The mechanism by which an increase in intracellular calcium stimulates VSM 
contraction is illustrated in Fig. 11. An increase in free intracellular calcium can result 
from either increased flux of calcium into the cell through calcium channels or by 
release of calcium from internal stores (e.g., sarcoplasmic reticulum; SR). The free 
calcium binds to a special calcium binding protein called calmodulin. Calcium- 
calmodulin activates myosin light chain kinase (MLCK), an enzyme that is capable of 
phosphorylating myosin light chains (MLC) in the presence of ATP. Myosin light
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Fig. 11. The mechanism by which an increase in intracellular calcium 
stimulates VSM contraction. See text for description.
chains are 20-kD regulatory subunits found on the myosin heads. MLC phosphorylation 
leads to cross-bridge formation between the myosin heads and the actin filaments, and 
hence, smooth muscle contraction (77).
In addition to activating MLCK and thus contraction, the calcium-calmodulin 
complex activates NOS proteins. Binding of the Ca2+/calmodulin complex to NOS is 
necessary for the enzyme’s catalytic activity to be functional. Substances such as 
acetylcholine, bradykinin, histamine, insulin, substance P, and All stimulate NO 
production through mechanisms involving Ca2+/calmodulin complexes (Fig. 12). 
Increased flow velocity on the luminal surface of the vascular endothelium can also 
stimulate intracellular calcium release and thus increase NOS activity.
Calmodulin binds to both nNOS and eNOS only in the presence of micromolar 
concentrations of intracellular calcium (137). Binding of Ca2+/calmodulin to its specific











Fig. 12. Illustration o f the mechanisms involved in the production and subsequent 
diffusion o f NO from endothelial cells into vascular smooth muscle cells, and the 
resulting relaxation o f the vascular smooth muscle cells.
motif on NOS displaces an adjoining (117) inhibitory loop on both nNOS and eNOS, 
thereby activating the NADPH:cytochrome-c reductase activity promoting NADPH- 
dependent electron flow from the reductase domain to the oxygenase domain of the 
protein. NOS protein domains are illustrated in Fig. 13. Activation of NOS activity by 
Ca2+/calmodulin is not affected by the absence or presence of heme and therefore seems 
to involve primarily the reductase region of the NOS enzymes (137). As intracellular 
calcium concentrations fall, calmodulin dissociates from NOS. Without bound 
Ca2+/calmodulin, NOS does not catalyze citrulline formation and NADPHxytochrome-
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c reductase activity is barely detectable (137). This bimodal conceptualization of 
Ca2+/calmodulin-dependent regulation of NOS has been greatly refined to include a 
complex array of protein-protein interactions.
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Fig. 13. The illustration o f the domains of the NOS proteins.
All has been found to increase intracellular free calcium in endothelial cells, 
thus initiating vasoconstriction and possibly a counter vasodilatory affect. All 
stimulated NO release from macrovascular endothelium may modulate the direct 
vasoconstrictor effect of All on smooth muscle cells (109). When NO is formed by an 
endothelial cell, it readily diffuses out of the cell and into adjacent smooth muscle cells 
where it binds to a heme moiety on guanylyl cyclase and activates this enzyme to 
produce cGMP from GTP. Increased cGMP activates a kinase that subsequently leads 
to the inhibition of calcium influx into the smooth muscle cell and decreased calcium- 
calmodulin stimulation of myosin light chain kinase (MLCK). This in turn decreases the 
phosphorylation of myosin light chains, thereby decreasing smooth muscle tension
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
33
development and causing vasodilation. There is also some evidence that increases in 
cGMP can also lead to myosin light chain de-phosphorylation by activating a 
phosphatase. The anti-platelet aggregatory effects of NO are also related to the increase 
in cGMP (77).
Intracellular calcium concentrations, therefore, are very important in regulating 
smooth muscle contraction. The concentration of intracellular calcium depends upon the 
balance between the calcium that enters the cells, the calcium that is released by 
intracellular storage sites (e.g., SR), and removal of calcium either back into storage 
sites or out of the cell. Calcium is re-sequestered by the SR by an ATP-dependent 
calcium pump. Calcium is removed from the cell to the external environment by either 
an ATP-dependent calcium pump or by the sodium-calcium exchanger (77). Studies 
have found that reduced sodium/calcium exchanger activity in the resistance arterioles 
is present in hypertensive rats, thus indicating a role of calcium influx/efflux in 
resistance arteriole constriction/dilation (28).
There are several signal transduction mechanisms that modulate intracellular 
calcium concentration and therefore the state of vascular tone. Three different 
mechanisms are described here: 1) phosphatidylinositol pathway, 2) G-protein-coupled 
pathway, and 3) nitric oxide-cGMP pathway (77).
The phosphatidylinositol pathway (Fig. 14) in VSM cells is similar to that found 
in the heart. Norepinephrine (NE) acting via alpha 1-adrenoceptors, angiotensin II (AH) 
acting via All receptors, and endothelin-I (ET-1) acting through ETA receptors activate 
phospholipase C (PL-C) causing the formation of inositol triphosphate (IP3 ) from 
phosphatidylinositol (PIP2 ). The IP3 then stimulates the sarcoplasmic reticulum (SR) to




Fig. 14. Three signal transduction mechanisms that modulate intracellular calcium.
(1.) phosphatidylinositol pathway, 2.) G-protein-coupled pathway,and 3.) nitric oxide- 
cGMP pathway.
release calcium. The formation of diacylglycerol (DAG) activates protein kinase C (PK- 
C), which can also contribute to VSM contraction via protein phosphorylation (77).
The G-protein coupled pathway (Fig. 14) either stimulates (via Gs protein) or 
inhibits (via Gi protein) adenylyl cyclase (AC), which catalyzes the formation of cAMP. 
In VSM, unlike the heart, an increase in cAMP (e.g., a beta-agonist such as epinephrine 
or isoproterenol) causes relaxation. Relaxation occurs as cAMP inhibits MLCK. This 
decreases MLC phosphorylation, thereby decreasing the interactions between actin and 
myosin. Therefore, drugs which increase cAMP (e.g., p2-adrenoceptor agonists, 
phosphodiesterase inhibitors) cause vasodilation (77).
A third mechanism that is very important in regulating VSM tone is the nitric 
oxide (NO)-cGMP system (Fig. 14). Increases in NO activate guanylyl cyclase causing 
increased formation of cGMP and vasodilation. The precise mechanisms by which
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cGMP relaxes VSM is unclear; however, cGMP can activate a cGMP-dependent protein 
kinase, inhibit calcium entry into the VSM, activate K+ channels, and decrease IP3 .
The inducible form of NOS (iNOS, or NOS II) is not calcium-dependent, but 
rather is stimulated by the actions of cytokines (e.g., tumor necrosis factor, interleukins) 
and bacterial endotoxins (e.g., lipopolysaccharide). Induction of this enzyme occurs 
over several hours and results in a production of NO that may be more than a 1,000-fold 
greater than that produced by nNOS or eNOS. This is an important mechanism in the 
pathogenesis of inflammation (77). However, under normal physiological conditions, 
iNOS does not play a role in normal vascular smooth muscle relaxation, and thus, is not 
discussed here.
Calcium channels in the resistance arterioles
Alterations in membrane potential and voltage-mediated changes in L- and T- 
type calcium channel activity play a prominent role in smooth-muscle excitation- 
contraction coupling and are especially important for the regulation of tone in resistance 
arterioles (98). Gordienko et al. provided electrophysiological evidence for the presence 
of L-type voltage-gated calcium currents and also for T-type calcium currents in single 
vascular smooth muscle cells of the afferent arteriole (46, 55). Experiments using 
various calcium channel blockers and/or measurement of intracellular calcium 
concentration all agree that L- and T- type voltage channels, plus additional calcium 
release from internal stores, regulate intracellular calcium concentrations in the 
preglomerular resistance arterioles (4, 27, 33, 34, 36, 56, 91, 102). The presence of T- 
and L- type channels in the preglomerular resistance arterioles was confirmed by
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Hansen et al. using mRNA expressional studies (55). Furthermore, Hansen et al. 
identified the expression of P-/Q-type voltage-gated calcium channels in renal afferent 
arterioles (44). Studies on young rats by Arendshorst et al. have found that store- 
operated calcium entry is exaggerated in preglomerular VSM cells (35,118).
Recent studies have determined that although the overall responses are similar, 
the calcium signaling pathways differ appreciably between pre- and post glomerular 
resistance vessels (4). The current theory is that calcium entry through voltage-operated 
channel predominates in preglomerular arteries/arterioles and that either calcium 
mobilization and/or calcium entry through channels insensitive to voltage are primary in 
efferent arterioles. Various studies have shown All induced afferent vasoconstriction is 
closely coupled to membrane depolarization (90). In the afferent arteriole, All causes 
VSM cells to depolarize, reducing the membrane potential from -40 to -29 compared 
with an unchanged resting potential during stimulation of the efferent arteriole (89). The 
stimulation by All in the afferent arteriole is mediated predominately by opening of 
voltage-gated L-type calcium entry channels as shown using microdissected isolated 
afferent arterioles and individual renal VSMC (21,22, 28, 65, 69). Iversen et al. was 
able to prove the presence of All stimulated calcium entry via voltage-gated calcium 
channels in the interlobular arteriole of the rat (6 8 ). All has also been found to stimulate 
calcium release in preglomerular smooth muscle cells from the internal calcium store, 
including the sarcoplasmic reticulum ( 1 1 0 ).
Studies aimed at identifying calcium channels in postglomerular resistance 
arterioles have provided conflicting results. Different studies have found both the 
absence and presence of T- and L- type channels in the efferent arterioles (4, 36, 56,
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110). Perhaps an explanation for such discrepancy can be attributed to experimental 
variations between groups, in particular, differences in the regions of the kidney that 
were used for experimentation. The mRNA expressional studies by Hansen et al. 
concluded that voltage-gated calcium channels are expressed and of functional 
significance in juxtamedullary efferent arterioles, and in outer medullary vasa recta, but 
not in cortical efferent arterioles (55). Other studies have found the internal calcium 
stores in the VSM cells of the efferent arteriole have an enhanced role in modulating 
internal calcium concentrations, a role that is more influential on calcium flux inside the 
cell as compared to that of L-/T- type voltage channels (27,91). Collectively, results to 
date suggest that All action on the efferent arteriole is probably due to calcium 
mobilization from internal stores and/of calcium entry through dihydropyridine 
insensitive nonspecific cation channels (4, 96). The latter may reflect calcium release- 
induced calcium entry via voltage-independent channels (4). Fig. 15 illustrates several 
signaling pathways by which All can elicit changes in cytosolic calcium concentration 
and contraction.
Although Ail preferentially constricts the efferent arteriole, it is the afferent 
arteriole that has attracted attention in the interaction between All and NO. This is 
mainly because it is considered likely that NO is the main vasodilator of the afferent 
arteriole. It has yet to be determined if the intracellular calcium mobilization elicited by 
All regulates NOS expression and function via the T- / L- type and / or internal store 
calcium channels in the kidney. Furthermore, the mechanism by which AH regulates 
NOS in the resistance arterioles has not been examined in the developing kidney.

























Fig. 15. Schematic diagram o f a vascular smooth muscle cell showing several signaling 
pathways by which All can elicit changes in cytosolic calcium concentration and 
contraction.




The experiments in this dissertation are divided into four sections. The overall 
hypothesis of the dissertation was the enhanced vasodilatory role of NO in the immature 
kidney is attributed to regulatory, expressional, and functional differences in the NOS 
isoforms from the adult. However, the overall hypothesis was broken into four parts to 
answer specific scientific questions with each of the four series of experiments in order 
to more thoroughly test the overall hypothesis.
The overall objectives of the dissertation was to: (1) determine which NOS 
isoform regulates immature renal hemodynamics by using functional whole animal 
studies utilizing intrarenal infusion of NOS inhibitors; (2) continue characterization of 
NOS expression in specific immature renal microstructures utilizing LCM (glomerular 
eNOS expression); (3) characterize developmentally regulated expressional and 
functional patterns of NOS isoforms, renin, and ATI and AT2 receptors in the 
immature preglomerular resistance vasculature utilizing novel microdissection 
techniques; and (4) determine All regulation of NOS expression and function in the 
immature renal vasculature using ATI and AT2 receptor inhibitors.
All experiments involving animal usage, including euthanasia, fulfilled AVMA 
guidelines and were approved by the Institutional Animal Care and Use Committee 
(IACUC).
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FIRST SERIES OF EXPERIMENTS
The first series of experiments used in vivo whole animal models to study the 
effects of the NOS nonspecific inhibitor L-NAME and the nNOS specific inhibitor L- 
SMTC on the characteristics of postnatal renal hemodynamics, as compared to that of 
the adult. The effects of intrarenal perfusion of L-NAME on RVR, RBF and GFR were 
analyzed in both the neonate and adult kidneys. The L-NAME effects were compared 
to the effects of intrarenal perfusion of L-SMTC in both the neonate and adult to 
determine if the effects of nonspecific NOS inhibition were mediated by nNOS or 
eNOS. If intrarenal perfusion of L-SMTC causes alterations in RVR, RBF, and GFR 
that are comparable to that seen by L-NAME alone, than nNOS would be considered 
the primary NOS isoform responsible for the enhanced role of NO seen in the neonate. 
However, if the effects of L-SMTC were not comparable to that seen with perfusion of 
L-NAME, than eNOS would be considered the major NOS isoform responsible for the 
enhanced role of NO in the neonate.
Previous whole kidney studies by our lab have indicated L-NAME does cause 
an increase in RVR with subsequent decreases in RBF and GFR. However, L-SMTC 
studies have not been performed to further determine specific input by individual NOS 
isoforms in the neonate’s vasculature. Previous whole kidney expressional and protein 
studies by our lab have pointed to nNOS as the primary isoform leading to the enhanced 
role of NO in the immature kidney. However, in vivo physiological whole kidney 
functional studies using L-NAME and L-SMTC are required to determine if in fact 
nNOS is responsible for enhanced NO activity in the immature kidney. The experiments
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in the first study of this dissertation were aimed at that specific goal. The objective of 
the first series of experiments was to intrarenally perfuse nonspecific NOS and nNOS 
specific inhibitors in whole animals to determine which NOS isoform is the major 
isoform regulating renal hemodynamics in the immature kidney. The hypothesis of the 
first series of experiments was nNOS is the major isoform regulating renal 
hemodynamics in the immature, but not the mature adult kidney.
SECOND SERIES OF EXPERIMENTS
Once the first series of experiments was completed, the next step was to 
determine exactly how NOS isoforms are regulated during development thus leading to 
the enhanced role of NO in the renal hemodynamics of the immature kidney. To 
determine this, localization and expressional abundance of NOS isoforms within 
specific vascular segments of the kidney were evaluated. Enhanced NO in the immature 
kidney may be a result of localization and expressional differences found in the 
postnatal kidney as compared to the adult While whole kidney expressional and protein 
studies may suggest developmental regulation of NOS isoforms within the kidney, the 
exact location and abundance of NOS isoforms cannot be delineated as either vascular 
or tubular. To determine if developmental regulation of NOS isoforms occur in the 
kidney vasculature, where NOS could play a major role in renal hemodynamics, then 
specific vascular segments must be investigated. The second and third series of 
experiments in this dissertation were aimed at determining the expressional and 
functional contributions of the NOS isoforms in specific renal vascular segments.
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Previous studies by our lab have observed developmental regulation of NOS 
expression in other kidney structures that have influence on renal hemodynamics, 
including the macula densa. However, no studies have been conducted to determine the 
developmental expression of NOS in the glomerulus. NOS would have an impact 
directly on GFR within the glomerulus through effects not only directed at vasoactive 
functions of the capillary beds within the glomerulus, but also through modulation of 
the ultrafiltration coefficient directly.
The second series of experiments were directed at determining the 
developmental regulation of eNOS in the glomeruli of the immature, as compared to 
the mature, kidney. In previous studies, it was determined nNOS is not present in the 
glomeruli and that eNOS is the major isoform found within the glomeruli. Furthermore, 
glomeruli developmental differences have been identified within different areas of the 
immature kidney. The juxtamedullary glomeruli develop before superficial glomeruli in 
the immature kidney, so differences in developmental regulation of NOS between 
different zones of the renal cortex were monitored in the second study as well. It is 
believed NO works to counterbalance All vasoconstriction and that AH may modulate 
NOS expression through the ATI receptor during development. To further investigate 
All modulation of eNOS within the glomerulus, the ATI receptor inhibitor candesartan 
was intrarenally perfused and its effects on eNOS expression were analyzed. The 
second series of experiments utilized the dissecting technique LCM. The LCM 
technique is ideal for expressional studies involving dissection of glomeruli. However, 
LCM techniques were limited in the amount of sample that could be obtained so as a 
result, protein studies involving NO activity were omitted from glomeruli studies.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
The objective of the second series of experiments was to compare endothelial 
nitric oxide synthase, eNOS, gene expression between superficial and juxtamedullary 
glomeruli during both basal conditions and angiotensin II type 1, ATI, receptor 
inhibition with candesartan using LCM to selectively harvest glomeruli from immature 
and mature porcine kidneys. The hypothesis of the second study was there are greater 
differences between superficial cortical and juxtamedullary glomerular eNOS 
expression in the immature kidney compared to the adult and that the ATI receptor 
modulates expression of eNOS in the glomeruli of the newborn kidney, but not in the 
adult.
THIRD SERIES OF EXPERIMENTS
The third series of experiments were designed to investigate NOS isoform 
expression and function in preglomerular resistance vessels including the arcuate, 
interlobular, and afferent arterioles. The efferent arterioles account for 35% of the 
vascular resistance found in the kidney. However, the preglomerular resistance vessels 
are the location of 50% of the vascular resistance found within the kidney, and are the 
major site of regulation of RBF and GFR. In this third set of experiments, 
preglomerular resistance vessels were dissected from immature and mature kidneys and 
analyzed for NOS expression and function. Immature and mature kidneys were 
intrarenally perfused blue-dyed microspheres to stain specific preglomerular 
microvessels, which were then dissected from kidneys and analyzed for NOS isoform 
expression and NOS enzymatic catalytic activity. Again, since it is believed there is an
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
44
interaction between NO vasodilation and All vasoconstriction, expression of RAS 
components in the preglomerular microvessels were also examined. Microdissection 
methods did not utilize LCM techniques in this third set of experiments for two reasons. 
The first reason was that LCM techniques are not conducive to obtaining kidney 
structures that are relatively large and of irregular shape, such as the resistance vessels. 
Secondly, the amount of sample obtained from LCM is relatively minute. In order to 
conduct NOS enzymatic catalytic assays, a fairly large amount of sample must be 
obtained.
The hypothesis of the third series of experiments was the enhanced role of NO 
functioning as a critical vasodilator is produced by developmentally regulated nNOS 
and eNOS expression and NO function in the immature renal vasculature, primarily in 
the resistance arterioles. These preglomerular resistance vessels were studied because 
they ultimately play the biggest role in determining RVR, RBF, and GFR. The objective 
of the study was to identify and compare the immature and mature expressional and 
functional differences of nNOS and eNOS in the renal vasculature, including the 
preglomerular resistance vessels arcuate, interlobular and afferent arterioles. Since it is 
believed there is an interactive counterbalancing between NO and the RAS, components 
of the RAS, including renin expression and ATI and AT2 receptor expression, were 
also observed and compared.
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FORTH SERIES OF EXPERIMENTS
The forth series of experiments were directed at determining the role of All as a 
regulator of nNOS and eNOS expression and function in the immature and mature renal 
resistance arterioles. Again, preglomerular microvessels, afferent arterioles, were 
dissected out of immature and mature kidneys with the visual aid of perfused blue-dyed 
microspheres. Once dissected, afferent arterioles were subject to experimental 
manipulation. Dissected vessels were administered All alone and in conjunction with 
candesartan, an ATI receptor inhibitor, or PD 123319, an AT2 receptor inhibitor. 
Following experimental manipulation, microvessels were evaluated for NOS isoform 
expression and NOS enzymatic catalytic activity to see if All regulated these aspects of 
NOS through the ATI and AT2 receptors.
The objective of the forth series of experiments was to determine the role of All 
as a regulator of nNOS and eNOS expression and function of NO production in the 
immature and mature renal resistance arterioles, primarily the afferent arteriole. The 
hypothesis of the study was that in the immature renal resistance vasculature, NOS 
expression and function are regulated by All through the ATI and AT2 receptors.
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CHAPTER IV 
STUDY 1: NEURONAL NITRIC OXIDE SYNTHASE, nNOS, 
REGULATES RENAL HEMODYNAMICS IN THE POSTNATAL 
DEVELOPING PIGLET
INTRODUCTION
The immature renal vasculature is highly responsive to intrarenal NO 
stimulation with acetylcholine and NO inhibition with the non-selective NOS inhibitor 
L-NAME (126). Intrarenal infusion of L-NAME, in both whole animals, anesthetized 
piglets (131,132), conscious lambs (121) and isolated perfused rabbit kidneys (124), 
produces significantly greater increases in RVR and decreases in RBF and GFR in the 
immature kidney than the adult. Since all previous studies in the developing kidney 
have utilized L-NAME, which non-selectively inhibits all NOS isoforms, it is not 
known which NOS isoform, either eNOS or nNOS, is regulating immature renal 
hemodynamics. Studies utilizing nNOS-specific inhibition with S-methyl-L- 
thiocitrulline (L-SMTC) suggest a renal hemodynamic role for nNOS in the adult rat 
during All-induced hypertension (61) and diabetes (80). However, recent reports 
indicate that in the adult rat, nNOS may not play a role in basal renal hemodynamics. 
Kakoki et al., using two nNOS-specific inhibitors, L-NPA and v-NIO, recently reported
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that nNOS does not regulate basal renal blood flow in adult rat (74). There are no 
studies utilizing nNOS specific inhibitors to examine developing renal hemodynamics.
Several characteristics of nNOS in postnatal renal maturation suggest that this 
isoform may importantly participate in renal hemodynamics after birth. Whole kidney 
nNOS gene and protein expression are greater in the developing piglet kidney than the 
adult pig throughout postnatal renal maturation, including at 2 1  days of age (128). 
nNOS expression also shows a distinct corticomedullary pattern in the developing 
porcine kidney. Cortical levels of nNOS protein during postnatal maturation, including 
the 14 to 21 day age range, are greater than the adult (128). Macula densa nNOS has a 
distinct postnatal maturational pattern in the postnatal maturing rat kidney (37). It is 
involved in the earliest stages of juxtaglomerular apparatus formation, and undergoes a 
pattern of extensive and abundant distal tubular localization, ultimately receding to the 
confines of macula densa in the adult. nNOS also demonstrates an interdependent 
morphologic relationship with the renin angiotensin system, RAS (37). The postnatal 
pattern of nNOS might have significance in relationship with the RAS. The RAS is 
highly activated at birth, with All a main vasoconstrictor (101, 140). There is an 
important renal hemodynamic regulatory interaction between NO and the RAS, perhaps 
mediated through the angiotensin II ATI receptor sub-type (132). The All receptor sub- 
types show a significant shift after birth, with the AT2 receptor, important for 
morphogenesis, decreasing after birth, with a concomitant increase in the ATI receptor, 
which is involved in mediating vasoconstriction (10). Although there is emerging 
evidence that NO/All regulation of renal hemodynamics involves a balance of the 
activities of the vasoconstricting ATI and the vasodilating AT2 receptors (20), this
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receptor functional interplay has not been examined during postnatal maturation. In the 
immature kidney, the highly activated RAS with elevated All (140) might mimic the 
intrarenal conditions seen in All-induced hypertension in which nNOS is an important 
hemodynamic regulator (24, 61). Given the postnatal developmental characteristics of 
nNOS and the interplay with the RAS, we generated the hypothesis that nNOS is the 
major isoform regulating renal hemodynamics in the immature kidney, but not in the 
mature adult kidney.
Since there are no selective eNOS inhibitors available, participation of this 
isoform in these functional studies must be inferred by comparing the responses of non- 
selective inhibition with L-NAME to selective nNOS inhibition. In our previous studies, 
intrarenal infusion of L-NAME, the non-selective a competitive inhibitor of all NOS 
isoforms at 3pg/kg/min, a dose that does not alter mean arterial pressure, produces 
significantly greater increases in RVR and decreases in RBF and GFR in the 21 day old 
piglet with immature renal function than the adult pig (131, 132).
The objective of these studies, therefore, was to compare the renal 
hemodynamic responses to the intrarenal infusion of the selective nNOS inhibitor L- 
SMTC with the intrarenal infusion of the non-selective NOS inhibitor L-NAME in both 
the 21 day old piglets and adult pigs. The specific parameters used to evalute renal 
hemodynamic responses to either L-NAME or L-SMTC included RVR, RBF, and GFR. 
In addition, urine flow and mean arterial pressure were observed to ensure conditions 
from experiment to experiment were consistant and systemic effects were absent.
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MATERIALS AND METHODS
Subjects. Experiments were performed on mixed breed piglets with an average age of 
21.5 days or adult pigs with mature renal function with an average age of 71.5 days. All 
groups received the same experimental preparation. As in our previous studies with 
developing piglets (131,132), all animals were fed a standard age-specific swine diet 
with normal sodium content (Southern States Cooperative, Inc., Richmond, VA). The 
21 day old piglet was selected for study in these experiments. At this age, nephrogenesis 
is completed, and renal function is still immature (40,100,101,131,132). nNOS 
expression abundance is greater in the 2 1  day old piglet than the adult for both whole 
kidney protein and mRNA expression (128). Also, cortical nNOS is greater in the 14 
day old piglet than the adult, an age window that includes the 2 1  day old piglet (128). 
NOS inhibitors and age groups. These experiments utilized the selective nNOS 
inhibitor L-SMTC, which is easier to infuse into the renal artery due to its excellent 
water-soluble properties (62,155). L-SMTC has been used in several studies examining 
the role of nNOS in renal hemodynamics including the blood-perfused juxtamedullary 
nephron preparation (62) or intrarenal infusion into the intact rat kidney (23,61, 63). 
The dose of 0.027 pg/kg/min for 75 min in these experiments is based on studies using 
a L-SMTC intrarenal infusion (23, 142). The non-selective NOS inhibitor, L-NAME, at 
the dose of 3.0 pg/kg/min for 75 minutes was chosen based on our previous studies 
(131, 132). L-SMTC was infused in 21 day old piglets, n = 8 , and adult pigs, n = 8 . L- 
NAME was infused in 21 day old piglets, n = 8  and adult pigs, n = 8 .
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Preparation. All animals were fed a standard age-specific pig diet and were fasted 
overnight before experiments with access to water. All animals received initial 
anesthesia with intramuscular ketamine (adults 10 mg/kg and piglets 5 mg/kg) followed 
by i.v. sodium pentobarbital bolus, lOmg/kg, and then sustaining anesthesia with 
intermittent i.v. sodium pentobarbital boluses, 0.5 mg/kg each. After tracheostomy, the 
animals were ventilated with small-animal respirator (Harvard Apparatus Co., Inc., S. 
Natick, MA), and constant low flow oxygen was given at 250-500 ml/min. Cannulas 
were placed in both external jugular veins for infusion of radioisotope and electrolyte 
solution. The left carotid artery was cannulated for monitoring MAP and blood 
sampling. The left kidney was exposed through a retroperitoneal flank incision and the 
left ureter was cannulated for timed urine collections. An electromagnetic flow probe 
(Carolina Instruments Electronics, Inc., King, NC) was placed around the renal artery to 
monitor renal blood flow. A 25-gauge right-angle needle was placed in the proximal 
renal artery for intrarenal infusions.
Experimental protocol. In the experimental design employed in these studies, each 
animal serves as its own control for the experimental infusion, obviating the need for 
separate time and vehicle controls. MAP and renal blood flow were monitored 
continuously throughout the experiment on a chart recorder (Grass Instrument Co., 
Quincy, MA). All animals received an i.v. maintenance infusion of 5% dextrose 0.45% 
sodium chloride (electrolyte solution) begun at 0.03 ml/kg/min. Glomerular filtration 
rate was determined by the clearance of 125 I-iothalamate (Glofil Isotex, Inc., Friends 
Wood, TX). A priming dose of 0.4 mBq/kg was followed by constant infusion 
throughout the experiment of 12 mBq at 0.3 ml/kg/h for adults and 2.4 mBq at 0.3
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ml/kg/h for piglets. Intrarenal infiision of 0.9% saline solution at 0.1 ml/min was 
initiated. After 60 min recovery period, a 20 min control urine collection was obtained, 
along with a midpoint 3 ml blood sampling.
At the end of the control collection period, intrarenal infusion of L-NAME, L- 
SMTC, or vehicle, 0.9% saline (for time controls), began at the same rate, 0.1 ml/min. 
Both NOS antagonists were delivered in same solution as vehicle, 0.9% saline, L- 
NAME at a rate of 3.0 pg/kg/min, and L-SMTC at a rate of 0.027 pg /kg/min for 75 
minutes. In all groups, the intrarenal infusion of L-NAME, L-SMTC, and vehicle were 
continued through a final 20 min experimental urine collection with a midpoint 3ml 
blood sampling. Blood and urine samples were evaluated for 125 I-iothalamate. The 
animals were euthanized with euthasol euthanasia solution, 2  ml i.v.
Statistics. As in our previous studies (131,132) experimental measurements were 
compared with control measurements using a paired t test. Differences between groups 
were determined by an impaired t test. Statistical significance was considered to be p < 
0.05. All data are expressed as mean ± SEM.
RESULTS
Neither L-NAME nor L-SMTC altered mean arterial pressure (MAP) from 
control in all age groups, as shown in Table 1. Control MAP in till 21 day-old piglet 
groups was significantly lower than the adult pig. L-NAME, L-SMTC, and control 
MAP values for piglets were significantly lower than adult values.
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The effects on renal vascular resistance (RVR) of intrarenal infusion of the non­
specific NOS inhibitor, L-NAME, or the nNOS selective inhibitor, L-SMTC, in piglets 
and adult pigs are shown in Fig. 16. As we have shown previously (32; 33), control 
RVR is significantly higher in both developing piglet control groups compared with the 
adult pig. The infusion of the non-selective NOS inhibitor, L-NAME, in the developing 
piglet produced RVR responses very similar to our previous studies (131,132). 
Following L-NAME infusion, RVR significantly increased from control level of 2.74 ± 
0.07 mmHg/ml/min to 3.35 ± 0.11 mmHg/ml/min, a significant 22.7 ± 6.4% increase 
(Fig. 19). Similarly in the piglet, intrarenal infusion of the selective nNOS inhibitor, L- 
SMTC, increased RVR from 2.58 ± 0.27 to 3.76 ± 0.41, a 46.4 ± 8 .6 % increase (Fig.
19). The percent increase of RVR in response to infusion of L-NAME or L-SMTC was 
not statistically different. Intrarenal L-NAME infusion in adults also produced results 
similar to those we have previously reported (124,125). Non-specific NOS inhibition 
with L-NAME significantly increased RVR from 1.24 ± 0.04 mmHg/ml/min to 1.39 ± 
0.06 mmHg/ml/min, a 8.35 ± 2.6% change. In contrast, RVR in the adult pig did not
Table 1. Effect o f L-NAME and L-SMTC on MAP in piglets and adult pigs
Control L-NAME Control L-SMTC
P ig let 97.2 ± 2* 96.9 ± 3* 95.9 1  5 96.3 1  5*
A dult 112.413.8 115.313.5 119.6 1 2 120 .912
Values are means ± SE. N=8. *P < 0.05, = piglet control vs. adult. $P < 0.05 = piglet L-NAME 
and L-SMTC vs. adult.
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Fig. 16. The effects on renal vascular resistance, RVR, by intrarenal arterial infusion 
o f L-NAME and L-SMTC in 2 1 day old piglets and adults. N=8. *P < 0.05, vs. 
control, {P < 0.05, vs. adult.
significantly change with L-SMTC intrarenal infusion, from 1.19 ± 0.09 mmHg/ml/min 
to 1.19 ± 0.1 mmHg/ml/min.
A similar pattern was seen in renal blood flow, RBF, responses to NOS 
inhibition with L-NAME or L-SMTC (Fig. 17). As previously demonstrated, the control 
period for both piglet groups RBF was significantly lower than the adult (131, 132). 
Intrarenal L-NAME significantly decreased RBF in the 21 day old piglet by 17.9 ±
3.8% (Fig. 19), from 1.57 ± 0.07 ml/min/gkw to 1.29 ± 0.08 ml/min/gkw. Similarly, the 
intrarenal infusion of L-SMTC significantly decreased RBF in the piglet by 30.4 ± 3.8% 
(Fig. 19), from 1.47 ± 0.13 ml/min/gkw to 1.02 ± 0.10 ml/min/gkw. Unlike the RVR 
responses, the RBF percent change in the piglet to L-SMTC was significantly greater 
than the L-NAME change. In the adult, L-NAME significantly decreased RBF from
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Fig. 17. The effects on renal blood flow, RBF, by intrarenal arterial infusion o f L-NAME 
and L-SMTC in piglets and adults. N=8. *P < 0.05, vs. control, $P < 0.05, vs. adult
1.83 ± 0.11 ml/min/gkw to 1.73 ± 0.13 ml/min/gkw, a 7.57 ± 1.8 % change (Fig. 19). 
However, L-SMTC intrarenal infusion in the adult pig did not alter RBF.
Fig. 18 demonstrates the glomerular filtration rate, GFR, responses to intrarenal 
infusion of the NOS inhibitors. The control period GFR in both piglet groups was 
significantly lower compared to the adult, as seen in our previous reports (131, 132). L- 
NAME infusion in the piglet decreased GFR 30.3 ± 9.4% (Fig. 18) from 0.43 ± 0.04 
ml/min/gkw to 0.30 ± 0.05 ml/min/gkw. Intrarenal L-SMTC produced a similar 
decrease in GFR in the piglet, 34.6 ± 10.5% (Fig. 18) from 0.40 ± 0.05 ml/min/gkw to 
0.27 ± 0.06 ml/min/gkw. As we have previously reported, intrarenal L-NAME in the 
adult did not significantly alter GFR (124,125). Additionally, GFR was not 
significantly altered in the adult pig after the intrarenal infusion of L-SMTC.
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□  C O N T R O L  
■  L-NAME
H  L-SM TC
Piglet Adult
Fig. 18. The effects on glomerular filtration rate, GFR, by intrarenal arterial infusion o f L-
NAME and L-SMTC in piglets and adults. N=8. *P < 0.05, vs. control, JP  < 0.05, vs. adult.
The percent change of RVR, RBF and GFR are compared between all the 
experimental groups in Fig. 19. The responses to L-NAME and L-SMTC in the 21 day 
old piglet were similar. Although the RVR increase of 46.4 ± 8 .6 % in the piglet was 
greater than the L-NAME increased RVR, 22.7 ± 6.4%, this was not statistically 
significant. However, the piglet RBF decrease in response to L-SMTC, 30.4 ± 3.8% was 
significantly greater than the L-NAME change of 17.9 ± 3.8%.
Neither L-NAME nor L-SMTC altered filtration fraction (FF) in either age 
group. For adults receiving L-NAME, FF remained unchanged from control, 0.30 ±
0.04 to L-NAME, 0.29 ± 0.03. Likewise, FF remained unchanged in adults receiving L- 
SMTC, from control, 0.30 ± 0.02 to L-SMTC, 0.32 ±0.1. Similar results were seen in
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Fig. 19. The percent changes o f RVR, RBF and GFR by intrarenal arterial infusion of L-NAME 
and L-SMTC in piglets and adults. N=8. *P < 0.05. vs. adult, #P < 0.05, piglet LSMTC vs. L- 
NAME, JP < 0.05, adult L-NAME vs. L-SMTC.
piglets. FF in piglets receiving L-NAME did not change from control, 0.26 ± 0.02 to L- 
NAME, 0.24 ± 0.02, and in those receiving L-SMTC from control, 0.27 ± 0..2 to L- 
SMTC, 0.26 ± 0.02.
In time control experiments, both animal groups received intrarenal vehicle, 
0.9% saline, in place of L-SMTC or L-NAME. Vehicle intrarenal infusion demonstrated 
no significant change in GFR, RBF, or RVR in either age group. Both L-NAME and L- 
SMTC caused significant reductions in urine flow volume in the piglet while only L- 
NAME decreased urine flow in the adult, as illustrated in Fig. 20.
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Fig. 20. The effects on urine flow rate, UV, by intrarenal arterial infusion of L-NAME and 
L-SMTC in piglets and adults. N=8. *P < 0.05, vs. control, JP < 0.05, vs. adult.
DISCUSSION
This is the first description of a role for nNOS in the renal hemodynamics of the 
postnatal developing animal. Our previous studies demonstrated that intrarenal infusion 
of L-NAME produced significantly greater renal hemodynamic responses in the 
immature piglet kidney than the adult (131,132). In these studies, intrarenal infusion of 
L-NAME in the adult, while not altering GFR, decreased RBF 9% and increased RVR 
13%. The adult responses to L-NAME in these experiments were similar to the previous 
descriptions (Fig. 4). Using the same dose of, 3.0 pg/kg/min, the piglet responses to L- 
NAME in the current studies are similar to our prior reports, producing significant
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reductions of GFR, 30.3%, and RBF, 17.9 %, with an increase in RVR of 22.7%. There 
are no eNOS specific inhibitors, therefore we utilized the nNOS blocker, L-SMTC, to 
determine the respective contributions of the two isoforms. The intrarenal infusion of 
the nNOS inhibitor, L-SMTC, significantly changed renal hemodynamics in the piglet, 
compared to no changes in the adult. Further, the responses to nNOS inhibition were 
similar to those caused by non-specific NOS blockade with L-NAME, and as shown 
previously significantly greater than the adult pig responses to L-NAME. L-SMTC 
inhibition of nNOS in the immature kidney resulted in decreases in RBF, 30.4%, and 
GFR, 34.6% and increased RVR, 46.4%. Further evidence for the functional importance 
of nNOS in the immature kidney is provided by the urine flow rate (UV) responses. In 
the piglet, both L-NAME and L-SMTC produce similar, significant reductions in UV. 
However, in the adult, only L-NAME reduced UV, with no change in UV occurring 
with intrarenal L-SMTC. The intrarenal infusion of either NOS inhibitor did not 
produce systemic effects, such as alteration of blood pressure. In these experiments, as 
we have shown previously, base line renal function and MAP were significantly 
different between the piglet and the adult.
The responses to inhibition of the nNOS isoform seen in only the immature 
kidney in our experiments suggest a more important role for NO produced by nNOS 
during postnatal renal maturation. However, the role of nNOS in adult basal renal 
hemodynamics may not be as critical as in the developing kidney. NO plays a major 
role in the maintenance of RBF and GFR in a number of adult animal models in a 
variety of experimental conditions (83). Both systemic and intrarenal adm inistration of 
competitive non-specific NOS inhibitors, such as L-NAME, leads to decreases in RBF
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
59
and, depending on the method, reduction in GFR (48, 87). However, Kakoki et al., 
using two nNOS-specific inhibitors, L-NPA and v-NIO, recently reported that nNOS 
does not regulate basal renal blood flow in adult rat, a finding similar to ours using L- 
SMTC in the adult pig (74). A major difference between the postnatal developing 
kidney and the adult in the basal state that might explain the responses to nNOS 
inhibition, is the highly activated RAS in the immature kidney, producing high 
intrarenal levels of All (140). The basal conditions of activated All in the developing 
kidney may be similar to pathophysiologic situations in the adult in which All is 
experimentally elevated. Under conditions in which All is elevated in the adult rat, All­
induced hypertension (24,61) and diabetes (80), nNOS-specific inhibition with L- 
SMTC produces significant renal hemodynamic changes. These experiments as were 
our previous studies (131,132) were conducted in anesthetized animals, as compared to 
studies in conscious lambs (121). While anesthesia, per se, may activate vasoactive 
factors, such as All in the adult, the highly activated RAS in immature piglets is 
comparably elevated in both anesthetized (131, 132) and conscious ( 1 0 1 ) conditions 
relative to the adult. Thus in increased AH conditions, either physiologic in the 
immature kidney, or pathophysiologic in the adult, nNOS appears to be an important 
hemodynamic regulator.
Further NO/All interaction is suggested by localization studies in the postnatal 
developing rat by Fischer et al. (37). The morphologic pattern of nNOS during 
nephrogenesis suggests an interdependent relationship with renin-producing cells in the 
juxtaglomerular apparatus. NO plays an important vasodilator role in counter-regulating 
the vasoconstriction of AH (132). This functional interaction between NO and AII may
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be mediated by the ATI receptor sub-type (132). The AT2 receptor, which is involved 
in nephrogenesis, undergoes a shift after birth such that the ATI receptor mediating 
vasoconstriction becomes predominant (10). However, emerging evidence suggests that 
the AT2 receptor has a vasodilator function mediated by NO in the kidney with the 
effect of All ultimately a balance between the two receptors (20). The functional 
interplay between ATI and AT2 receptors and the interaction between AT2 receptors 
and NO in the postnatal renal kidney is not known.
This “neuronal” NOS isoform is readily available to participate in regulating 
renal hemodynamics (146). In the adult kidney, nNOS localizes predominantly to the 
macula densa, with additional expression in the afferent arteriole (92,138). nNOS 
mRNA also is identified in microdissected renal vascular segments including the 
afferent arteriole (92). NO produced from nNOS participates in regulating the 
glomerular microcirculation (62) and glomerular filtration rate (122). The exact 
mechanism of macula densa nNOS regulation of afferent arteriolar tone is not known. 
Rather than directly diffusing into the afferent arteriole, NO from nNOS, acting within 
the macula densa, stimulates a cGMP-dependent signaling pathway producing 
vasodilation ( 1 1 1 ).
While there are no studies localizing or quantifying nNOS specifically in the 
renal resistance vasculature, several characteristics of nNOS in postnatal renal 
maturation suggest that this isoform may importantly participate in renal hemodynamics 
after birth. Whole kidney nNOS gene and protein expression are greater in the 
developing piglet kidney than the adult pig throughout postnatal renal maturation, 
including at 21 days of age (128). nNOS expression also shows a distinct cortico-
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medullary pattern in the developing porcine kidney (128), where cortical nNOS is 
greater in the immature than mature kidney (128). The location of nNOS in the 
developing juxtaglomerular apparatus may contribute to vasoactive function. Although 
the direct localization of nNOS in resistance arterioles has not been performed, Fischer 
et al. demonstrated that macula densa nNOS undergoes maturational regulation in the 
rat kidney in a pattern that suggests an interdependent relationship with renin-producing 
cells (37). Thus, the developmental postnatal pattern of nNOS in both localization and 
abundance support the important role for this isoform in the immature kidney.
In summary, intrarenal arterial infusion of the nNOS-specific inhibitor, L-SMTC 
in the immature piglet resulted in significant changes in RBF, GFR and RVR that were 
similar to those seen with L-NAME. However, infusion of L-SMTC in the adult did not 
alter renal hemodynamics or function.
In conclusion, under basal, physiologic conditions, nNOS is an important 
regulator of renal hemodynamics and function in the immature kidney, but not in the 
adult, and may be the predominate vasoactive NOS isoform during postnatal renal 
maturation.
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CHAPTER V
STUDY 2: THE DEVELOPMENTAL AND INTRACORTICAL 
PATTERN OF GLOMERULAR eNOS GENE EXPRSSION DURING 
PORCINE POSTNATAL RENAL MATURATION AND THE 
EFFECT OF ATI RECEPTOR INHIBITION
INTRODUCTION
Fetal kidneys receive less than approximately 3% of cardiac output (103,116). 
At the moment of birth, there is an immediate increase in renal blood flow characterized 
by a redistribution of blood flow from the inner cortex to the outer superficial cortex in 
newborns (2,103). The distribution of intrarenal blood flow in the young, however, is 
different from that reported in the adult (108). The neonate kidney has a greater 
percentage of blood flow to the inner cortical and medullary areas than does the adult 
kidney (108). Blood flow to each region of the immature kidney increases with 
maturation (1, 19, 72, 79, 99,18,113,114). The newborn receives approximately 1 0 - 
15% of the cardiac output, however, this is still considerably less than the greater than 
25% of the cardiac output the adult kidney receives.
In the weeks after birth, there is an associated rise in arterial pressure that 
contributes to an increase in renal blood flow with a corresponding decrease in renal 
vascular resistance (51,72,112). However, these factors do not appear to account for
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the primary driving force behind the postnatal changes in renal hemodynamics because 
the rise in arterial pressure is of lesser magnitude than the rise in renal blood flow (108). 
Thus, it appears that other factors including structural / anatomical changes such as 
glomerulogenesis and vasculogenesis, physical factors such as autoregulatory response, 
and vasoactive factors such as the renin-angiotensin system contribute and possibly 
mediate the alteration in the neonate's renal hemodynamic state.
The contribution of structural changes to the maturational changes of renal 
vascular resistance in the developing kidney is an important consideration. Renal 
vascular resistance in the newborn kidney is a function of the number existing vascular 
channels, as well as the arteriolar resistance offered by each channel (30, 31, 70). The 
increase in renal blood flow in the immature kidney is influenced by structural changes 
in the kidney including the formation of new glomeruli, angiogenesis that accompanies 
nephrogenesis, and vascular remodeling. In swine, nephrogenesis continues after birth 
and is not complete until the third week after birth. However, renal blood flow 
continues to increase in species long after nephrogenesis and vasculogenesis is 
completed thus further implicating an enhanced role of vasoactive factors in the 
modulation of the neonate’s renal hemodynamic state (60, 72, 113, 116). The neonate’s 
renal vasculature does undergo hypertrophic outward remodeling and contributes to a 
rise in renal blood flow. The increase in the diameter of resistance vessels during 
maturation is greater in the kidney than in any other organ, however, renal vascular 
resistance remains elevated to a greater extent than in any other organ. Taken 
collectively, morphological changes in renal resistance vessels cannot account for the 
change in renal blood flow that occurs in the period of renal hemodynamic maturation.
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Recent studies indicate the functional vasoactive characteristics of the immature 
renal vessels determine the decrease in renal vascular resistance that, in turn, dictates 
renal blood flow. Although structural and physical development may contribute to the 
changes in the developing kidney by reducing renal vascular resistance, the functional 
vasoactive factorial changes that occur within the renal microvasculature are the main 
factors that produce the maturational changes in renal hemodynamics.
In the developing porcine kidney, glomerular maturation increases from 
immature superficial to more advanced juxtamedullary nephrons. Numerous studies 
have found that the major NOS isoform within glomeruli contributing to the neonate’s 
hemodynamic state is the endothelial NOS isoform (eNOS). Our lab has previously 
shown that eNOS undergoes distinct whole kidney and corticomedullary developmental 
regulation during postnatal maturation (129). However, the postnatal developmental 
pattern of specific renal structures, such as the glomerulus, is unknown. In the postnatal 
developing porcine kidney, which maintains nephrogenesis until 21 days of age, 
individual glomerular maturation increases from immature superficial cortical to more 
advanced juxtamedullary nephrons. The hypothesis of this study is that there are greater 
differences between superficial cortical and juxtamedullary glomerular eNOS 
expression in the immature kidney, compared to the adult, and that the ATI receptor 
modulates expression of eNOS in the glomeruli of the newborn kidney, but not in the 
adult. The objective of this study was to compare endothelial nitric oxide synthase, 
eNOS, gene expression between superficial, SG, and juxtamedullary, JMG, glomeruli 
during both basal conditions and angiotensin II type 1, ATI, receptor inhibition with
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candesartan using Laser Capture Microdissection, LCM, to selectively harvest 
glomeruli from immature and mature porcine kidneys.
The experimental method used in this glomerular studied utilized LCM, 
which permits direct microscopic visualization and one-step procurement of 
selected cell populations from a slide-mounted section of complex tissue, such 
as the kidney. The method involves placing a thin, transparent transfer film over 
a tissue section on a standard histopathology slide, visualizing the tissue 
microscopically, and selectively adhering the cells of interest to the transfer film 
with a fixed-position, short-duration, focused pulse from an infrared laser. The 
brief, mild thermal transients experienced by the tissue in the capture process do 
not damage DNA, RNA, or proteins. The transferred tissue, firmly embedded in 
the transfer film, is accessible to aqueous solutions necessary for further 
analysis.
MATERIALS AND METHODS
Animals. All animals were fed a standard age-specific pig diet and were fasted 
overnight before experiments with access to water. The animals used were mixed breed 
piglets and adults (Smithfield, VA). Piglets were ages representative of the postnatal 
developmental spectrum, newborn, 7, 14 and 21 days. Three to four animals per age 
group were used for each experiment. Experiments were repeated on animals in order to 
obtain statistical significance.
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Basal glomerular NOS expression. Animals were sacrificed with a lethal dose of 
euthasol (1.5 ml / kg or 10 mg / kg) (Virbac, Fort Worth, Texas) and kidneys were 
exposed and excised through a retroperitoneal flank incision.
Glomerular NOS expression after ATI receptor inhibition. All animals received initial 
anesthesia with ketamine intramuscularly (adults 10 mg / kg; piglets 5 mg/kg) followed 
by intravenous sodium pentobarbital bolus (lOmg / kg). An anesthesia was sustained 
with intermittent intravenous sodium pentobarbital boluses (0.5 mg / kg each).
Following tracheotomy, animals were ventilated with an animal respirator (Harvard 
Apparatus Co., Inc., U.S.A.) with constant low flow oxygen administered at 250-500 
ml/min. Cannulae were placed in both external jugular veins for infusion of 
maintenance solution (5% dextrose, 0.33% normal saline) at a rate of 0.03 ml/kg/min. 
The left carotid artery was cannulated and used to monitor mean arterial pressure 
(MAP) and blood sampling. The left kidney was exposed through a retroperitoneal 
flank incision. A 25-gauge right angle needle was place proximal in the renal artery for 
intrarenal infusions. Kidneys were initially perfused with 0.9% saline solution at 0.1 
ml/min for 20 min followed by perfusion of the ATI receptor antagonist candesartan at 
a rate of 1 ug/kg/min for 60 minutes. Candesartan administered at 1 ug/kg/min has been 
shown not to change systemic blood pressure. A series of preliminary experiments 
(n=3) were conducted to obtain the optimal infusion time of candesartan.
Sampling. After removal, kidneys were decapsulated, snap frozen in O.C.T. fixing 
compound (VWR, Bridgeport, NJ), and stored at -80°C. Cortico-medullary 10 um slices 
were cut from the frozen kidneys and stained with the Arcturus HistoGene Staining Kit 
(Arcturus, Mountain View, Calif.) immediately prior to Laser Capture Microdissection,
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LCM, sampling. The system used for LCM was the PixCell He Laser Capture 
Microdissection System (Arcturus, Mountain View, CA). During LCM microdissection, 
glomeruli were chosen for dissection based on location within the cortex, either 
superficial or juxtamedullary.
RNA isolation and RT-PCR. Each sample consisted of 80 dissected glomeruli. The 
desired glomeruli were selectively adhered onto transfer caps (Arcturus, Mountain 
View, CA) during LCM microdissection, then placed in a clean 0.5 ml microtube 
containing GITC lysis buffer (Qiagen, Inc., Valencia, CA) with 10 pl/ml p- 
mercaptoethanol and subject to immediate isolation of RNA using QIAshredders and 
the RNeasy kit (Qiagen, Inc., Valencia, CA). Isolated RNA from LCM-obtained 
glomeruli was concentrated via vacuum centrifugation. Concentrated RNA was used to 
synthesize cDNA. For removal of mRNA secondary structures, 5 ug of isolated RNA 
was incubated for 3 minutes at 70°C with 5X reaction buffer (Invitrogen, Carlsbad,
CA), which contained 250 mM Tris-HCl (pH 8.3), 375 KC1, and 15 mM MgCL. After 
removal of secondary structures, RNA was hybridized with 2 ul of random primers 
(Applied Biosystems, Alameda, Calif.), 2 ul of DTT (Invitrogen, Carlsbad, CA), 1 ul of 
10 mM dNTP (containing 10 mM each of dATP, dGTP, dCTP, and TI P) (Invitrogen, 
Carlsbad, CA), 0.5 ul of RNasin (Promega, Madison, WI), and 0.5 ul of MI-MLV 
reverse transcriptase (Invitrogen, Carlsbad, CA) in a 20 ul reverse transcriptase reaction 
mixture. The reaction was carried out in a thermocycler (Biometra, Bigetten, Germany) 
at 25°C for 5 min, 37°C for 1 hr, and 70°C for 10 min. The cDNA was analyzed for 
eNOS mRNA gene expression by real-time RT-PCR (Lightcycler, Roche Applied 
Science, Indianapolis, IN) using the LightCycler FastStart DNA Master SYBR Green I
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6 8
amplification kit (Roche Applied Science, Indianapolis, IN). Individual reactions were 
20 ul in total volume which included: 50 ng of RT reaction, 10 uM of each primer, 2.5 
mM MgCh, and 10 ul of LightCycler FastStart DNA Master SYBR Green I 
amplification mix. Primers used were specific for eNOS and 18s rRNA. Following an 
initial 15 minute preheating period at 95°C for polymerase enzyme activation, 
polymerase amplification was carried out for 40-45 cycles (94°C denaturing cycle for 
15 sec., 55°C annealing cycle for 30 sec., and 72°C extension cycle for 10-20 sec.). The 
PCR products were separated and visualized by electrophoresis in agarose gel 
containing ethidium bromide under UV light to confirm product specificity. Porcine 
specific primers were used to amplify a 190 bp region within the eNOS gene (1495- 
1684 bp). Primer sequences for eNOS were (sense) 5’-GAGCACAGAGATTGGC-3’ 
and (antisense) 5’-GTCCACAATGGTCACTTT-3\ 18s rRNA was used as an internal 
reference. The expression of 18s rRNA is an effective internal reference because it does 
not undergo significant regulation in the postnatal immature kidney. The 18s rRNA 
primer sequences were (sense) 5’-GGGCATTCGTATTGCG-3’ and (antisense) 5’- 
AGCTATCAATCTGTCAATCCT-3’. The 18s rRNA primers amplified a 371 bp 
region within the 18s rRNA gene (176-546 bp).
Standard curves. To generate eNOS and 18s rRNA cDNA standard curves, eNOS and 
18s rRNA PCR products were separated by agarose gel electrophoresis. The products 
were purified from the gel using a gel extraction kit (Qiagen, Inc., Valencia, CA), 
quantitated by measuring absorbance at 260 nm, and used as DNA templates for 
quantifications using real-time RT-PCR. Products of varying concentrations were 
subject to amplification and subsequent real-time RT-PCR crossing points were used
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for generation of standard curves. Product concentrations were placed on the y-axis 
while crossing points were placed on the x-axis for standard curves of all cDNA genes 
studied.
Statistical analysis. Experiments were repeated x 7. All data are reported as means ± 
SE. Differences between age groups were determined by an unpaired t test. Values of p 
< 0.05 were considered statistically significant.
RESULTS
Superficial Glomeruli
Basal expression of eNOS mRNA was observed in superficial glomeruli of 
porcine kidneys of all ages (Fig. 21). The lowest eNOS expression was observed in 

















NB 7d 14d 2 Id Adult
Fig. 21. Expression of eNOS mRNA in superficial glomeruli in porcine ages newborn. 7, 
14 and 21 days, and adult. Results normalized to 18s rRNA. N=7. *P < 0.05, vs. newborn. 
+P < 0.05, vs. 7 day old.
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there was observed an approximately eight fold increase in expression. Expression of 
eNOS continued to increase in superficial glomeruli with maturation. Greatest eNOS 
expression was observed in the 21 day old and adult kidney. Adult and 21 day old 
eNOS expression was ten times greater than newborn and 7 day old expression.
Juxtamedullary Glomeruli
The basal expression of eNOS mRNA was also observed in juxtamedullary 
glomeruli of porcine kidneys of all ages (Fig. 22). Juxtamedullary glomerular eNOS 
was significantly greater than superficial glomerular eNOS only in the newborn 
immature kidney. The expression of juxtamedullary glomerular eNOS dropped six fold 
after birth to reach it lowest levels at 7 days old. Preceding the decline in expression 
seen in the 7 day kidney was a twelve fold increase which was observed in the 14 day 
kidney. The level of eNOS expression maintained consistent values from 14 day 
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Fig. 22. Expression o f eNOS mRNA in juxtamedullary glomeruli in porcine ages newborn, 
7. 14 and 2 1 day-old. and adult. Results normalized to 18s rRNA. N=7. +P < 0.05. vs. 7 day 
old.
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exhibited the greatest levels of eNOS expression in juxtamedullary glomeruli. Adult 
eNOS expression was almost twice that seen in the newborn kidney and fifteen times 
greater than that observed in the 7 day kidney.
Total Glomeruli
Total glomerular eNOS mRNA expression followed our previously described 
eNOS whole kidney expressional pattern that was characterized with a dip at 7 days, 
and greater expression observed in the 14 day, 21 day, and adult kidneys (Fig. 23). 
Newborn eNOS expression was comparable to eNOS expression in the more mature 
animals. At 7 days, eNOS expression decreased by almost four fold. After 7 days, 
eNOS expression increased six fold as seen in the 14 day old kidney. After 14 days, 
eNOS expression remained constant with maturation with a slight increase in the adult 
kidney. Greatest expression was observed in the adult kidney.
NB 7d 14d 21d Adult
Fig. 23. Expression o f eNOS mRNA in total glomeruli (superficial + 
juxtamedullary) in porcine ages newborn, 7. 14 and 21 day old, and adult. Results 
normalized to 18s rRNA. +P < 0.05. vs. 7 dav old.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
72
ATI Receptor Inhibition in Superficial Glomeruli
The renal perfusion of the ATI receptor inhibitor candesartan resulted in 
significant blunting of eNOS mRNA expression in the superficial glomeruli of 
newborn, but not adult (Fig. 24). In the newborn, administration of candesartan resulted 
in an almost twenty-five fold decrease in eNOS expression. The expression of eNOS in 
the adult was very low in both control and experiment kidneys, as compared to the 
newborn control. Adult levels of control eNOS were significantly lower than that in the 
newborn control. There was no statistical difference between control and experiment 
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NB AO
Fig. 24. Expression o f eNOS mRNA in superficial glomeruli in porcine ages 
newborn, 7, 14 and 2 1 day-old, and aduh in control animals and animals 
intrarenally perfused the ATI receptor inhibitor candesartan. Results 
normalized to 18s rRNA. N=7. +#*P < 0.05, vs. newborn AT IX, aduh control, 
and adult AT IX.
ATI Receptor Inhibition in Juxtamedullary Glomeruli
Renal perfusion of candesartan significantly attenuated eNOS expression in 
juxtamedullary glomeruli of the newborn but not in the adult (Fig. 25). When given
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candesartan, the newborn experienced a six fold decrease in eNOS expression. Adult 
control levels of eNOS expression were significantly lower than newborn control levels. 















■  Control 
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NB AD
Fig. 25. Expression o f eNOS mRNA juxtamedullary glomerulus in porcine ages newborn, 7,
14 and 2 1 days, and adult in control animals and animals renally perfused the ATI receptor 
inhibitor candesartan. Results normalized to 18s rRNA. N=7. +*P < 0.05, vs. newborn AT IX, 
adult control, and adult ATIX.
DISCUSSION
The distribution of intrarenal blood flow in the young is different from that 
reported in the adult (108). The neonate kidney has a greater percentage of blood flow 
to the inner cortical and medullary areas than does the adult kidney (108). The inner 
cortex is the site of juxtamedullary glomeruli while the outer cortex contains the 
superficial glomeruli. In the superficial areas of the cortex, nephrogenesis and
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angiogenesis are still occurring in the newborn porcine kidney. Thus, glomeruli and the 
accompanying vasculature are not fully operational in the superficial areas of the cortex. 
As a result, blood flow is routed to areas of the kidney that contain glomeruli that are 
fully functional. The glomeruli within the juxtamedullary zone are functional and so the 
majority of blood flow is directed to these glomeruli. This would explain why a greater 
percentage of blood flow goes to the inner cortical and medullary areas in the newborn 
as compared to the adult. The intrinsic mechanisms that occur during development to 
modulate intrarenal blood remain unstudied.
In the results of this study, newborn juxtamedullary glomeruli exhibited a high 
level of eNOS expression when compared to newborn superficial glomeruli. This would 
suggest NO may be required for the increase in renal blood flow that is directed toward 
the inner cortex. The glomeruli are the sites of filtration within the kidney, so blood 
flow through the glomerulus is critical. While the main sites determining renal blood 
flow are the preglomerular microvessels, the capillary beds within the glomeruli can 
also effect renal blood flow and directly influence filtration within the Bowman’s 
capsule. While NO effects the vasoproperties of the glomerulus’ capillary bed, NO can 
have direct effects on glomerular filtration properties, including alterations in the 
ultrafiltration coefficient.
The increase in renal blood flow to the neonate’s inner cortical region and 
juxtamedullary glomeruli would suggest an increase in the need for vasodilators such as 
NO in that specific cortical area. This was observed in the newborn’s juxtamedullary 
glomeruli data provided in this study. eNOS expression was relatively high in the 
newborn’s juxtamedullary glomeruli. On the other, with low blood flow, the newborn’s
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outer cortex would not require vasodilators. This was also seen in this study where 
newborn superficial glomeruli demonstrated low levels of eNOS as compared to 
juxtamedullary glomeruli.
As the kidney continues to develop and nehrogenesis nears completion, blood 
flow distribution widens to increase flow to the outer cortex to newly functioning 
superficial glomeruli. In the data presented in this study, after 14 days, eNOS 
expression is fairly constant throughout the rest of maturation in both juxtamedullary 
and superficial glomeruli. The 14 day age may mark the period when most renal 
glomeruli, both juxtamedullary and superficial, become fully functionable and capable 
of handling plasma filtration loads comparable to that seen in the adult. At 14 days, 
vasoactive substances, particularly vasodilators, in the vasculature in all renal cortical 
zones, both inner and outer, are required to reach normal physiological renal function.
Interestingly, there is a significant decrease in eNOS expression in both 
juxtamedullary and superficial glomeruli at 7 days. In whole kidney eNOS studies 
involving porcine, the same expressional dip was observed in 7 day old animals. The 
significance of the drop in eNOS expression at 7 days remains unexplained. One theory 
is that there is a transition that occurs at 7 days post birth. Maternal programming may 
ready the fetus’s renal hemodynamic state for birth, then during and immediately after 
birth, the renal hemodynamics of the newborn may be directed through mechanisms 
that acclimate the newborn’s kidney to function without maternal input Once the 
immediately newborn period passes, the newborn may undergo another renal transition 
at 7 days post-birth in which the developing kidney undergoes intrinsic transitional 
mechanisms in order to take on adult like renal hemodynamics to begin functioning
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with adult renal capabilities. A factor that may be a signaling mechanism, or just a part 
of the overall process, may include a reduction in eNOS expression as seen in the 7 day 
old in both juxtamedullary and superficial glomeruli. Whatever the reason, the decrease 
in eNOS expression seen in the 7 day old kidney, both on the whole kidney level and on 
the level of glomeruli, requires further investigation.
As discussed previously, the increased RVR found in the developing kidney is a 
result of the enhanced vasoconstrictor response of All. In this study, blockade of the 
ATI receptor inhibited eNOS expression in both juxtamedullary and superficial 
glomeruli of the newborn, but not of the adult. This suggests eNOS in both the 
juxtamedullary and superficial glomerulus are regulated by All through the ATI 
receptor. In the inner cortical area of the developing kidney, NO may be required to 
overcome the All induced increase in RVR to allow renal blood flow to functioning 
juxtamedullary glomeruli for filtration. Even though blood flow to superficial glomeruli 
is low immediately after birth, All serves to regulate eNOS expression through the ATI 
receptor. However, the decrease in renal blood flow to the outer cortex may not be a 
result of enhanced All vasoconstriction because basal eNOS levels are low in 
superficial glomeruli even though it was observed in this study that All regulates eNOS 
expression in superficial glomeruli through the ATI receptor. Thus, other mechanisms, 
mainly structural, may account for the low blood flow to outer cortical areas of the 
newborn kidney. However, once those structural factors are overcome, All regulates 
eNOS expression in the superficial glomeruli of the developing kidney. Once the kidney 
has matured, it appears from the adult data provided in this study, All does not regulate 
eNOS expression in neither the adult juxtamedullary nor superficial glomeruli.
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The regulation of eNOS expression and translation appears to be complex in the 
neonate. This study provides evidence for All regulation of eNOS expression in the 
glomeruli of the neonate. Other factors appear to contribute to the regulation of eNOS 
in the newborn as well. Estrogen has been found to upregulate eNOS mRNA and 
protein expression (129). Immediately after birth, the newborn has high levels of 
estrogen and estrogen receptor (129). Estrogen may influence glomerular eNOS 
expression. Two growth factors present in the neonate have also been found to regulate 
eNOS expression. Transforming growth factor-pi, which is highly expressed during 
renal development, upregulates eNOS (129). Vascular endothelial growth factor 
(VEGF)-A also upregulates eNOS. VEGF-A is a participant in nephrogenesis and 
angiogenesis during the formation of glomerular vessels (129). In regard to neonate 
renal hemodynamics, the role of eNOS may be critical in modulating the 
vasoconstrictor response of All and thus is regulated by the ATI receptor in the renal 
vasculature. However, there are other potential factors relevant to the regulation of 
eNOS in the developing kidney including cell growth and proliferation, hormones such 
as estrogen, and growth factors.
It is important to remark on one of the differences found between basal eNOS 
and AT IX control eNOS expressional values. In the basal experiments, eNOS 
expression in both juxtamedullary and superficial glomeruli in the newborn was lower 
than that found in the adult However, in the AT1X experiments, control levels of 
juxtamedullary and superficial glomeruli eNOS were higher in the newborn than in the 
adult. This may be explained by differences in experimental methods. In the basal 
experiments, animals were sacrificed and kidneys were immediately removed,
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glomeruli were dissected, and eNOS expression was analyzed promptly. The procedure 
for ATI inhibition required a longer experimental period. Animals were anestitized and 
candesartan was intrarenally perfused for 60 minutes. Effects from anesthesia and 
prolonged experimental period required for candesartan perfusion may account for the 
discrepancies seen between basal and AT IX control eNOS expression.
While other studies have described the absence of nNOS in the glomeruli and 
the presence of eNOS in glomeruli in adult kidneys, this is the first study that has 
observed glomerular eNOS expression in the developing kidney. The data in this study 
demonstrated eNOS glomerular expression is developmentally regulated with 
differences observed between juxtamedullary and superficial glomeruli and between 
neonate and adult glomeruli. In the newborn kidney, juxtamedullary glomeruli 
exprience high eNOS expression compared to low superficial glomerular eNOS 
expression. There is a significant decrease in eNOS expression in both juxtamedullary 
and superficial glomeruli in the 7 day old kidney. At 14 days, eNOS expression 
increases and maintains a fairly constant level of expression throughout the rest of 
maturation to adulthood in both juxtamedullary and superficial glomeruli. Blockade of 
the ATI receptor inhibited eNOS expression in both juxtamedullary and superficial 
glomeruli of the newborn, but not in the adult. The data from this study confirms the 
hypothesis that there are greater differences between superficial cortical and 
juxtamedullary glomerular eNOS expression in the immature kidney, as compared to 
the adult, and that the ATI receptor modulates expression of eNOS in the glomeruli of 
the newborn kidney, but not in the adult.
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CHAPTER VI
STUDY 3: NITRIC OXIDE SYNTHASE, RENIN AND 
ANGIOTENSIN II RECEPTOR EXPRESSION AND NITRIC 
OXIDE PRODUCTION IN THE RENAL RESISTANCE 
VASCULATURE DURING PORCINE POSTNATAL 
DEVELOPMENT
INTRODUCTION
The uniqueness of the neonate’s renal hemodynamics impacts newborn clinical 
management, and predisposes the immature kidney to develop vasomotor-mediated 
acute renal failure due to a variety of perinatal pathologies such as hypoxia, ischemia, 
shock, and prematurity complications. Newborn RBF is low relative to the adult. 
Thereafter, RBF progressively increases during postnatal maturation to adult levels. At 
the moment of birth, there is an immediate increase in renal blood flow characterized by 
a redistribution of blood flow from the inner cortex to outer superficial cortex (2,103). 
The predominant factor contributing to the low RBF is high RVR. The increase in RBF 
during maturation is due to reductions in RVR. There is an associated rise in systemic 
arterial pressure that contributes to the increase in renal blood flow while renal vascular 
resistance continues to decrease, but the rise in arterial pressure is of lesser magnitude 
than the rise in renal blood flow (51, 72, 112). Thus, it appears that other factors
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including structural / anatomical changes, physical factors, and vasoactive factors 
mediate the alteration in the neonate's renal hemodynamic state.
RVR in the newborn kidney is a function of the number of existing vascular 
channels, as well as the arteriolar resistance offered by each channel (30, 31, 70). RBF 
continues to increase in species long after nephrogenesis and vasculogenesis is 
completed thus further implicating an enhanced role of vasoactive factors in the 
modulation of the neonate’s renal hemodynamic state (60, 115,131). Taken 
collectively, morphological changes in renal resistance vessels cannot account for the 
change in RBF that occurs in the period of renal hemodynamic maturation.
Many studies have indicated the primary vasoactive factor that influences 
neonate RVR is the RAS. All components of the RAS are highly expressed in the 
developing kidney. An intact and functional RAS are required for normal kidney 
development. Pharmacological blockade of the RAS in developing kidneys has been 
found to cause papillary atrophy, abnormal wall thickening of intrarenal arterioles, 
tubular atrophy associated with expansion of the interstitium, impairment in urinary 
concentrating ability, and impairment of nephrogenesis (7). AD has both hypertrophic 
and proliferative effects on the various cell types found within the kidney (60). Under 
most circumstances, renin secretion is the rate-limiting step in the production of All 
(108).
During development, renin and subsequent All levels are very high. In fact, fetal 
angiotensin levels are twice that as found in the maternal plasma (108). Circulating 
levels of All remain high during the newborn period and decrease with age paralleling 
the changes in active renin (108). The enzymes that are responsible for All degradation
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are relatively inactive in the developing animal, and therefore, high levels of circulating 
All are maintained during early life (108). The major components of the RAS are 
highly present in the immature kidney but their anatomical distribution and activities are 
quite different than those seen in the adult kidney. In immature rats, renin is found to be 
expressed throughout the renal preglomerular vasculature including the arcuate, 
interlobular and afferent arterioles (44). Upon maturation, renin expression is confined 
to structures more localized around the juxtaglomerular apparatus.
All effects are mediated through two receptors in the kidney, the ATI and AT2 
receptors. In general, studies have found the ATI receptor to be of low abundance at 
birth and increases in expression with maturation while the AT2 receptor declines with 
postnatal age. The functions of the ATI and AT2 receptors during fetal and neonate 
development remain incompletely studied.
The potent vasoconstrictor response of All remains intact in the newborn and 
appears to be the major factor contributing to the high RVR found in the immature 
kidney. The 8 6 % decrease in RVR that occurs during maturation is attributed to a 
reduction in the distribution and abundance of All and its receptors in the preglomerular 
vasculature (51). The intrarenal infusion of a non-peptide ATI receptor antagonist 
produces greater increases in RBF in newborn piglets than in adults, demonstrating that 
All is a more important vasoconstrictor in the developing kidney than in the adult (132). 
Unchecked, the potent vasoconstrictor response of highly active An in the newborn can 
lead to adverse renal complications including ARF.
As discussed in earlier chapters, NO is an important regulator of renal 
hemodynamics in the immature kidney, and functions as a critical vasodilator to
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counterbalance highly activated All (132). The immature rend vasculature is highly 
responsive to alterations of NOS. The intrarenal infusion of the NOS inhibitor L-NAME 
in piglets and adult swine produces greater renal hemodynamic responses in the 
newborn than in the adult (121,131). This data suggest that renal NO production by 
NOS is greater in young animals than in adults. This increase in NO production is 
supported by the distinct developmental patterns in the postnatal maturing porcine 
kidney (128,129). Furthermore, studies by Han et al. showed that eNOS expression in 
rats is elevated at birth, decreases temporarily, then rises up to adult levels with 
continued maturation (53). Studies by Mattson et al. identified both nNOS and eNOS 
isoforms in the preglomerular vessels of the adult rat kidney including the arcuate, 
interlobular, and afferent arterioles, a finding that supports similar observations from 
other laboratories (7,141). However, no studies have investigated the presence of either 
NOS isoform in the neonate’s vasculature. NO is believed to counter balance the highly 
activated RAS and protect the immature kidney from the deleterious effects of adverse 
perinatal events that lead to vasomotor ARF (108).
The exact relationship between All and NO and the ability of NO to buffer AD 
vasoconstriction has not been elucidated in the renal vasculature of the immature 
kidney, particularly in the preglomerular resistance vasculature including the afferent, 
interlobular and arcuate arterioles. In the adult rat, the vasoconstrictor response to AD in 
the preglomerular resistance vasculature was enhanced in eNOS knock out mice (105). 
All upregulated NO production via the ATI receptor in the preglomerular resistance 
vasculature of rats, specificly in the afferent arteriole (104). ATI receptor inhibition 
inhibited All stimulated NO production in the renal arteries of adult rats (135). Recent
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studies clearly indicate there is an immediate relationship, or interaction, between NOS 
isofom expression, NOS enzymatic catalytic activity (thus leading to NO production), 
and All in the adult kidney. Numerous studies have indicated renal All levels are high 
in the fetus and neonate, and is required for normal renal development. With increased 
renal All levels, vasoconstriction within the preglomerular resistance vasculature is also 
enhanced. Upregulation of NOS expression and function maybe the mechanism by 
which the preglomerular resistance vasculature of the immature kidney counterbalances 
increased vasoconstrictor activity. However, All and NO interaction has yet to be 
studied in the renal vasculature of the immature kidney.
The hypothesis of this study was the enhanced role of NO as a critical 
vasodilator, counteracting highly activated constrictors such as All during postnatal 
renal maturation, is produced by developmentally regulated nNOS and eNOS 
expression and NO function in the immature renal vasculature, primarily in the 
resistance arterioles. These preglomerular resistance vessels were studied because they 
ultimately play the biggest role in determining RVR, RBF, and GFR. The objective of 
the study was to identify and compare the immature and mature expressional and 
functional differences of nNOS and eNOS in the renal vasculature, including the 
preglomerular resistance vessels arcuate, interlobular and afferent arterioles. Since it is 
believed there is an interactive counterbalancing between NO and the RAS, components 
of the RAS, including renin expression and ATI and AT2 receptor expression, were 
also observed and compared.




Animals. These experiments utilized the preparation and study of kidney slices from 
ages representative of the developmental spectrum, newborn, 7,21 day piglets and 
adults. All experiments were performed on mixed breed swine obtained from the same 
local vendor (Smithfield, VA). All animals were transported and housed under the same 
conditions. Kidneys of pre-weanling piglets (newborn and 7 days old) were harvested 
on arrived. Kidneys of weaned piglets (21 days old) and adults >70 days of age were 
harvested 24 hr after arrival to allow for dietary and climatic adjustment. Animals were 
fed a standard age-specific pig diet and were fasted overnight before experiments with 
access to water.
Preparation. Animals were initially anesthetized with intramuscular ketamine (adults 
10 mg/kg; piglets 5 mg/kg), followed by a sacrificial intravenous euthasol infusion (50 
mg/kg each) (Delmorva Laboratories, Midlothian, VA). The left kidney was exposed 
through a retroperitoneal flank incision. The aorta was tied closed both proximal and 
distal from the renal artery branching from the aorta. A 20 - 25 gauge right angle needle 
was placed in the proximal renal artery for intrarenal perfusion.
Microdissection o f renal microvessels. The techniques were modified from previous 
publication (106). The left kidney was perfused with 10 ml of 37°C dissecting solution 
(DS) at a rate of 1 ml per minute (10 minute total DS perfusion period). The DS 
consisted of (in mM) 135-140 NaCl, 3-5 KC1, 1.5 CaCl2, 1-1.2 MgS04, 5-5.5 glucose, 5 
HEPES (pH 7.4), 10 sodium acetate, 5 L-alanine, and 5 L-succinic acid (Sigma, St.
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Louis, MO). Following perfusion of DS, kidneys were perfused with 2 -  3 ml of 
polybead polystyrene blue dyed microsphere mixture containing particles of 0.2, 0.5,
1.0, 3.0, 6.0 and 10 um in diameter (Polysciences, Warrington, PA). Polybeads were 
incubated to 37°C prior to infusion. Microspheres were in solution with 10% bovine 
serum albumin (Sigma, St. Louis, MO). After decapsulation and removal of the 
collecting system, the kidney was excised and cut into 500-600 um coronal slices that 
contained the entire cortico-medullary axis (McILwain tissue chopper, The Mickle 
Laboratory Engineering Company). Coronal slices were placed into DS containing 0.7 
2  mg/ml collagenase (192 U/mg; Worthington Biochemical, Freehold, NJ), 1 mg/ml 
dithiothreitol (Invitrogen, Carlsbad, CA), and 1 mg / ml BSA and incubated on a shaker 
at 37°C with 95 % oxygen and 5 % carbon dioxide for 25-30 minutes. Kidney slices 
were rinsed twice with collagenase free DS to remove any collagenase. Kidney slices 
were then placed in a petri-dish containing ice-cold DS, 5 - 1 0  mM vanadyl 
ribonucleoside complex (Sigma, St. Louis MO), 0.1 mg/ml trypsin inhibitor (Sigma, St. 
Louis MO), 5 mM dithiothreitol, and 1 % BSA. The petri-dish was placed on a 
stereomicroscope stage (Bausch and Lomb, Rochester, NY) and the slices/solution were 
maintained at 4°C during microdissection. Microscopy settings for microdissection 
included using dark: field illumination and magnification ranging from 16 -  21 Ox. 
Dissection of various intrarenal vessels included using #5 dissecting forceps, iris 
scissors, glass pipettes rinsed in 10% BSA, suture forceps, and 30 -  33 gauge stainless 
steel needles. Dissecting time was restricted to a maximum of 1.5 hrs. During 
dissection, 1 0 - 2 0  mm (measured via the microscopes eye piece micrometer) of 
microvessels were obtained. Dissected microvessels were placed on the side of the
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petri-dish for removal of unwanted segments. Microvessels were rinsed with fresh 
dissecting solution containing 2 U/ul RNasin (Promega, Madison WI) and 5 mM DTT. 
Dissected vessels were transferred to a small microcentrifuge tube containing 10 ul of 
ice-cold DS and centrifuged at 12,000 g for 2 min. Supernatant was discarded. Lysis 
buffer was added to dissected vessels and placed on ice (4°C) for 60 minutes to 
permeabilize the microvascular cells. RNA isolation was started following the 60- 
minute lysis period.
Tissue Analysis Techniques for mRNA studies
Once microvessels were dissected, they were subject to RNA isolation.
Dissected vessels were subject to 60 minutes of lysis buffer (from the RNeasy Kit) on 
ice (4°C) to permeabilize the microvascular cells followed by RNA isolation. The 
RNeasy Kit (Qiagen, Valencia, CA) protocol was applied to isolate RNA. After RNA 
isolation, samples were subject to vacuum centrifuge for 1 hr to increase RNA 
concentration. Once RNA was concentrated, it underwent reverse transcriptase to obtain 
the sample’s cDNA for subsequent PCR. The protocols for semi-quantitative RT-PCR 
including reverse transcriptase procedures, LightCycler PCR procedures, and the primer 
sequences for eNOS and the internal control 18s rRNA were described previously in the 
materials and methods section of Chapter V. Other primers used for real-time RT-PCR 
in these experiments included primers specific for nNOS, the ATI receptor, the AT2 
receptor, and renin (Invitrogen, Carlsbad, CA). The nNOS primer sequences were 
(sense) 5’-ACTTACCAGCTCAAGGAC-3’ and (antisense) 5’- 
GGCAGACCTGAGGTTC-3’. The nNOS primers amplified a 198 bp region within the
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nNOS gene (1887-2084 bp). The ATI receptor primer sequences were (sense) 5’- 
TAGCACTGGCTGACTTAT-3’ and (antisense) 5 ’ - AGGCGGGACTTC ATTG-3 ’. The 
ATI receptor primers amplified a 205 bp region within the ATI receptor gene (590-794 
bp). The AT2 receptor primer sequences were (sense) 5’-TCTGACCTTCCTGGATG- 
3’ and (antisense) 5’-CCCTTGGAGCCAAGTA-3’. The AT2 receptor primers 
amplified a 205 bp region within the AT2 receptor gene (984-1188 bp). The renin 
primer sequences were (sense) 5’-GTGCAGCCGTCTCTAC-3’ and (antisense) 5’- 
CCGTGACCTCTCCAAAC-3’. The renin receptor primers amplified a 188 bp region 
within the renin gene (392-579 bp). 18s rRNA was used as an internal reference. The 
expression of 18s rRNA is an effective internal reference because it does not undergo 
significant regulation in the postnatal immature kidney.
Standard curves. To generate eNOS, nNOS, ATI receptor, AT2 receptor, renin and 18s 
rRNA cDNA standard curves, PCR products were sepiarated by agarose gel 
electrophoresis. The products were purified from the gel using a gel extraction kit 
(Qiagen, Inc., Valencia, CA), quantitated by measuring absorbance at 260 nm ona  DU- 
65 Spectrophotometer (Beckman-Coulter, Inc., Fullerton, CA), and used as DNA 
templates for quantifications using real-time RT-PCR. Products at varying 
concentrations were subject to amplification and subsequent real-time RT-PCR crossing 
points were used for generation of standard curves.
Statistical analysis. Experiments were repeated x6 . All data are reported as means ± SE. 
Differences between age groups were determined by an unpaired t test. Values of p < 
0.05 were considered statistically significant.
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Tissue Analysis Techniques for NOS Activity Assay
Homogenization. Once microvessels were dissected, they were also subject to a NOS 
activity assay. Homogenization buffer was added to dissected vessels. The amount of 
homogenization buffer added to vessels was 4x (four times tissue to total volume). 
Homogenization buffer volume was approximately 1 ml. Homogenization buffer 
consisted of the following: EDTA ImM, EGTA ImM (6 N NaOH was added as needed 
to dissolve EDTA and EGTA in d ^ O ), sucrose 320 mM, Tris-HCl 50 mM, DTT 1 
mM, PMSF ImM, leupeptin 0.002 mM, pepstatin A 0.001 mM, mercaptoethanol 12 
mM (Sigma, St. Louis, MO). The solution’s final pH was adjusted to 7.4. Microvessels 
were homogenized via sonication using a Micro Ultrasonic Cell Disrupter (Kontes, 
Vineland, NJ) at 13 W.
NOS activity assay. 50 ul of the crude microvessel protein homogenate was used for the 
activity assay. 20 ul of assay buffer I was added to 50 ul of homogenate. Assay buffer I 
consisted of the following: Tris-HCl 25 mM, CaCh 1.25 mM (pH adjusted to 7.2), 
NADPH ImM, valine 10 mM, and proline 10 mM (Sigma, St. Louis, MO). 15 ul of 
cofactor solution was added to the sample. Cofactor solution consisted of the following: 
FAD 1.12 uM, FMN 1.12 uM, BH4 3.36 uM, calmodulin 0.112 uM, and DTT 1.12 uM 
(Sigma, St. Louis, MO). Samples were vortexed and incubated in a hot bath at 37°C for 
15 minutes. 20 ul of assay buffer II was added to samples. Assay buffer II consisted of 
the following: Tris-HCl 25 mM, CaCL 1.25 mM (pH adjusted to 7.2), NADPH 1 mM, 
25.3 nmoles (4 mCi) of radio labeled 3 H-arginine (Perkin-Elmer, Boston, MA) (4 ul of 
3 H-arginine per rxn). Non-labeled arginine was added to assay buffer II to bring the 
total arginine concentration up to 5 uM. After addition of assay buffer II, samples were
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vortexed and placed in a hot bath at 37°C for 45 minutes. 400 ul of stop rxn buffer was 
added to samples following hot bath incubation. Samples were vortexed. Stop rxn 
buffer consisted of the following: EDTA 50 mM (6 N NaOH was added as needed to 
dissolve the EDTA in dfhO) and HEPES 500 mM with pH adjusted to 5.5. 400 ul of 
Dowex hydrogen form resin (Sigma-50X8-400) (Sigma-Aldrich, St. Louis, MO) was 
added to samples. The Dowex resin was dissolved in a 50:50 suspension with dH2 0 . 
Samples were vortex for 5 minutes and centrifuged at 4000 rpm for 4 minutes. 500 ul of 
the resulting supernatant was combined with scintillation cocktail (Research Products 
International Corp., Mount Prospect, 111.) in scintillation vials, mixed thoroughly, and 
subject to DPM count assessment using a LS 6500 Multi-Purpose Scintillation Counter 
(Beckman-Coulter, Inc., Fullerton, CA). For negative samples, all buffers and solutions, 
including fresh homogenization buffer and required NOS substrates, were added as 
described above except crude protein homogenate was excluded from the sample. 
Protein concentration assay. To determine the total amount of protein in each sample, a 
fraction of each sample’s crude homogenate was used in a QuickStart Bradford Protein 
Assay (Bio-Rad, Hercules, CA). Protocol was followed as described in the Bradford 
Protein Assay. Samples of unknown protein concentration, samples with no protein 
(blanks), and standards with known protein concentration were used in the protein 
assay. Absorbance of each sample was taken on a spectrophotometer at 595 nm. Blank 
absorbance was subtracted form unknown samples and standards. Standards were used 
to generate a standard curve on which the quantity of protein was calculated for 
unknown samples.
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Calculations. Fractional conversion of the conversion of L-arginine to L-citrulline was 
calculated by the following equation: [(sample DPMMnegative sample DPM)]/[(total 
activity per sample without resin application)-(negative sample DPM)] = fractional 
conversion of L-citrulline. The total activity per sample was obtained by adding fresh 
homogenization buffer (no protein), assay buffer I, cofactor solution, and assay buffer II 
and then assessing the amount of activity (in DPMs) in the solution using scintillation 
cocktail and the LS 6500 Multi-Purpose Scintillation Counter without the application of 
Dowex resin. Fractional conversion was multiplied by total arginine (3 H-arginine plus 
non-labeled arginine) in each sample to determine the amount of converted L-citrulline 
in each sample. The value for converted L-citrulline was expressed as moles of 
citrulline converted per minute of incubation during the activity assay per gram of total 
protein in each sample.
RESULTS
The successful staining of newborn renal microvessels with perfused blue-dyed 
polybeads is demonstrated in Fig. 26.
eNOS expression
The expression of eNOS mRNA increased in total preglomerular microvessels 
with maturation (Figs. 27 and 28). Lowest level of eNOS was found in the newborn 
while highest levels were observed in the adult. The expression of eNOS increased the 
greatest in the afferent arteriole during maturation. The lowest level of eNOS was
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observed in the afferent arteriole of the newborn. The level of eNOS expression 
consistently increased in the afferent arteriole until reaching its greatest level of 
expression in the adult. The expression of eNOS did not experience much change in the 
interlobular arteriole during maturation. The expression of eNOS in the arcuate 
increased with maturation with a peak at 21 days. Arcuate arteriolar eNOS expression 
was the lowest in the newborn, while highest expression was observed in the more 




Fig. 26. A newborn 500 um corticomedullary renal slice with polybead stained microvessels 
under stereomicroscope I6x magnification.












NB 7d 2 Id AD
Fig. 27. Expression o f eNOS mRNA in preglomerular microvessels in porcine ages newborn, 7, 














NB Id 21d AD
Fig. 28. Sum of eNOS mRNA expression in total (aff/int/arc) preglomerular microvessels in 
porcine ages newborn, 7, 21 day old and adult. N=6. *P < 0.05, newborn vs. 21 day and adult.
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The expression of eNOS in the vasa recta of the porcine kidney increased with 
maturation, similar to what was observed in preglomerular vessels (Fig. 29). The lowest 
level of eNOS expression was observed in the newborn while greatest expression was 
found in the adult. eNOS expression increased consistently in the 7 day and 21 day.
20
NB 7d 2 Id AD
Fig. 29. Expression o f eNOS mRNA in vasa recta in porcine ages newborn, 7,21 day old and 
adult. N=6. *P < 0.05, newborn vs. 21 day and adult.
nNOS expression
The expression of nNOS in total preglomerular vessels was greater at all 
immature ages than in the adult (Figs. 30 and 31). The expression of nNOS was found 
to increase from newborn to 7 day, then decrease from 7 day to 21 day before dipping to
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NB 7d 2 Id AD
Fig. 30. Expression o f nNOS mRNA in preglomenilar microvessels in porcine ages newborn, 
7, 21 day old and adult. N=6. *P < 0.05, newborn, 7 day, and 21 day aff, int, and arc vs. adult 
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Fig 31. Sum o f nNOS mRNA expression in total (aff/int/arc) preglomerular microvessels in 
porcine ages newborn, 7, 21 day old and adult. N=6. *P < 0.05, vs. adult. #P < 0.05. 7 day vs. 
newborn and 21 day.
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the lowest expression found in the adult. Highest nNOS expression was observed at 7 
days. The expression of nNOS in specific vessels showed that expressional changes in 
the afferent arteriole were minimal, while the greatest changes occurred in the 
interlobular and arcuate arterioles. The interlobular and arcuate arterioles both showed 
highest expression of nNOS at 7 days, while the adult displayed extremely low nNOS 
expression in all vessels studied.
The expression of nNOS in the porcine vasa recta was lowest, and relatively 
equivalent, in the newborn and 7 day kidneys, and increased with age to the highest 
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Fig. 32. Expression o f nNOS mRNA in vasa recta in porcine ages newborn, 7, 2 1 day old and 
adult. N=6. *P < 0.05, newborn and 7 day vs. adult.
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level in the 21 day kidney before dropping off slightly in the adult. The lowest level of 
expression was observed in the newborn.
Renin expression
The expression of renin in total preglomerular vessels was similar to that 
observed for nNOS (Figs. 33 and 34). Renin expression was highest in the newborn and 
7 day and then decreased with age reaching its lowest expressional levels in the 21 day 
and adult. Renin expression was highest in the 7 day preglomerular vessels and lowest 
in the adult. Renin expression moderately changed in the afferent arteriole during 
maturation with highest renin levels found in the 7 day kidney followed by the newborn 
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Fig. 33. Expression o f renin mRNA in preglomerular microvessels in porcine ages newborn, 7, 2 1 
day old and adult. N=6. *P < 0.05. newborn and 7 day aflf and int vs. 21 day and adult aff and int.






















Fig. 34. Sum o f renin mRNA expression in total (aflf/int/arc) preglomerular microvessels in 
porcine ages newborn, 7, 21 day old and adult. N=6. *P < 0.05, newborn and 7 day vs. 2 1 day and 
adult.
greatest change in renin expression occurred in the interlobular arteriole. Both the 
newborn and 7 day kidneys experienced very high renin expression in the interlobular 
arterioles before abruptly dropping to very low levels, which were found in the 2 1  day 
and particularly the adult. Low levels of renin expression were observed in the arcuate 
arterioles of porcine of all ages studied.
ATI receptor expression
The ATI receptor showed an expressional increase with maturation with a spike 
at 7 days (Figs. 35 and 36). ATI receptor expression was lowest in the newborn and 
highest in the 7 day and adult kidneys. The greatest expressional change occurred in the 
afferent arterioles. The afferent arterioles followed the same pattern as did total
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Fig. 35. Expression o f ATI receptor mRNA in preglomerular microvessels in porcine ages 
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Fig. 36. Sum o f ATI receptor mRNA expression in total (aff/int/arc) preglomerular microvessels 
in porcine ages newborn, 7, 21 day old and adult. N=6. *P < 0.05, newborn and 21 day vs. 7 day 
and adult.
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preglomerular expression, with lowest levels found in the newborn and highest levels 
found in the 7 day and adult kidney. There was slight fluctuation of ATI receptor 
expression in the interlobular arteriole with highest levels found in the 7 day old kidney, 
while expression in the arcuate arterioles remained fairly constant at all ages.
AT2 receptor expression
The AT2 receptor showed expression that decreased with age with a substantial 
dip at 7 days in total preglomerular vessels (Figs. 37 and 38). AT2 receptor expression 
was by far highest in the newborn and lowest in the adult. AT2 receptor levels in the 
adult were near minimal detection limits. Fluctuation of AT2 receptor expression was 
apparent in all vessels between all ages, but particularly in the afferent arteriole. The 
afferent arteriole of the 7 day kidney had the greatest level of expression. The afferent,
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Fig. 37. Expression of AT2 receptor mRNA in preglomemlar microvessels in porcine ages 
newborn, 7, 21 day old and adult. N=6. *P < 0.05, newborn and 21 day aff, int, and arc vs. 7 day 
and adult aff. int, and arc.
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interlobular and arcuate arterioles all peaked in AT2 receptor expression in the 
newborn. All vessels studied showed lowest expression in the adult.
M  Afferent 




Fig. 38. Sum o f AT2 receptor mRNA expression in total (aff/int/arc) preglomerular microvessels 
in porcine ages newborn, 7, 2 1 day old and adult. N=6. *P < 0.05, vs. newborn and 21 day. #P < 
0.05, 7 day vs.newbom, 21 day, and adult.
NOS activity assay
In the newborn, the production of NO, as measured by L-citrulline production 
and normalized by amount of total protein, was greatest in the interlobular arteriole 
followed by the arcuate and afferent, respectively (Fig. 39). NO production in the 
interlobular arteriole was over twice as high as that in the afferent arteriole in the 









7d 2 1 d













Fig. 39. Conversion o f L-arginine to L-citrulline and subsequent production o f NO as measured by 
NOS catalytic activity assay in preglomerular microvessels in porcine ages newborn, 7, 2 1 day old 
and adult. N=6. *P < 0.05, newborn aff vs. 2 1 day aff, int, arc; newborn aff vs. adult aff, int; #P < 
0.05, newborn int vs. 7 day aff; newborn int vs. 2 1 day aff, int, arc; newborn int vs. adult aff, int, 
arc; tP  < 0.05, = newborn arc v. 2 1 day aff, int, arc; newbon arc vs. adult aff, int.; §P < 0.05, 7 day 
aff vs. newborn int.; 7 day aff vs. 2 1 day aff, int, arc; 7 day aff vs. adult aff, int; &P < 0.05, 7 day 
vs. 2 1 day aff, int, arc; 7 day vs. adult aff, int, arc; JP  < 0.05, 7 day vs. 2 1 day aff, int, arc; 7 day 
vs. adult aff, int.
and interlobular arterioles, as found in the 7 day old kidney, however, NO production 
increased in the arcuate arteriole. In the 7 day old, NO production was highest in the 
arcuate arteriole, followed by the interlobular and afferent arterioles. After 7 days, NO 
production dramatically dropped off with kidney maturation. In the 21 day 
preglomerular vessels, levels of NO production were nearly equivalent in all vessels 
with the afferent arteriole producing just slightly lower levels of NO as compared to the 
interlobular and arcuate arterioles. The amount of NO production seemed to level off at 
21 days and adulthood as the adult exhibited NO production that was comparable to that 
found in the 21 day old. In the adult, afferent and interlobular arterioles produced
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relatively the same amounts of NO while the arcuate arteriole produced slightly more 
NO.
The production of NO, as measured by L-citrulline production, was greater in all 
preglomerular vessels in the newborn as compared to the adult (Fig. 40). The afferent 
arteriole of the newborn produced over twice as much NO as the adult afferent arteriole. 
The interlobular arteriole of the newborn produced five times as much NO as the adult 
interlobular arteriole. The arcuate arteriole of the newborn produced three times as 
much NO as the adult arcuate arteriole.
The production of NO, as measured by L-citrulline formation, in total 
preglomerular vessels decreased with age (Fig. 41). NO production was highest in the 




























Fig. 40. Conversion o f L-arginine to L-citrulline and subsequent production o f NO as measured by 
NOS catalytic activity assay in preglomerular microvessels in porcine ages newborn and adult. 
N=6. tP  < 0.05, newborn aff vs. adult aff. int; *P < 0.05, newborn int vs. adult aff, int.; #P < 0.05 
newborn arc vs. adult aff and int.
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day and adult preglomerular vessels. Lowest levels of NO production were observed in 
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Fig. 4 1. Conversion o f L-arginine to L-citrulline and subsequent production o f NO as measured 
by NOS catalytic activity assay in total preglomerular microvessels in porcine ages newborn, 7,
2 1 day old and adult. N=6. tP  < 0.05, newborn vs. 2 1 day and adult; *P < 0.05, 7 day vs. 2 1 day 
and adult.
DISCUSSION
In the immature kidney, NO functions to provide counterbalancing vasodilation 
against the vasoconstriction of the highly activated RAS (124, 132). Intrarenal infusion 
of the NOS inhibitor, L-NAME, in both whole animal (piglets) (132), and isolated 
perfused kidneys (rabbits) (124), produces greater renal hemodynamic responses in the
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immature kidney than in the adult. Such studies indicate that the renal hemodynamics of 
the young is much more dependent on NO derived from NOS than the adult in order to 
maintain normal physiological kidney function. However, quantification and 
comparison of NOS isoform expression and function in immature and mature 
preglomerular resistance vasculature has yet to be investigated.
Previous results from our lab indicate expressional levels of eNOS mRNA in 
whole kidney models are comparable between immature and mature kidneys with an 
exception of an expressional dip at 7 days post birth (129). A similar eNOS 
expressional pattern was confirmed by Han et al. (53) in studies on the developing rat 
kidney. A difference in cortical and medullary eNOS expression was observed in our 
lab where we found the renal cortex contains more eNOS than the medulla in the 
immature whole kidney while the medulla contains more eNOS in the adult (129). 
Interestingly, in this study, whole kidney trends of eNOS mRNA expression were not 
observed in the preglomerular vessels of the developing porcine kidney. Instead, total 
preglomerular eNOS expression was lowest at birth and progressively increased to its 
highest levels in the adult. Reports from other labs using in situ hybridization have 
localized eNOS expression to much of the developing renal vasculature including the 
glomerular resistance vasculature (81, 83,132,141). In this study, eNOS was localized 
to the afferent, interlobular, and arcuate arterioles. The afferent arteriole experienced the 
greatest increase in eNOS expression with maturation. The expression of eNOS in the 
afferent nearly tripled between the newborn and adult. The expression of eNOS in the 
interlobular arteriole approximately stayed the same during maturation. The expression 
of eNOS in the arcuate doubled during maturation. Although in whole kidney models
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eNOS expression maintained a fairly constant level of expression throughout maturation 
from birth to adulthood, with the exception at 7 days post birth, the preglomerular 
resistance vessels showed a completely different novel developmentally regulated 
pattern of expression.
The lowest levels of eNOS expression at birth may indicate the isoform plays 
only a slight role in the newborn’s renal hemodynamics, but a much larger role in the 
adult kidney. There is a significant eNOS expressional increase in the afferent arteriole 
where eNOS expression triples with maturation from neonate to adult. It appears 
through interpretation of expressional data, that eNOS may play a more important role 
in the adult vasculature than in the newborns’. It is of worth to note the increased 
expression of eNOS in the arcuate arteriole during maturation. The arcuate arteriole of 
the adult contained more eNOS expression than did that of the newborn. The data from 
our study agrees with other studies that have found arcuate arteriole endothelial cells 
strongly express eNOS from gestation throughout maturation into adult stages (78). 
eNOS in the adult arcuate arteriole may play a more pronounced role in RBF and GFR 
than it was previously thought.
While localization experiments in the piglet, confirmed by Fischer et al. (37), 
provide evidence that vascular nNOS distribution and expression in the developing 
kidney differs from that in the adult, the results of Fischer et al. indicates the absence of 
nNOS in the preglomerular resistance arterioles of the developing kidney. Other studies 
have led to variable results indicating both the presence and absence of nNOS in either 
the perivascular nerves or endothelium of the afferent arterioles, interlobular arterioles, 
and medullary vasa recta (7, 81, 83, 126). Studies by Mattson et al. identified both
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nNOS and eNOS isoforms in the preglomerular vessels of the adult rat kidney including 
the arcuate, interlobular, and afferent arterioles, a finding that supports similar 
observations from other laboratories (7, 37, 141).
In this study, the expression of nNOS was observed in all vascular segments 
studied including the afferent, interlobular, and arcuate arterioles. Notably, the 
expressional pattern of nNOS was different than that for eNOS. The expression of 
nNOS was statistically higher at all immature ages in total preglomerular vessels as 
compared to the adult. Expression of nNOS was highest in the 7 day kidney, which was 
statistically higher than all other ages studied. In the interlobular and arcuate arterioles, 
the expression of nNOS was considerably higher than in the adult.
While our studies have indicated the presence of nNOS in the preglomerular 
vessels, the exact cellular location of nNOS mRNA is not known rather present in the 
perivascular nerves, vascular smooth muscle cells, or in the endothelial cells 
themselves. The perivascular nerves innervate the smooth muscle cells that are a part of 
the preglomerular resistance vessels. Kavdia et al. showed that NO derived through 
nNOS in the perivascular region can be a significant contributor to smooth muscle NO 
and thus would significantly effect available smooth muscle NO (76). The exact cellular 
location of nNOS within the preglomerular vessels requires further exploration.
In previous studies by our lab, nNOS expression was greatest in the whole 
kidney immediately after birth and decreased in expression with maturation to the 
lowest levels, which was observed in the adult, suggesting the role of nNOS was 
enhanced in the postnatal kidney (128). The elevation of nNOS expression seen in the 
preglomerular resistance vessels in this study suggests the augmented role of NO in the
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immature kidney is in part a function of developmentally regulated nNOS expression. 
The NOS isoform expressional results from this study indicate that during the postnatal 
period when the vasodilatory role of NOS is increased, NO may be predominately 
supplied by nNOS, rather than eNOS, as illustrated by the high nNOS expressional 
levels compared to the low levels observed for eNOS. The results in this study suggest 
nNOS serves as the main contributor of NO in the preglomerular vasculature of the 
immature kidney. As eNOS expression, initially low in the newborn, increases with 
maturation to adult levels, the need for nNOS in the resistance vasculature diminishes 
and thus nNOS expression decreases.
The expressional pattern for eNOS in the vasa recta was very similar to that 
found in the preglomerular resistance vessels. The expression of eNOS mRNA 
increased progressively with maturation with the newborn exhibiting the lowest level of 
expression and the adult expressing the highest level. The results here agree with other 
studies that found eNOS expression in the vasa recta gradually increased in the renal 
medulla after birth (78). The results of nNOS expression in the vasa recta were very 
similar to that observed for eNOS. The expression of nNOS increased with maturation 
with lowest levels being found in the newborn and highest levels found in the more 
mature animals. The only exception between eNOS and nNOS vasa recta expression 
was nNOS mRNA levels were slightly higher in the 21 day kidney as compared to the 
adult kidney while eNOS mRNA was highest in the adult. The significance for the up- 
regulation of either isoform in the vasa recta is not clear. As the mammalian kidney 
continues to mature, less sodium is reabsorbed and is therefore excreted by way of the 
tubules and collecting duct. NO derived from NOS within the vasa recta may serve two
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purposes. One possibility may involve blood flow through the vasa recta. Increased 
NOS may in turn lead to increased NO levels in the vasa recta thus causing enhanced 
vasodilation. The increase in vessel luminal diameter would increase the blood flow 
through the vasa recta. The increase in blood flow in the vasa recta would increase 
hydrostatic pressure and thus reduce the amount of filtrate that is reabsorbed by the vasa 
recta causing an increase an excretion of ions such as sodium. Another way NO may 
influence reabsorption within the vasa recta is through a paracrine fashion. NO 
generated within the vasa recta may permeabilize the capillaries and enter the tubules 
and directly inhibit antiporters that function to transport and reabsorbed filtrate from the 
tubule lumen back into the bloodstream. At this point, the significance of increasing 
either vasa recta eNOS or nNOS expression with maturation is unknown.
Renin mRNA expression was high in preglomerular vessels in the newborn and 
7 day kidney, but dropped considerably at 21 days and adult. Renin expression in the 
newborn and 7 day preglomerular resistance vessels was three and four fold, 
respectively, greater than in the adult. Expression of renin in the newborn and 7 day old 
was spread throughout both the afferent and interlobular arterioles, while the arcuate 
arteriole contained only very small amounts. Upon maturation, high renin expression 
receded to the afferent arteriole in the 2 1  day old before declining significantly 
throughout all preglomerular resistance vessels in the adult. The data from this study 
agrees with the data obtained from Gomez et al., in which it was found in rats, that renin 
expression is high throughout the preglomerular resistance vasculature, including the 
afferent and interlobular, of the immature kidney but expression declines and recedes 
back to the afferent arteriole with maturation (44).
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Bachmann et al. demonstrated that changes in NOS and NOS gene expression 
parallel changes in renin and renin gene expression (9,42). Studies directed at defining 
the type of NOS involved in renin changes have pointed to nNOS, with no consistent 
correlation with eNOS nor iNOS (42). The expressional results from this study would 
further suggest an interaction between nNOS and renin expression and activity. The 
developmental expressional pattern of nNOS and renin are almost identical. Both nNOS 
and renin expression is high in the newborn, peaks in the 7 day old, drops drastically in 
the 21 day old, and bottoms out in the adult. Both nNOS and renin are heavily 
expressed in the afferent and interlobular arteriole. The only difference between 
localization and abundance of mRNA transcription between the two genes is that nNOS 
is expressed in greater abundance than renin in the arcuate arteriole.
In adult models, NO has been found to influence renin secretion. NO inhibits 
cAMP degradation thus causing more renin to be secreted. However, NO mechanisms 
that alter intracellular calcium and activation of protein kinase C inhibit renin secretion 
(8 6 ). Although no direct correlation can be drawn between nNOS and renin expression 
or secretion in this study, the results here indicate nNOS and renin are both 
developmentally regulated and in a near identical pattern. It may be nNOS is the crucial 
NOS isoform in the immature preglomerular vasculature that provides defense against 
the enhanced vascular resistance found in the neonate kidney. Progressively, the kidney 
and vasculature matures, All levels drop, and resistance declines, meanwhile nNOS 
levels decrease and eNOS expression increases and becomes the critical NOS isoform 
in the adult renal vasculature.
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The sensitivity and reactivity to All is influenced by fluctuations in expression 
of the receptors that mediate the actions of All. In porcine, the effects of All are 
mediated through two receptors, the ATI and AT2 receptors. When activated, it is 
believed both receptors activate G-protein associated second messengers, with the AT2 
receptor activating phosphotyrosine phosphatases resulting in the inactivation of 
MAPKs (73). It is accepted that AT2 receptors are the abundant receptor type in the 
developing fetus and decrease in expression with birth and maturation. On the other 
hand, the ATI receptor is minimally expressed in the fetus and newborn but increases 
with maturation to be by far the most abundant receptor subtype in the adult kidney. In 
fetal rat kidneys, 80% of All receptors are the AT2 subtype (73). It is believed that 
vasoconstriction, sodium reabsorption, and growth promotion occur via All through the 
ATI receptor, while the AT2 receptor mediates vasodilation, natriuresis, and growth 
inhibition (73). Since all the components of the RAS are present in the developing 
embryo and are found in the kidney before the onset of fetal urine production, it is 
possible that the renal RAS may regulate growth and differentiation of developing 
nephrons in the fetus and neonate (73). Once kidney structures are completely formed, 
the RAS may then switch to a more primary role in regulating renal hemodynamics and 
sodium transport (73).
Both the ATI and AT2 receptors exhibited developmentally regulated patterns 
in this study. Overall, ATI receptor expression in the preglomerular vasculature was 
lowest at birth and progressively increased with maturation to its highest levels in the 
adult. The AT2 receptor exhibited highest expression in the immature preglomerular 
vessels and decreased to minute expression in the adult. Interestingly, the ATI receptor
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exhibited a spike in expression at 7 days while the AT2 receptor experienced an 
expressional dip, possibly indicating a compensatory mechanism between the receptor. 
Both nNOS and renin expression was also highest at 7 days. It appears that there is an 
event, or possible transition of sorts, that occurs in the renal preglomerular vasculature 
at 7 days as indicated by the results of this study. Intrinsic mechanisms within the 
kidney may lead to neonatal changes during birth that effects mean arterial blood 
pressure and alters renal blood flow and glomerular filtration rate. Another change may 
occur at 7 days that allows renal hemodynamics to switch from the newborn state to an 
immature condition that much more resembles adult renal proficiencies.
Other studies have found interactions between the expression of renin, All 
formation and the All receptor subtype expression. Renal plasma All inhibits AT2 
receptor expression (20). However, this is contradictive in the fetus and neonate where 
both AT2 receptor and All plasma levels remain high. When the ATI receptor is 
activated, renin secretion is inhibited (20). The up-regulation of expression of the ATI 
receptor that occurs in the maturing kidney, particularly at 7 days, may be one 
mechanism used by the renal vasculature to decrease highly activated renal All. Studies 
by other labs have demonstrated up-regulation of the AT2 receptor down-regulates the 
ATI receptor (20, 25,44, 8 6 ). Another contributing mechanism to neonate renal 
hemodynamics may be that ATI receptor expression, maintaining relatively low levels 
in the fetus and neonate, gradually increases with maturation as the inhibitory effects of 
the AT2 receptor wear off as expression of the AT2 receptor diminishes with age.
In this study, both the ATI and AT2 receptors were expressed throughout the 
preglomerular vasculature. However, expression of the ATI receptor was greatest in the
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afferent arterioles indicating an enhanced role for the ATI receptor in the afferent 
arteriole as compared to the interlobular and arcuate arterioles. The receptor findings in 
this study agree with previous data that indicates that AT2 receptor is more important in 
the immature kidney than the adult while the role of the ATI receptor increases with 
maturation. Nevertheless, it appears an alteration in expression of both receptors is 
required for events that occur in the 7 day old preglomerular vasculature. The exact 
relationship between ATI receptor, AT2 receptor, and NOS expression (particularly 
nNOS expression) is unknown. The results in this study indicate AH receptors, NOS 
and renin are all developmentally regulated in similar fashion with expression mirroring 
each other in the immature preglomerular resistance vessels. The RAS and nNOS 
isoform may possibly not only interact with each other to influence their expression, 
translation and physiological effects, but may as well be regulated by the same 
developmental factors.
Studies have found that increased NOS expression can influence NOS activity 
(26, 29, 59). Since protein expression does not always correlate with enzyme activity 
and NO production (59), it is important to observe actual NO production to accurately 
access the NO function in newborn renal hemodynamics. The NOS activity assay used 
in this study clearly identified an upregulation of NO production within the 
preglomerular resistance vessels of the immature kidney. NO activity was three to four 
times higher in the newborn and 7 day piglet as compared to the more mature 21 day 
piglet and adult. The NOS enzymatic activity assay data provides further evidence that 
the role of NO is enhanced in the neonate.
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In 1993, Solhaug et al. (131) showed that NO modulates renal hemodynamics in 
the newborn piglet and that NO plays a much more important role in the renal 
hemodynamics of the immature kidney as compared to the adult kidney. Since that 
time, many studies have been designed to investigate the role of NO production in 
physiological adult renal hemodynamics, modulating All vasoconstriction, and 
modulating tubuloglomerular feedback. There have not been any studies designed to 
investigate the role of NO in the vasculature of the developing kidney, particularly in 
the preglomerular resistance vessels. In the adult preglomerular vasculature, Patzak et 
al. identified an interaction between All and NO release in afferent arterioles of the rat. 
Patzak et al. found that vasoconstrictor responses to All were enhanced in eNOS 
knockout mice and that All upregulates NO production via the ATI receptor (104, 105). 
Thorup et al. found that inhibition of the ATI receptor inhibited All stimulated NO 
production (135). An interaction between All and NO has been identified in the adult 
kidney. However, to day, the exact relationship between All and NO in the newborn 
kidney has not yet been fully investigated.
At the same time that the RAS is upregulated in the newborn’s preglomerular 
resistance vasculature, NO levels are also upregulated. In this study, the newborn’s 
interlobular arteriole produced the most NO followed by the arcuate and the afferent. In 
the 7 day old, the arcuate produced the most NO followed by the interlobular and the 
afferent. In the more mature kidneys, NO production was significantly and consistently 
lower in all preglomerular vessels examined.
The increase in NO production in the interlobular and arcuate may suggest an 
augmented role of these vessels in the modulation and regulation of RVR, RBF and
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GFR in individual vascular channels within the kidney. In the newborn piglet kidney, 
nephrogenesis and angiogenesis are not complete until week three. As a consequence, 
many afferent arterioles are not developmentally ready to function and control filtration 
rates through branching nephrons. This may shift glomerular hemodynamic regulation 
to vessels that develop quicker than the afferent arterioles, including the interlobular 
and arcuate arterioles. Serving as a control valve to distribute blood flow to developing 
afferent arterioles, the arcuate and interlobular arterioles would be the more prominent 
site of vascular control. An enhanced role of vascular control would mean the role of 
vaso-active agents would also be enhanced in these segments.
Renin expression was widespread throughout the interlobular and afferent 
arterioles of the postnatal kidney. The ATI and AT2 receptors were also widespread 
throughout the preglomerular vessels as well, but the ATI and AT2 receptor transcripts 
were in much more abundance in the afferent arteriole, possibly suggesting an increase 
in afferent AH sensitivity. Increased action of All in the afferent arteriole, particularly 
afferents attached to glomeruli that are still developing, would result in decreased blood 
flow to these glomeruli thus lowering their individual GFR. This may be a mechanism 
by which the immature kidney routes blood flow to more developed nephrons. 
Juxtamedullary nephrons have been found to develop before superficial nephrons.
While resistance remains high in developing afferent arterioles throughout the immature 
kidney, particularly to superficial nephrons, blood flow may be distributed to fully 
developed glomeruli, particularly juxtamedullary nephrons, within the kidney by 
modification of resistance offered in the interlobular and arcuate arterioles.
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NO production was highest in the interlobular and arcuate arterioles of the 
newborn and 7 day old kidney suggesting an enhanced need for NO production in those 
vascular segments. The NOS enzyme whose expression was elevated in the interlobular 
and arcuate segments of the newborn and 7 day old was nNOS, further implicating 
nNOS as the critical source of NO that opposes enhanced All activity. As the kidney 
develops and finishes with nephrogenesis and angiogenesis, the renal vasculature 
reaches adulthood status. In the adult, RVR is lower, RBF and GFR are higher, RAS 
activity decreases, nNOS expression decreases, and eNOS expression increases, and 
thus the primary control site for single nephron filtration is in the resistance offered by 
the afferent arteriole, while the role of resistance in the interlobular and arcuate 
arterioles, once critical in the neonate, is much more attenuated and secondary to the 
afferent arteriole resistance offered in the adult.
The results from this study demonstrated distinctive postnatal developmental 
expressional patterns were observed for nNOS, eNOS, renin and the ATI and AT2 
receptors in the preglomerular resistance vessels, as well as the vasa recta. The 
enhanced role of NO during postnatal maturation maybe produced by developmentally 
regulated NOS expression, particularly nNOS, in the immature renal vasculature, 
primarily the resistance arterioles. The expression of renin and All receptors follow the 
same developmental pattern observed for the high renal vasculature resistance found in 
the immature preglomerular resistance vessels. The expression of RAS components 
follows the same pattern as nNOS expression in the immature preglomerular resistance 
vessels. NOS enzymatic activity, also high in the neonate’s preglomerular resistance
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vessels, decreases with maturation in similarly to nNOS expression and expression of 
RAS components.
The results of this study would agree with the hypothesis that the enhanced role 
of NO serving as a critical vasodilator, counteracting highly activated constrictors such 
as All during postnatal renal maturation, is produced by developmentally regulated 
NOS expression and function in the immature preglomerular resistance vessels.
While it was found that NO production was significantly upregulated in the neonate, it 
may be the result of increases in nNOS expression in the preglomerular resistance 
vasculature. Furthermore, this study indicates that the interlobular and arcuate arterioles 
may play a more important role in neonatal preglomerular resistance, subsequent RBF 
and GFR, and possibly single nephron filtration as compared to its adult counterpart. 
However, more studies are needed to investigate the role of NO in the preglomerular 
resistance vasculature of the immature kidney with particular emphasis on mechanisms 
of NOS expression and activity, and the role of NO in counterbalancing the enhanced 
vasoconstriction of All.
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CHAPTER VII 
STUDY 4: ANGIOTENSIN II REGULATES NITRIC OXIDE 
SYNTHASE EXPRESSION AND NO FUNCTION IN THE RENAL 
RESISTANCE VASCULATURE DURING PORCINE POSTNATAL 
MATURATION
INTRODUCTION
Ubiquitous production of NO has been shown to be involved in the regulation of 
multiple processes throughout the body. In particular, NO plays a crucial role in 
multiple processes within the kidney including modulation of RBF. As time goes on and 
our knowledge of NO in the vasculature increases, the role of NO and its importance in 
maintaining normal physiological homeostasis increases as well. Although structural 
and physical factors play a role in the change in RVR and RBF seen in the developing 
kidney, it is accepted that an increase in functional vasoactive agents is the major cause 
for the increase in the neonate’s RVR.
The primary site of renal vascular resistance in the newborn kidney occurs in the 
preglomerular microvessels. The main site for the reduction in vascular resistance is the 
afferent arterioles, which are directly adjacent to glomeruli. Fluctuations in reactivity 
within the afferent arteriole directly impacts RBF and GFR. Thus, a decrease in 
vascular resistance in the afferent arteriole would have a large influence on the rate of
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filtration. Therefore, an interaction, or counterbalancing between All vasoconstriction 
and NO vasodilation in the afferent arteriole would impact RBF and GFR the greatest.
Both eNOS and nNOS mRNA and protein are developmentally regulated during 
postnatal maturation. Furthermore, developmental patterns of eNOS and nNOS are 
different suggesting the isoforms have different regulatory factors and functional 
contributions in the postnatal kidney (128, 129). Whole kidney studies demonstrate 
nNOS expression is greatest in the newborn and progressively decreases with 
maturation (128). nNOS may serve as an more important vasodilator in the newborn 
than in the adult. However, all studies by Solhaug et al. used whole kidney models. The 
exact relationship between NO and All in the newborn vasculature has not been 
examined. To fully understand the interaction between NO and All, particularly in 
terms of counterbalancing All vasoconstriction and influencing neonate renal 
hemodynamics, it would be ideal to observe the interaction between NO and All in 
isolated microvessels of the newborn kidney and compare the results with that of the 
adult. To our knowledge, no studies have looked at this relationship directly between 
NO and Ail in the neonate’s pre-glomerular vasculature.
Studies aimed at looking at the potential interaction between NO and All have 
been conducted in adult models, primarily in rats and mice. In the adult, Patzak et al. 
showed the vasoconstrictor response to AH was enhanced in eNOS knockout mice 
(105). Patzak also showed that All upregulated NO production via the ATI receptor in 
the afferent arteriole of adult rats (104). Thorup et al. observed ATI receptor inhibition 
inhibited All stimulated NO production in the renal arteries of adult rodents (135). 
Hennington et al. found that acute Ail infusion (110 minutes) increased eNOS mRNA
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by 70% without changing eNOS protein levels, whereas chronic infusion of All (10 
days) increased eNOS protein by 90% without changing eNOS mRNA levels (108). All 
these experiments were conducted in the absence of changes in flow or perfusion 
pressure as to avoid input from other factors such as the myogenic response and shear 
stress. Clearly, there is an important interaction between NO and All in the renal 
vasculature. However, the exact relationship has yet to be studied, or even identified, in 
the renal vasculature of the immature kidney.
The objective of this study was to determine the role of All as a regulator of 
nNOS and eNOS expression and function of NO production in the immature and mature 
renal resistance arterioles, primarily the afferent arteriole. The hypothesis of the study is 
that in the immature renal resistance vasculature, NOS expression and function are 
regulated by AD through the ATI and AT2 receptors.
MATERIALS AND METHODS
Microdissection o f microvessels. The animals, animal preparation, age of animals, 
surgery, intrarenal perfusion of polybeads, and microdissection of specific renal 
vasculature for these experiments followed the same protocol as was discussed in the 
materials and methods section of Chapter IV. At the conclusion of the microvessel 
microdissection, the experiment followed the following protocols.
Tissue analysis techniques for mRNA studies. At the conclusion of the 1.5 hr dissection 
period, microvessels were centrifuged at 12,000 g for 2 min. Supernatant was discarded. 
Assay buffer was added to microvessels. The assay buffer consisted of dissecting
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solution, 2 U / ul RNasin, 5 mM DTT and either 0.1 uM All (Sigma) for All, 0.1 uM 
candesartan and 0.1 uM All for AT1X, 0.1 uM PD 123319 and 0.1 uM All for AT2X, 
or nothing for control. While in assay buffer, the microvessels were placed in a water 
bath at 37°C for 1 hr. At the conclusion of the 1 hr, lysis buffer (from the RNeasy Kit) 
was added to the microvessels and mRNA isolation was started. To begin mRNA 
isolation, microvessels were homogenized via sonication at 13 W using a Micro 
Ultrasonic Cell Disrupter (Kontes, Vineland, NJ). After homogenization, the RNeasy 
Kit (Qiagen, Valencia, CA) protocol was applied to isolate mRNA. After RNA 
isolation, samples were subject to vacuum centrifuge for 1 hr to increase RNA 
concentration. Once RNA was concentrated, it underwent reverse transcriptase 
procedures to obtain the sample’s cDNA. The protocols for semi-quantitative RT-PCR 
including reverse transcriptase procedures, LightCycler PCR procedures, primer 
sequences for eNOS, nNOS and the internal control 18s rRNA, standard curves, and 
statistical analysis were described previously in the materials and methods section of 
Chapters V and VI.
Tissue Analysis Techniques for NOS Activity Assay
NOS activity assay. At the conclusion of the 1.5 hr dissection period, microvessels were 
centrifuged at 12,000 g for 2 min. Supernatant was discarded. In a total volume of 55 ul, 
pre-made assay buffers were added which contained the following: assay buffer 1 ( 1 0  
ul) - DTT 1 mM, PMSF ImM, leupeptin 0.002 mM, pepstatin A 0.001 mM, 
mercaptoethanol 12 mM (Sigma, St. Louis, MO); assay buffer II (20 ul) - Tris-HCl 25 
mM, CaCh 1.25 mM (pH adjusted to 7.2), NADPH 1 mM, valine 10 mM, and proline
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10 mM (Sigma, St. Louis, MO); assay buffer III (15 ul) - FAD 1.12 uM, FMN 1.12 uM, 
BH4  3.36 uM, calmodulin 0.112 uM, and DTT 1.12 uM (Sigma, St. Louis, MO). To 
bring the volume up to 55 ul, either water (for control and AH samples), 0.1 uM 
candesartan for AT1X samples, or 0.1 uM PD 123319 for AT2X samples was added. 
Samples were vortexed and incubated in a hot bath at 37°C for 15 minutes. After 
incubation, either 5 ul of All, at a final concentration of 0.1 uM, or water was added to 
designated samples. 20 ul of assay buffer IV was added to all samples. Assay buffer IV 
consisted of the following: Tris-HCl 25 mM, CaCh 1.25 mM (pH adjusted to 7.2), 
NADPH 1 mM, 25.3 nmoles (4 mCi) of radiolabeled 3 H-arginine (Perkin-Elmer,
Boston, MA) (4 ul of 3-H arginine per rxn). Non-labeled arginine was added to assay 
buffer IV to bring the total arginine concentration up to 5 uM. Samples were mixed by 
pipeting and placed in a hot bath at 37°C for 60 minutes. 400 ul of stop rxn buffer was 
added to samples following hot bath incubation. Samples were vortexed. Stop rxn 
buffer consisted of the following: EDTA 50 mM (6 N NaOH was added as needed to 
dissolve the EDTA in dH2 0 ) and HEPES 500 mM with pH adjusted to 5.5. Samples 
were briefly centrifuged to pelletize microvessels and the pellet was removed and used 
in the protein concentration assay described later for analysis of total protein content. 
400 ul of Dowex hydrogen form resin (Sigma-50X8-400) (Sigma-Aldrich, St. Louis, 
MO) was added to samples’ remaining supernatant. The Dowex resin was dissolved in a 
50:50 suspension with (IH2 O. Samples were vortex for 5 minutes and centrifuged at 
4000 rpm for 4 minutes. 500 ul of the resulting supernatant was combined with 
scintillation cocktail (Research Products International Corp., Mount Prospect, 111.) in 
scintillation vials, mixed thoroughly, and subject to DPM count assessment using a LS
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6500 Multi-Purpose Scintillation Counter (Beckman-Coulter, Inc., Fullerton, CA). For 
negative samples, all assay buffers and homegenization solutions (including required 
NOS substrates) were added as described above except microvessels were excluded 
from the sample.
Protein concentration assay. To determine the total amount of protein in each sample, 
the palletized microvessels removed from the NOS activity assay were used in a 
QuickStart Bradford Protein Assay (Bio-Rad, Hercules, CA). Pelletized microvessels 
were placed in 1 ml of Bradford Protein Assay solution and homogenized using a 
sonicator at 13 W. Sonic homogenization was done in increments to ensure adequate 
homogenization of microvessels. Microvessel samples remained on ice during 
homogenization. The entire resulting homogenate was subject to the Bradford Protein 
Assay protocol as described in the kit. Samples of unknown protein concentration, 
samples with no protein (blanks), and standards with known protein concentration were 
used in the protein assay. Absorbance of each sample was taken on a spectrophotometer 
at 595 nm. Blank absorbance was subtracted form unknown samples and standards. 
Standards were used to generate a standard curve on which the quantity of protein was 
calculated for unknown samples. For protein concentration calculations, absorbances of 
unknown protein samples were used to calculate protein concentration using the 
standard curve.
Calculations. Fractional conversion of the conversion of L-arginine to L-citrulline, total 
activity, and all other NOS activity assay calculations were followed as described 
previously in the materials and methods section in Chapter VI.
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RESULTS
The successful staining of microvessels, by perfusion of blue-dyed polybeads, is 
illustrated in Figs. 42 and 43. In Figs. 42 and 43, a corticomedullary kidney slice from a 
7 day old piglet is stained with polybeads and the microvessels, including the arcuate, 
interlobular, and afferent arterioles, plus the capillary bed of the glomerulus, are visible. 
As illustrated, vessel diameters were less than 5 pm.
Fig. 42. Magnification (50x) o f a porcine newborn corticomedullary kidney slice stained with 
perfused blue-dyed polybeads. Microvessels stained by polybeads include the arcuate, interlobular 
and afferent arterioles, plus the glomerular capillary bed.
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Fig. 43. Magnification (60x) o f a porcine 7 day old corticomedullary kidney slice stained with 
perfused blue-dyed polybeads. Microvessels stained by the polybeads include the arcuate, 
interlobular and afferent arterioles plus the glomerular capillary bed.
eNOS Expression
Control expression of eNOS mRNA in afferent arterioles was highest in the 
newborn, and lowest in the 7 day afferent arterioles (Fig. 44). The control value for 7 
day was 56% lower than newborn, while 21 day and adult control values were 15% and 
17% lower, respectively, than newborn control.
All administration resulted in a statistically insignificant reduction of eNOS 
expression at all ages (Fig. 44).
Blockade of the ATI receptor cause the greatest attenuation in eNOS expression 
in the newborn and the least attenuation in the 7 day (Fig. 44). When the ATI receptor 
was blocked with candesartan before application of All in newborn afferent arterioles, 
eNOS expression was reduced 95%. When the 7 day ATI receptor was blocked prior to
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Ail administration, eNOS mRNA levels were reduced by 64%. When the 21 day ATI 
receptor was inhibited, eNOS expression was reduced by 76%. Blockade of the adult 
ATI receptor resulted in a 6 8 % reduction in eNOS expression.
Inhibition of the AT2 receptor caused the greatest eNOS expressional 
attenuation in the newborn, and the least in the 7 day (Fig. 44). When the AT2 receptor 
in newborns was blocked by PD 123319 prior to All application, eNOS expression was 
reduced by 72%. When the 7 day AT2 receptor was blocked prior to All administration, 
eNOS mRNA levels were reduced by 51%. AT2 receptor inhibition in the 21 day 
resulted in a 64% reduction in eNOS. Blockade of the adult AT2 receptor resulted in a 
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Fig. 44. The expression of eNOS mRNA in the afferent arterioles o f porcine of 
varying developmental ages as measured by real-time RT-PCR. N=6. *P < 0.05. vs. 
control. tP  < 0.05, vs. All.
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nNOS Expression
Control expression for nNOS mRNA was highest in the afferent arterioles of the 
newborn (Fig. 45). Control nNOS expression in the 7 day was 82% lower than 
newborn, while 21 day and adult control nNOS expression was 76% and 90% lower, 
respectively, than the newborn.
The newborn demonstrated higher nNOS expression during administration of 
All as compared to all other ages studied (Fig. 45). AH administration alone caused 
statistically insignificant alterations in nNOS expression in the newborn, 7 day, 21 day, 
and adult.
While ATI receptor inhibition resulted in significant attenuation in nNOS 
expression in all immature afferent arterioles, the greatest attenuation was observed in 
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Fig. 45. The expression o f nNOS mRNA in the afferent arterioles o f porcine of varying 
developmental ages as measured by real-time RT-PCR. N=6. *P < 0.05, vs. control. +P < 0.05, 
vs. All. #P < 0.05, newborn control and All vs. all columns o f all other ages.
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administration caused an 85% decrease in expression. 7 day ATI receptor inhibition 
reduced nNOS expression by 79%. When the 21 day ATI receptor was blocked, nNOS 
mRNA levels dropped by 72%. ATI blockade in the adult caused a 9% increase in 
nNOS expression.
Blockade of AT2 receptors caused the greatest attenuation of nNOS expression 
in the newborn and 21 day, with little effect on 7 day and adult nNOS expression (Fig.
45). AT2 receptor inhibition prior to All administration in the newborn resulted in a 
52% attenuation in nNOS expression. The blockade of AT2 receptors in the 7 day 
afferent arterioles resulted in only a slight 5% decline in nNOS expression. When the 21 
day AT2 receptor was blocked, nNOS mRNA levels dropped by 65%. Blockade of the 
adult AT2 receptor before administration of All resulted in a 23% decrease in nNOS 
expression.
NO Activity
Measurement of NO production in afferent arterioles by NOS activity assay 
resulted in a newborn control value that was 25% greater than control values for the 
adult (Fig. 46). When given All, NO production in newborn and adult afferent arterioles 
increased 18% and 24%, respectively.
When the newborn afferent arterioles were given the ATI receptor inhibitor 
candesartan prior to All administration, NO production was attenuated by 31% (Fig.
46). Blockade of the ATI receptor in the adult afferent arterioles caused a 63% 
attenuation in NO production (Fig. 46).
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When the newborn afferent arterioles were given the AT2 receptor inhibitor PD 
123319 prior to All administration, NO production was attenuated by 44% (Fig.46). 






















Fig. 46. The production o f nitric oxide (NO) in the afferent arterioles of 
porcine ages newborn and adult as measured by quantification of H ' labeled L- 
citrulline formation using the NOS activity assay. N=6. #P < 0.05, newborn 
control vs. adult control. *P < 0.05, vs. control. +P < 0.05, vs. All.
DISCUSSION
These studies show both the ATI and AT2 receptors control mRNA expression 
of eNOS. At each age studied, from immature to mature, inhibition of either All 
receptor resulted in significant reductions in eNOS mRNA transcripts within afferent 
arterioles. To our knowledge, this is the first report that inhibition of the ATI and AT2
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receptors results in a decrease of eNOS expression in the immature afferent arterioles of 
swine. The control eNOS expression data matches the data provided by our lab in whole 
kidney models in which eNOS expression was relatively high in the newborn and adult 
with a dip in expression at 7 days (129). In studies on rats by Han et al., the same whole 
kidney eNOS expressional dip was observed at 7 days (53). There may be a transition in 
the undeveloped kidney from the immediate period after birth, in which maternal 
factors or fetal programming may carry over into the period immediately after birth, 
until a transition in the immature kidney occurs 7 days after birth. However, the 
significance of such a transition has not been identified.
Although statistically insignificant, there was a trend of down regulation 
observed with acute All administration. It is essential to note that All administration in 
these experiments was topical and lasted only for 60 minutes at 37°C. The 60 minute 
incubation period with All did result in increases in NO production as measured by the 
NOS catalytic activity assay. Hennington et al. observed a 70% increase in eNOS 
mRNA after 110 minutes of All infusion (58). However, in those experiments, there 
were no recorded changes in eNOS protein levels and NO activity was not recorded. 
Since the vasoactive component is the free radical NO molecule itself, the measurement 
of NO would be the crucial item to be observed in experiments involving microvessels. 
Studies have shown the NO serves as a negative-feedback regulator of eNOS expression 
(47, 143). Therefore, All may serve to upregulate eNOS expression when levels of NO 
are low, however, once protein levels increase and/or NOS catalytic activity increases to 
produce more NO, the All induced increase in eNOS expression would be attenuated to 
stop over NO production. As seen in numerous studies, NO can also serve as a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
130
negative-feedback regulator of the NOS protein itself. Thus, the degree of expression 
does not always correlate with enzymatic activity because increased NO levels can 
result in inhibition of NOS expression and/or activity. In regard to the studies by 
Hennington et al., NO levels may not be enhanced for a long duration such as 110 
minutes, thus the negative feedback that accompanies increase NO production would be 
absent and as a result, eNOS may have been upregulated by All. Although no reports 
have been seen that specifically links NO to inhibiting nNOS expression, it would not 
be surprising if it were the case as well.
There is substantial evidence provided in the data obtained from the ATI and 
AT2 receptor inhibition experiments to provide a link between the two receptors and 
eNOS expression. At each age, blockade of each receptor resulted in a significant 
decrease in eNOS expression. It was generally thought that the AT2 receptor caused 
vasodilation (4). However, the results of this study indicated at all ages, blockade of the 
ATI receptor caused a greater attenuation of eNOS expression. Previous in vivo 
functional studies in whole kidney models by our lab have also indicated the role of the 
ATI receptor in modulating the NOS response (132). Some studies have shown the 
AT2 receptor assumes a more important role when NOS is inhibited (4). Nevertheless, 
both receptors significantly influenced the mRNA expression of eNOS in this study.
Unlike eNOS expression, the mRNA expression of nNOS was only influenced 
by All receptor inhibition in the immature kidneys. In control afferent arterioles, nNOS 
expression was the greatest in the newborn before dropping by 80% in the 7 day, and 21 
day, and adult kidneys. The control expressional values of nNOS agreed with the whole 
kidney nNOS expressional data obtained previously by our lab in which the highest
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levels of nNOS expression was found in the newborn while lowest levels were recorded 
in the adult. Even though overall expression of nNOS was relatively lower than eNOS 
expression in the preglomerular vasculature of the newborn, recent studies by Kavdia et 
al. indicate that a source of NO derived through nNOS in the perivascular region can be 
a significant contributor to smooth muscle NO, thus effecting its vasodilatory state (76).
Inhibition of the ATI receptor resulted in significantly reduced nNOS 
expression in all immature kidneys, but not in the adult. Inhibition of the AT2 receptor 
resulted in attenuated nNOS expression only in the newborn and 21 day kidney. As was 
the case with eNOS, the ATI and AT2 receptors play a role in the regulation of nNOS 
expression in the afferent arterioles of the immature kidney. However, unlike eNOS, 
neither the ATI nor the AT2 receptor plays a role in the expression of nNOS in the 
adult. Furthermore, the expression of nNOS was augmented in the newborn, suggesting 
a more crucial role of nNOS in the newborn’s vasculature, and much more influenced 
by All receptor inhibition, particular inhibition of the ATI receptor subtype. Blockade 
of the ATI receptor in the newborn blocked 85% of the expression of nNOS. The 
results from this study agree with previous results from our lab that have indicated an 
enhanced role of nNOS in the developing kidney of the newborn as compared to the 
adult (128). The data obtained here also indicates that nNOS is heavily regulated by All 
through the ATI and AT2 receptors in the newborn, but not in the adult. This may 
indicate that NO produced by nNOS may be an important influence in modulating 
newborn renal hemodynamics opposing the enhanced activity of the RAS.
The exact mechanism by which antagonist block either eNOS or nNOS 
expression is unknown. Both receptor subtypes have been localized to the surfaces of
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endothelial cells and vascular smooth muscle cells (VSMC). Activation of the receptors 
on endothelial cells can promote the production of NO from presumably eNOS, nNOS 
expression may as well be effected. Generation of NO within VSMC from activated All 
receptors on the VSMC would require the NOS enzyme to be present within the VSMC, 
thus requiring the transcription of NOS within the cell. There may as well be some sort 
of cross talk between AH receptors on endothelial or VSMC and the perivascular nerves 
that release nNOS mediated NO. In VSMC, the ATI receptor activates at least two 
calcium mechanism as well as protein kinase C (PKC). The ATI receptor is linked to a 
G-protein which can activate phospholipase C thus leading to formation of IP3 and 
subsequent calcium release from internal stores. The ATI receptor has also been shown 
to open channels in the cell membrane to allow an influx of calcium to occur. Activated 
PKC and voltage-gated channels within the membrane can also effect calcium influx. It 
may well be the case that the same increase in intracellular calcium that marks the 
vasoconstrictor response to All induces not only the NO production from NOS 
isoforms, but also the expression of NOS isoforms.
The exact mechanism by which the AH receptor subtypes influence NOS 
expression is not know. The 5’- flanking sequences of eNOS and nNOS have been 
obtained in other molecular studies (39). The nNOS 5’- flanking sequence contains a 
TATA box and two inverted CAAT boxes. Potential binding sites for transcription 
factors are found such as AP-2, transcriptional enhancer factor-1 /M-CAT binding 
factor, CREB (cAMP response element binding protein), ATF (activating transcription 
factor), c-fos, Ets, NF-1 (nuclear factor 1), and nuclear factor kB (NF-kB) (39). The 5’- 
flanking genomic region of eNOS indicates that eNOS is ‘TATA’-less and exhibits
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proximal promoter elements consistent with a constitutively expressed gene in 
endothelial cells such as Spl and GATA motifs (156). The eNOS promoter contains 
consensus sequences for the binding of transcription factors AP-1, AP-2, NF-1, nuclear 
factor IL6 , NF-kB, PEA3, and CREB (39). Upon All receptor activation, the signaling 
cascade may lead to NOS transcription through the activation of such transcription 
factors.
As more data is obtained regarding NO in the preglomerular vasculature of 
either immature or mature kidneys, it seems the regulation of NOS activity is paramount 
in controlling NO production and that expressional control is secondary. In our study 
here, topical administration of All caused an increase in NO production in both the 
newborn and adult kidney. There was a 25% greater NO production in control newborn 
kidney as compare to the adult kidney. In the newborn, AT2 receptor blockade 
attenuated NO production greater than ATI receptor blockade (44% and 31%, 
respectively). In the adult, the opposite occurred. ATI receptor inhibition attenuated NO 
production greater than AT2 receptor inhibition (63% and 34%, respectively). The 
results are in agreement with the results found by Patzak at al. and Thorup et al. in adult 
rodents that All through the ATI receptor regulates NO production (104, 135). 
Furthermore, results from the data in this study may explain why in previous studies 
performed in our lab found that L-NAME caused alterations in newborn but not adult 
renal hemodynamics. The role of NO is enhanced in the newborn and that blockade of 
NOS activity would have an augmented impact on newborn renal hemodynamics.
In the newborn, control and All alone NO production was in the range of 0.15- 
0.20 nanomoles of L-citrulline converted per minute per total nanograms of protein.
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One mechanism through which NO elicits its vasodilatory effect on VSMC is through 
soluble guanylate cyclase (sGC). NO binds to the heme molecule in guanylate cyclase 
thus activating it causing an elevation in levels of cGMP. The effects of cGMP are 
mediated through the receptor proteins for cGMP. There are three major types of 
receptor proteins for cGMP: cGMP-binding phosphodiesterase, cGMP-dependent 
protein kinases, and cGMP-regulated ion channels. Even though cGMP kinases are the 
major receptor proteins expressed in vascular smooth muscle cells and play a large role 
in counterbalancing vasoconstriction with vasodilatation, contributions from 
phosphodiesterases and ion channels cannot be ignored (73). The reported NO 
concentration required for half-maximal activation of sGC is 1.7 nM (50). The range of 
NO production observed in this study is in the range of the required concentration 
needed to activate sGC. The reduced amount of NO produced from All receptor 
inhibition, particularly in the newborn, supports the hypothesis of this study that NOS 
function and NO production are regulated through the ATI and AT2 receptors. The data 
from this study fits with the theory that NO counterbalances All in the immature 
kidney. When All activates All receptors, NO production goes up thus activating sGC 
causing a cascade of events that would counterbalance the All induced constriction of 
the afferent arteriole in the immature kidney. When the All receptors are inhibited, thus 
mimicking decreased levels of All, NO production is reduced and the effects on sGC 
activation are reduced.
The tight regulation of NOS and the production of NO occurs through multiple 
levels including transcription, spatial proximity near the intended target, enzyme 
covalent modifications, and allosteric regulation of the enzymes (82). Spatial proximity
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
135
near the intended target and enzyme covalent modifications seems to be the first line of 
regulation in terms of NO production by NOS enzymes. When NO is required quickly 
to oppose vasoconstriction, as would be the case in vivo in preglomerular resistance 
vessels, a fast working mechanism to turn on NO production would be required. In 
addition, the NO molecule has a very short half life of only 5-6 seconds and can be 
scavenged quickly in the vasculature by hemoglobin, albumin, and reactive oxygen 
species, so it is essential that NOS enzymes be in the most advantageous location 
possible which would be very near the intended target. Also, it’s vital the NOS enzyme 
be localized in the cell where its required substrates are readily available for NO 
production.
Most of eNOS in endothelial cells dock to the plasma membrane in a complex 
with caveolin-1, which serves to inactivate NO production. When endothelial cells are 
activated by increases in intracellular calcium, eNOS disassociates away from the 
caveolin complex and becomes active. The increase in calcium also promotes the 
interaction of eNOS to porin to further augment NO production (97). The early calcium 
dependent activation of eNOS is followed by a late phosphorylation dependent 
activation by protein kinase B/Akt and protein kinase A (18, 29,41). Heat-shock protein 
90 binds eNOS and facilitates calmodulin dependent disruption of eNOS binding with 
caveolin and mediates the interaction between eNOS and protein kinase B/Akt (17, 38, 
49). Heat-shock protein 90 links eNOS to sGC in such cells. Efficient supply with 
substrate during this is ensured by localization of the arginine transporter cationic amino 
transporter (CAT1) in caveolae and its direct interaction with eNOS (93). NOSIP and 
NOSTRIN are two proteins that bind to eNOS and inactivate the enzyme.
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In the perivascular nerve cells, the N-terminus of nNOS binds via PDZ-PDZ 
interaction to postsynaptic density proteins, PSD95 or PSD93, which further couple 
nNOS to N-methyl-D-aspartate (NMDA) receptors (16, 26). This location puts the 
nNOS protein in close proximity to calcium through NMDA glutamate induced calcium 
influx. The PSD95 proteins link nNOS to sGC thus allowing close proximity for NO to 
travel to activate sGC in such cells. Heat shock protein 90 interacts also with nNOS and 
may help facilitate calcium-calmodulin dependent nNOS activation. CAPON is a 
binding protein in neuronal cells that inhibits nNOS when it binds to the enzyme.
Besides protein-protein interactions, direct phosphorylation of the NOS enzymes 
themselves has been found to activate or inactivate the enzymes. Increased 
phosphorylation of the threonine residue at 495 and the serine residue at 633 has been 
shown to decrease NOS catalytic activity. Serine phosphorylation at residues 1177 and 
1179 has been found to increase NO catalytic activity (88). Taken collectively, NO 
production and NOS regulation is a complex issue.
It is essential to ask what is the effect of NO on renin secretion. In some studies, 
NO has been found to both inhibit and enhance renin release (84, 86,144). NO is 
known to inhibit cAMP degradation through cGMP mediated mechanisms. With the 
build up of cAMP, MLC phosphorylation decrease thus decreasing vasoconstriction and 
invoking more renin to be secreted into the vasculature (86). At the same time, calcium 
influx into the cell and the activation of PKC inhibits renin release (86). Overall, NOS 
blockade causes decreases in plasma renin activity and plasma angiotensin II while no 
change occurs in kidney tissue All with an increase in All effects on the renal
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microvasculature (42). The effect of NO on renin secretion still requires further 
investigation.
The studies here demonstrate both All receptor subtypes regulate of NOS 
expression and function in the neonate’s afferent arterioles. ATI and AT2 receptor 
inhibition attenuated eNOS expression in afferent arterioles of kidneys all ages. ATI 
and AT2 receptor inhibition attenuated nNOS expression only in the immature kidney’s 
afferent arteriole. In the immature afferent arterioles, ATI receptor inhibition caused a 
greater attenuation of both eNOS and nNOS expression than did AT2 receptor 
inhibition. nNOS demonstrated increased expression in the afferent arteriole of the 
newborn as compared to the adult, further suggesting the role of nNOS is enhanced in 
the neonate’s preglomerular resistance vessels. NOS enzymatic activity was also 
attenuated by both ATI and AT2 receptor inhibition in both newborn and adult 
afferents. AT2 receptor inhibition caused greater attenuation in NOS activity in the 
afferents of the newborn while ATI receptor inhibition attenuated NOS activity to a 
greater extent in the adult. In all expressional studies, the ATI receptor was shown to 
influence both eNOS or nNOS expression to a greater extent than the AT2 receptor.
This may suggest differing roles between the two receptors during renal maturation 
where the ATI receptor influences NOS expression to a greater extent in the immature 
afferent while the AT2 receptor’s role in the neonate’s afferent may be to modulate 
NOS enzymatic activity. The data provided here supports the hypothesis that in the 
immature renal resistance vasculature, primarily the afferent arteriole, NOS expression 
and function are regulated by All via the ATI and AT2 receptors.




While many studies have been directed towards studying the role of NOS 
isoforms in the adult renal vasculature and the subsequent effect NO has on the adult’s 
renal hemodynamics, to date, no labs have investigated the role of NOS isoforms in 
neonate renal hemodynamics. The renal homodynamic state of the neonate is quite 
different than that of the adult. Systemic blood pressure is lower in the newborn and 
leads to variable effects in the kidney. Autoregulation exists in the newborn kidney but 
is set at a lower perfusion pressure and is less efficient than in the adult.
Tubuloglomerular feedback in the newborn has a lower maximal response and lower 
flow rate than in the adult, thus vasoactive feedback in the newborn is effected as well. 
Nephrogenesis and angiogenesis, complete in some species by birth, continues in the 
porcine kidney after birth. Developmental up and down regulation of various 
vasoconstrictors, vasodilators, and hormones also occurs in the neonate’s developing 
kidney. All these factors work in a complex, dynamic fashion to produce a renal 
hemodynamic state that is unique to the neonate. The unique renal hemodynamic state 
of the neonate predisposes the newborn to develop vasomotor ARF from adverse 
pathologies that further decrease the already low RBF found in the developing kidney, 
such as hypotension and hypoxia of perinatal asphyxia, or complications of prematurity. 
With this in mind, it is critical to gain an understanding into what are the main factors 
that control the renal hemodynamic state of the neonate.
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Previous studies by our lab have indicated unspecific NOS inhibition with L- 
NAME in whole porcine kidneys causes an increase in RVR, with subsequent 
reductions in RBF and GFR in the immature, but not mature, kidney. This finding was 
the first to suggest NOS derived NO plays a more important role in the renal 
hemodynamics of the neonate than in the adult. Other studies found All is the major 
factor that contributes to the enhanced RVR that is observed in the immature kidney.
Our lab investigated the role of NO vasodilation providing counterbalancing to All 
vasoconstriction in whole porcine kidneys and found that in the newborn, blockade of 
the ATI receptor attenuated the response of L-NAME in the newborn, but not in the 
adult kidney. This finding was the first to suggest a developmental interaction between 
All vasoconstriction and NO vasodilation. Our lab continued to study this phenomenon 
by studying the mRNA expression and protein translation of NOS isoforms in the 
kidney during development. Both expressional and translational studies indicated that in 
the immature whole kidney, nNOS and eNOS isoforms were developmentally 
regulated. Whole kidney expressional studies further suggested nNOS may be the major 
NOS isoform responsible for the enhanced role of NO in the immature kidney. These 
previous studies by our lab have indicated NO plays an enhanced role in the renal 
hemodynamics of the neonate as compared to the adult, and that NO works to buffer 
All vasoconstriction, but the mechanism of developmental regulation, which isoform 
does what, the localization of specific NOS isoforms, and the exact relation of 
interaction between All and NO were unknown and required further study.
Based on previous results and preliminary data, the overall hypothesis of this 
dissertation was generated, which was the enhanced vasodilatory role of NO in the
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immature kidney is attributed to regulatory, expressional, and functional differences in 
eNOS and nNOS isoforms from the adult. The objective of the studies in this 
dissertation was to: (1) determine which NOS isoform regulates immature renal 
hemodynamics by using functional whole animal studies utilizing intrarenal infusion of 
NOS inhibitors; (2) continue characterization of NOS expression in specific immature 
renal microstructures utilizing LCM (glomerular eNOS expression); (3) characterize 
developmentally regulated expression and functional patterns of NOS isoforms, renin, 
and ATI and AT2 receptors in the immature preglomerular resistance vasculature 
utilizing novel microdissection techniques; and (4) determine All regulation of NOS 
expression and function in the immature renal vasculature using ATI and AT2 receptor 
inhibitors.
The first study in this dissertation was designed to compare the renal 
hemodynamic responses to the intrarenal infusion of the selective nNOS inhibitor L- 
SMTC with the intrarenal infusion of the non-selective NOS inhibitor L-NAME in both 
the immature kidney of the piglet and the mature kidney of the adult. The intrarenal 
arterial infusion of the nNOS-specific inhibitor, L-SMTC, in the immature piglet 
resulted in significant changes in RBF, GFR and RVR that were similar to those seen 
with L-NAME. However, infusion of L-SMTC in the adult did not alter renal 
hemodynamics or function. The piglet responses to nNOS inhibition were significantly 
greater than the adult pig responses to L-NAME. The responses to inhibition of the 
nNOS isoform seen in only the immature kidney in our experiments suggest a more 
important role for NO produced by nNOS during postnatal renal maturation. The 
findings from these results suggested nNOS was the major NOS isoform contributing to
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the enhanced role of NO in the immature, but not mature, kidney. The findings 
supported the hypothesis of the first series of experiments that nNOS is the major 
isoform regulating renal hemodynamics in the immature, but not in the mature adult 
kidney. The conclusions of the first series of experiments were under basal, physiologic 
conditions, nNOS is an important regulator of renal hemodynamics and function in the 
immature kidney, but not in the adult, and may be the predominate vasoactive NOS 
isoform during postnatal renal maturation.
Our lab had previous started to identify expressional developmental regulation 
of NOS isoforms in specific kidney structures. The macula densa was studied and it was 
found nNOS, the major NOS isoform present within this structure, was developmentally 
regulated in the macula densa. The expression of nNOS was greatest in the newborn 
and progressively decreased with maturation to reach its lowest expressional level in the 
adult. nNOS in the macula densa plays a role in tubuloglomerular feedback. NO derived 
from macula densa nNOS contributes to the vasoactive function of the resistance 
arterioles, the afferent and efferent, but its role appears to be primarily to buffer the 
TGF response, primarily in the afferent arteriole. During the TGF response, All levels 
are increased in the resistance arterioles and nNOS increases NO release from the 
macula densa to buffer All vasoconstriction. When the macula densa senses high levels 
of NaCl, the TGF response of the macula densa cells do not increase the release of renin 
and macula densa nNOS production of NO is reduced. The tubuloglomerular feedback 
mechanism primarily works to insulate the kidney during changes in pressure, thus it 
appears NO derived from macula densa nNOS only plays a role in adjusting the
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filtration load into the tubules and does not play a role in normal continous basal 
physiology of the renal vasculature during development.
At this point, the developmental regulation of NOS in the macula densa was 
established and it was time to investigate NOS in other renal microstructures during 
renal development. The second series of experiments in this dissertation were designed 
to do just that. The second series of experiments were aimed at investigating basal 
eNOS expression and eNOS regulation by All in the glomeruli of the developing 
kidney. Furthermore, the second series of experiments also looked at the differences in 
eNOS expression in glomeruli located in the inner cortex, juxtamedullary glomeruli, as 
compared to the outer cortex, superficial glomeruli. Juxtamedullary glomeruli develop 
before superficial glomeruli during renal maturation so differences in eNOS expression 
were expected. Previous studies have determined nNOS is not present in the glomeruli 
so only eNOS was analyzed in the second series of experiments. The objective of the 
second series of experiments was to compare eNOS gene expression between 
superficial and juxtamedullary glomeruli during both basal conditions and ATI receptor 
inhibition with candesartan using LCM to selectively harvest glomeruli from immature 
and mature porcine kidneys. The hypothesis of the second series of experiments was 
there are greater differences between superficial cortical and juxtamedullary glomerular 
eNOS expression in the immature kidney compared to the adult and that the ATI 
receptor modulates expression of eNOS in the glomeruli of the newborn kidney, but not 
in the adult.
The data in the second series of experiments was able to show eNOS expression 
was much higher in the juxtamedullury glomerui than superficial in the newborn.
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Juxtamedullary glomerular eNOS expression is constant throughout maturation with the 
exception of an expressional decrease at 7 days. eNOS expression in superficial 
glomeruli is initially low in the newborn kidney, but increases in expression two weeks 
after birth. The expression of eNOS in either juxtamedullary or superficial glomeruli is 
regulated by All via the ATI receptor in the newborn, but not in the adult. The results 
of this study support the original hypothesis of this series of experiments. At this point, 
all studies, including whole kidney, macula densa, and glomeruli studies, exhibited 
developmental regulation of both eNOS and nNOS. Such findings support the theory 
that the enhanced role of NO as a critical vasodilator is produced by developmentally 
regulated nNOS and eNOS expression. Functional studies involving whole animals and 
NOS inhibitors in the first series of experiments indicated nNOS was the primary NOS 
isoform that influences neonate renal hemodynamics. Glomerular eNOS may contribute 
to the newborn’s renal hemodynamic state, particularly to counterbalance All 
vasoconstriction, but the major site controlling the neonate’s renal hemodynamics is 
present in the resistance arterioles, particularly in the preglomerular microvessels.
The third series of experiments was aimed at comparing nNOS and eNOS 
expressional and NO functional differences between the preglomerular microvessels, 
including the afferent, interlobular, and arcuate arterioles, of the immature as compared 
to the mature kidney. Previous studies have identified the preglomerular microvessels as 
the primary site of RVR within the kidney. Therefore, vasoactive substances that effect 
RVR in the preglomerular microvessels would have the greatest impact on RBF and 
GFR within these vessels. The highly activated RAS has been shown to maintain the 
high RVR present in the immature preglomerular microvessels. Previous studies by our
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lab have indicated NO produced within the renal microvasculature counterbalance All 
vasoconstriction in the immature kidney. However, regulation and location of NOS 
within the immature renal vasculature was yet to be studied. The objective of the third 
series of experiments was to analyze mRNA expression of nNOS and eNOS along with 
NOS enzymatic catalytic activity in the preglomerular microvessels during renal 
maturation. The hypothesis of the third series of experiments was that the enhanced role 
of NO as a critical vasodilator, counteracting highly activated constrictors such as All 
during postnatal renal maturation, is produced by developmentally regulated nNOS and 
eNOS expression and NO function in the immature renal vasculature, primarily in the 
resistance arterioles. Since it is believed there is an interactive counterbalancing 
between NO and the RAS, components of the RAS, including renin expression and ATI 
and AT2 receptor expression, were also observed and compared.
The results from the first series of experiments in this dissertation indicated 
nNOS was the primary NOS isoform responsible for the enhanced role of NO in the 
immature renal vasculature. The mRNA expressional data from this third series of 
experiments further support the hypothesis that nNOS is the major NOS isoform 
effecting renal hemodynamics in the immature kidney. nNOS expression was greatest in 
all preglomerular microvessels of the newborn and 7 day old immature kidneys, but 
decreased progressively with maturation after spiking at 7 days. The greatest change in 
nNOS expression occurred in the interlobular and arcuate arterioles. Conversely, eNOS 
expression was lowest in the newborn, but slowly increased with maturation. The 
greatest increases in eNOS expression occurred in the afferent and arcuate arterioles. 
This further suggests nNOS is the crucial NOS isoform in the neonate’s renal
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vasculature, while eNOS is the more critical NOS isoform in the adult kidney. The 
results from the NOS enzymatic catalytic activity assay showed NO production was the 
greatest in all preglomerular resistance microvessels of the newborn and 7 day old 
kidneys, and the lowest in the preglomerular resistance vessels of the older, more 
mature, 21 day old and adult kidneys. NO production was greatest in the newborn’s 
interlobular and arcuate arteioles. The results from the NOS enzymatic catalytic activity 
assay are further evidence that NO production within the renal vasculature is enhanced 
in the immature kidney as compared to the mature kidney. Thus, in the newborn when 
eNOS expression is low and nNOS expression is high, the production of NO is the 
greatest further implicating the role of nNOS in the immature renal resistance 
vasculature is augmented.
Previously, it was believed the afferent and interlobular arterioles were the main 
preglomerular microvessels that influence RBF and GFR. The results from this study 
indicate the arcuate arteriole may also play a crucial role in RBF and GFR in the 
neonate. Both nNOS and eNOS expression was also detected in the vasa recta of the 
developing kidney. However, both NOS isoforms were lowest in expression at birth and 
gradually increased with maturation to highest levels in the adult vasa recta. While not 
effecting RBF and GFR, NOS expression in the vasa recta is still of importance because 
dilation and constriction of vasa recta capillaries directly influence the reabsorption of 
substances from the tubules back into the blood in addition to the direct effect NO has 
on reabsorption activity.
Interestingly, the expression of renin paralleled the expression of nNOS in all 
preglomerular resistance vessels at all ages, particularly in the newborn and 7 day old
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
146
immature kidney. Renin expression was greatest in the newborn and spiked at 7 days 
while lowest expression was observed in the adult kidney. Greatest maturational change 
in renin expression occurred in the afferent and interlobular arterioles. ATI receptor 
expression was lowest at birth and progressively increased with maturation with the 
exception of an expressional spike at 7 days. Expression of the AT2 receptor was high 
in the newborn and progressively decreased with maturation, with greatest expression in 
the newborn and 21 day. These results suggest the AT2 receptor may play an enhanced 
role in the newborn while the ATI receptor plays a more crucial role in the adult 
However, at 7 days, AT2 receptor expression decreases significantly before increasing 
again at 14 days. During that period of AT2 receptor downregulation, the ATI receptor 
is upregulated suggesting a cross-talk mechanisms between both receptor subtypes.
Both receptors were expressed heavily in the afferent and interlobular arterioles, 
however, the AT2 receptor was much more abundantly expressed in the arcuate 
arteriole than was the ATI receptor. These results suggest nNOS, eNOS, renin, ATI 
receptor, and AT2 receptor are all developmentally regulated in the immature porcine 
kidney. Furthermore, these studies suggest a developmental interaction between renin 
expression and nNOS expression in preglomerular microvessels. The actions of AC 
may be mediated through primarily the AT2 receptor in the newborn and the ATI 
receptor in the adult while both receptors coodinate to mediate All responses in the 7 
day old kidney. When nNOS expression is high and eNOS expression is low, NO 
production is the greatest in the neonate further suggesting nNOS is the major NOS 
isoform effecting renal hemodynamics in the neonate. Renin expression and All 
receptor expression parallel nNOS expression to a certain degree suggesting an
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interaction between the RAS and nNOS during development. The results here are in 
agreement with the hypothesis of the third series of experiments.
The third series of experiments was able to show developmental regulation 
mRNA expression of NOS isoforms and NO production in the preglomerular 
microvessels with considerable similarities between expression of nNOS and 
components of the RAS. The expression of renin and AT receptors follow the 
developmental pattern associated with high renal vasculature resistance found in the 
immature kidney. The components of RAS also follows the regulation of NOS, 
particularly nNOS, in the immature kidney. NOS enzymatic activity in the 
preglomerular resistance vessels was high in the newborn and decreased with 
maturation. The enhanced role of NO during postnatal maturation maybe produced by 
developmentally regulated NOS expression, particularly nNOS, in the immature renal 
vasculature, primarily the resistance arterioles.
The focus of the forth series of experiments was to investigate the role of NO 
vasodilation regulation by AII since it is believed NO vasodilation counterbalances All 
vasoconstriction. The objective of the forth series of experiments was to determine the 
role of All as a regulator of nNOS and eNOS expression and function of NO production 
in the immature and mature renal resistance arterioles, primarily the afferent arteriole. 
The hypothesis of the forth series of experiments was that in the immature rend 
resistance vasculature, NOS expression and function are regulated by All through the 
ATI and AT2 receptors.
Inhibition of the ATI receptor by candesartan resulted in reduction of eNOS 
expression in afferent arterioles of kidneys of all ages studied, both immature and
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mature. Attenuation o f  eNOS expression was greatest in the newborn where eNOS 
expression was reduced by 96%. Attenuation o f  eNOS expression was comparable in 
afferent arterioles o f  kidneys o f  all other ages studied ranging from 64% to 76% 
reduction in eNOS expression. Inhibition o f  the AT2 receptor by PD 123319 also 
resulted in a decrease o f  eNOS in afferent arterioles o f  kidneys o f  all ages. Again, the 
greatest reduction in eNOS expression was witnessed in the newborn’s afferent arteriole 
with 72% reduction in eNOS expression with AT2 receptor inhibition. Inhibition o f  the 
AT2 receptor in afferent arterioles o f  kidneys at other stages o f  maturation resulted in 
reduction o f  eNOS expression that ranged from 51% to 64%.
The results here demonstrated ATI and AT2 receptor inhibition attenuated 
eNOS expression in afferent arterioles of kidneys all ages. ATI and AT2 receptor 
inhibition attenuated nNOS expression only in the immature kidney’s afferent arteriole. 
In the immature afferent arterioles, ATI receptor inhibition caused a greater attenuation 
of both eNOS and nNOS expression than did AT2 receptor inhibition. NOS enzymatic 
activity was attenuated by both ATI and AT2 receptor inhibition in both newborn and 
adult afferents. AT2 receptor inhibition caused greater attenuation NOS activity in the 
afferents of the newborn than adult.
Interestingly, even when the ATI receptor was low in expression, such as in the 
newborn and 21 day old afferent arterioles, as observed in the third series of 
experiments, inhibition of the ATI receptor still resulted in significant reduction in 
eNOS expression. Similar, even when the AT2 receptor was observed to be reduced in 
expression, as seen in the 7 day old and adult afferent arterioles, as observed in the third
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series of experiments, inhibition of the AT2 receptor still resulted in significant 
reduction in eNOS expression.
Earlier experiments in this dissertation have suggested nNOS is the crucial NOS 
isoform operating within the neonate’s preglomerular resistance vessels working to 
oppose enhanced All activity. It would be expected that All would have an influence on 
nNOS expression in the afferent arterioles of the neonate. The expression of nNOS was 
attenuated in the afferent arterioles to a greater extent by inhibition of the ATI receptor 
than by inhibition of the AT2 receptor. ATI receptor inhibition attenuated nNOS 
expression the greatest in the newborn reducing nNOS expression by 85%. ATI 
receptor inhibition also caused significant nNOS expression attenuation in the 7 day old 
and 21 day old, but not in the adult. AT2 receptor inhibition attenuated nNOS 
expression the greatest in the newborn and 21 day old afferent arterioles reducing nNOS 
expression by 52% and 65%, respectively. However, it was observed that AT2 receptor 
inhibition did not significantly attenuate nNOS expression in the afferent arterioles of 
neither the 7 day old nor the adult. Since basal levels of nNOS in the afferent arterioles 
of the adult are very low and not believed to play a critical role in adult renal 
hemodynamics, the lack of nNOS regulation via the ATI and AT2 receptors should be 
expected. However, it was surprising to see inhibition of the AT2 receptor in the 
afferent arterioles of the 7 day old kidney did not attenuate nNOS expression. While 
results from the third series of experiments in this dissertation indicated AT2 receptor 
expression was low in the 7 day old preglomerular microvessels, the ATI receptor was 
significantly increased in expression at 7 days. This may suggest the ATI receptor is 
unregulated in the 7 day preglomerular microvessels to regulate nNOS expression
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during a period when AT2 receptor expression is low. Based on the studies here, nNOS 
expression is not regulated by All via the AT2 receptor in afferent arterioles of the 7 
day old kidney, a period when AT2 receptor expression is at its lowest in the neonate 
kidney. This suggests a possible cross signaling between the ATI and AT2 receptor in 
the immature kidney vasculature.
Similar to what was seen regarding eNOS expression, at ages when the 
expression of the ATI and AT2 receptor was low, inhibition of either receptor still 
resulted in significant attenuation of nNOS expression. The results in this study indicate 
nNOS expression is regulated by All via both the ATI and AT2 receptors, but the ATI 
receptor, even though decreased in expression in the immature kidney, has greater 
influence on nNOS expression than does the AT2 receptor in the afferent arterioles of 
the developing kidney. It was previously believed the ATI receptor was responsible for 
the vasoconstrictor response to AII while the AT2 elicited the All vasodilation 
response. The results from this study indicate that both receptors regulate the NOS 
vasodilation response to AII stimulation.
The results of the NOS enzymatic catalytic activity assay indicated inhibition of 
either receptor, both ATI and AT2, lead to attenuation of NO production in both the 
newborn and the adult. However, inhibition of the ATI receptor resulted in greater 
reduction of NO production in the adult while inhibition of the AT2 receptor resulted in 
greater attenuation of NO production in the newborn. It appears AII regulates NO 
formation by either receptor in the newborn afferent arteriole, but more so through the 
AT2 receptor. Taken collectively with the expressional data, All regulates eNOS and 
nNOS mRNA expression and NOS enzymatic activity in the afferent arterioles of the
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immature kidney through both ATI and AT2 receptors, but expression is more 
influenced by the ATI receptor, while NOS enzymatic activity is more influenced by 
the AT2 receptor. The results in this forth series of experiments support the hypothesis 
that All regulates NOS expression and function via the ATI and AT2 receptors.
Overall, the studies in this dissertation were able to identify expressional and 
functional developmental patterns for both nNOS and eNOS in the preglomerular 
resistance vessels and glomeruli of the neonate. The expression of eNOS was low in 
both preglomerular vessels and glomeruli in the neonate and progressively increased 
with maturation suggesting eNOS may contribute to the renal hemodynamics of the 
neonate, but is not the critical NOS isoform in the neonate’s vasculature. The 
expression of nNOS, while absent in the glomerulus, was high in the neonate’s 
preglomerular resistance vessels and decreased with maturation suggesting the role of 
nNOS is enhanced in neonate renal hemodynamics. Functional studies showed NO 
production was elevated in all preglomerular vessels of the neonate, with decreased NO 
production occurring with maturation. In the neonate’s preglomerular resistance 
vasculature, when eNOS expression is low and nNOS expression is high, NO 
production is at its greatest. Studies observing All regulation of NOS were able to 
provide evidence that both eNOS and nNOS mRNA expression and NOS enzymatic 
catalytic activity are regulated by All through the ATI and AT2 receptors, particularly 
in the afferent arterioles. Whole animal studies using the NOS unspecific inhibitor L- 
NAME and the nNOS specific inhibitor L-SMTC indicated nNOS is the major NOS 
isoform that is crucial to neonate renal hemodynamics. Thus, both whole animal studies 
utilizing NOS inhibitors and novel microdissection techniques aimed at analyzing
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expression and function of NOS isoforms suggest nNOS is the crucial NOS isoform in 
the immature preglomerular resistance vessels.
Overall conclusions of this dissertation include: nNOS is the major isoform 
regulating renal hemodynamics in the immature, but not the mature, kidney. eNOS 
expression is developmentally regulated in glomeruli with differences found between 
intracortical location of glomeruli. NOS enzymatic activity in preglomerular resistance 
vessels is greater in the newborn than in the adult. This increase in enzymatic activity 
may be due to the upregulation of nNOS expression that was observed in the 
preglomerular resistance vessels. While All regulates eNOS expression and NOS 
enzymatic activity, via the ATI and AT2 receptors, in preglomerular resistance vessels 
of both newborn and adults, nNOS expression is regulated by All only in the newborn.
The significance of the findings in this dissertation ultimately may impact the 
care given to neonates with compromised health conditions. Blockade of All through 
ATI receptor inhibition in the immature kidney significantly downregulates NOS 
expression. This is an important finding for possibly uncovering the role of NO in two 
types of neonatal ARF, ACE inhibitor-related ARF and vasomotor ARF. Angiotensin 
Converting Enzyme, ACE, inhibition has been well described to produce ARP in the 
neonate, in the absence of other mitigating factors. Administration of the Angiotensin 
Converting Enzyme ACE, inhibitor, either prenatally or in the mother or in the neonate 
(139) is associated with oligo-anuric acute renal failure. Until now, the mechanism 
causing the ARP from the perinatal and neonatal use of ACE inhibitors was not well 
understood. The observations that ATI receptor inhibition downregulates NOS in the 
postnatal developing kidney provides a possible pathophysiologic basis for this type of
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neonatal ARP. Perhaps with ACE inhibition, the neonatal kidney loses the upregulatory 
action of All on NOS isoforms resulting in a decrease in NOS expression and function. 
Neonatal ACE downregulation of NOS occurs at a time when NO is a critical modulator 
of renal hemodynamics, thus the immature kidney loses the protective NO vasodilation 
(139). With ACE administration, even though All vasoconstriction is alleviated, other 
highly activated vasoconstrictors operant in the neonatal kidney, such as endothelin, are 
functioning unopposed by NO (14, 120). These findings may not only lead to further 
caution in the use of ACE or ATI receptor antagonists in the newborn, but also direct 
attention to NOS as a possible beneficial factor in preventing or treating this type ARF 
in the newborn.
The newborn kidney is vulnerable to vasomotor ARF from adverse pathologies 
that further decrease RBF, such as the hypotension and hypoxia of perinatal asphyxia, 
or complications of prematurity. These conditions induce an intense renal 
vasoconstriction, considered to be mediated by All, resulting in vasomotor ARF (6,
139). NO vasodilation is vitally protective in this type of ARF. The protective role of 
NO, and its relationship with regulatory factors in vasomotor ARF have not been 
examined. Currently, therapeutic options are limited in the care of the neonate with 
vasomotor acute renal failure from any perinatal cause (139). Thus, studying the 
regulatory relationship of All and NO may lead to the prevention or therapy of neonatal 
vasomotor ARF.
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